id	sid	tid	token	lemma	pos
ijpds-3865	1	1	mandumpala	mandumpala	VERB
ijpds-3865	1	2	a	a	DET
ijpds-3865	1	3	caution	caution	NOUN
ijpds-3865	1	4	for	for	ADP
ijpds-3865	1	5	judicial	judicial	ADJ
ijpds-3865	1	6	antibiotic	antibiotic	ADJ
ijpds-3865	1	7	use	use	NOUN
ijpds-3865	1	8	vol	vol	NOUN
ijpds-3865	1	9	2	2	NUM
ijpds-3865	1	10	|	|	NOUN
ijpds-3865	1	11	issue	issue	NOUN
ijpds-3865	1	12	1	1	NUM
ijpds-3865	2	1	|	|	ADV
ijpds-3865	2	2	jan	jan	PROPN
ijpds-3865	2	3	–	–	PUNCT
ijpds-3865	2	4	mar	mar	PROPN
ijpds-3865	2	5	2023	2023	NUM
ijpds-3865	2	6	indian	indian	PROPN
ijpds-3865	2	7	j	j	PROPN
ijpds-3865	2	8	pharm	pharm	PROPN
ijpds-3865	2	9	drug	drug	PROPN
ijpds-3865	2	10	studies	study	NOUN
ijpds-3865	2	11	|	|	ADV
ijpds-3865	2	12	11	11	NUM
ijpds-3865	2	13	review	review	NOUN
ijpds-3865	2	14	article	article	NOUN
ijpds-3865	2	15	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	2	16	resistance	resistance	PROPN
ijpds-3865	2	17	–	–	PUNCT
ijpds-3865	2	18	a	a	DET
ijpds-3865	2	19	caution	caution	NOUN
ijpds-3865	2	20	for	for	ADP
ijpds-3865	2	21	judicial	judicial	ADJ
ijpds-3865	2	22	antibiotic	antibiotic	ADJ
ijpds-3865	2	23	use	use	NOUN
ijpds-3865	2	24	janice	janice	NOUN
ijpds-3865	2	25	jacson	jacson	NOUN
ijpds-3865	2	26	mandumpala	mandumpala	NOUN
ijpds-3865	2	27	from	from	ADP
ijpds-3865	2	28	,	,	PUNCT
ijpds-3865	2	29	pharm	pharm	NOUN
ijpds-3865	2	30	d	d	PROPN
ijpds-3865	2	31	intern	intern	NOUN
ijpds-3865	2	32	,	,	PUNCT
ijpds-3865	2	33	nirmala	nirmala	PROPN
ijpds-3865	2	34	college	college	PROPN
ijpds-3865	2	35	of	of	ADP
ijpds-3865	2	36	pharmacy	pharmacy	NOUN
ijpds-3865	2	37	,	,	PUNCT
ijpds-3865	2	38	ernakulam	ernakulam	PROPN
ijpds-3865	2	39	,	,	PUNCT
ijpds-3865	2	40	kerala	kerala	PROPN
ijpds-3865	2	41	,	,	PUNCT
ijpds-3865	2	42	india	india	PROPN
ijpds-3865	2	43	corresponding	correspond	VERB
ijpds-3865	2	44	to	to	PART
ijpds-3865	2	45	:	:	PUNCT
ijpds-3865	2	46	janice	janice	VERB
ijpds-3865	2	47	jacson	jacson	PROPN
ijpds-3865	2	48	mandumpala	mandumpala	PROPN
ijpds-3865	2	49	,	,	PUNCT
ijpds-3865	2	50	pharm	pharm	NOUN
ijpds-3865	2	51	d	d	PROPN
ijpds-3865	2	52	intern	intern	NOUN
ijpds-3865	2	53	,	,	PUNCT
ijpds-3865	2	54	department	department	NOUN
ijpds-3865	2	55	of	of	ADP
ijpds-3865	2	56	pharmacy	pharmacy	NOUN
ijpds-3865	2	57	practice	practice	NOUN
ijpds-3865	2	58	,	,	PUNCT
ijpds-3865	2	59	nirmala	nirmala	PROPN
ijpds-3865	2	60	college	college	PROPN
ijpds-3865	2	61	of	of	ADP
ijpds-3865	2	62	pharmacy	pharmacy	NOUN
ijpds-3865	2	63	,	,	PUNCT
ijpds-3865	2	64	ernakulam	ernakulam	PROPN
ijpds-3865	2	65	,	,	PUNCT
ijpds-3865	2	66	kerala	kerala	PROPN
ijpds-3865	2	67	,	,	PUNCT
ijpds-3865	3	1	india	india	PROPN
ijpds-3865	3	2	.	.	PUNCT
ijpds-3865	3	3	email	email	NOUN
ijpds-3865	3	4	:	:	PUNCT
ijpds-3865	3	5	janice.jacson@gmail.com	janice.jacson@gmail.com	X
ijpds-3865	3	6	abstract	abstract	ADJ
ijpds-3865	3	7	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	3	8	is	be	AUX
ijpds-3865	3	9	a	a	DET
ijpds-3865	3	10	broad	broad	ADJ
ijpds-3865	3	11	-	-	PUNCT
ijpds-3865	3	12	spectrum	spectrum	NOUN
ijpds-3865	3	13	antibiotic	antibiotic	NOUN
ijpds-3865	3	14	that	that	PRON
ijpds-3865	3	15	is	be	AUX
ijpds-3865	3	16	effective	effective	ADJ
ijpds-3865	3	17	against	against	ADP
ijpds-3865	3	18	both	both	PRON
ijpds-3865	3	19	gram	gram	NOUN
ijpds-3865	3	20	-	-	PUNCT
ijpds-3865	3	21	negative	negative	ADJ
ijpds-3865	3	22	and	and	CCONJ
ijpds-3865	3	23	gram	gram	NOUN
ijpds-3865	3	24	-	-	PUNCT
ijpds-3865	3	25	positive	positive	ADJ
ijpds-3865	3	26	isolates	isolate	NOUN
ijpds-3865	3	27	.	.	PUNCT
ijpds-3865	4	1	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	4	2	resistance	resistance	PROPN
ijpds-3865	4	3	research	research	NOUN
ijpds-3865	4	4	is	be	AUX
ijpds-3865	4	5	useful	useful	ADJ
ijpds-3865	4	6	in	in	ADP
ijpds-3865	4	7	determining	determine	VERB
ijpds-3865	4	8	its	its	PRON
ijpds-3865	4	9	current	current	ADJ
ijpds-3865	4	10	status	status	NOUN
ijpds-3865	4	11	.	.	PUNCT
ijpds-3865	5	1	as	as	ADP
ijpds-3865	5	2	a	a	DET
ijpds-3865	5	3	result	result	NOUN
ijpds-3865	5	4	,	,	PUNCT
ijpds-3865	5	5	we	we	PRON
ijpds-3865	5	6	aimed	aim	VERB
ijpds-3865	5	7	to	to	PART
ijpds-3865	5	8	understand	understand	VERB
ijpds-3865	5	9	the	the	DET
ijpds-3865	5	10	prevalence	prevalence	NOUN
ijpds-3865	5	11	of	of	ADP
ijpds-3865	5	12	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	5	13	resistance	resistance	NOUN
ijpds-3865	5	14	in	in	ADP
ijpds-3865	5	15	bacteria	bacteria	NOUN
ijpds-3865	5	16	isolated	isolate	VERB
ijpds-3865	5	17	from	from	ADP
ijpds-3865	5	18	various	various	ADJ
ijpds-3865	5	19	clinical	clinical	ADJ
ijpds-3865	5	20	specimens	specimen	NOUN
ijpds-3865	5	21	.	.	PUNCT
ijpds-3865	6	1	resistance	resistance	NOUN
ijpds-3865	6	2	to	to	ADP
ijpds-3865	6	3	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	6	4	has	have	AUX
ijpds-3865	6	5	been	be	AUX
ijpds-3865	6	6	steadily	steadily	ADV
ijpds-3865	6	7	increasing	increase	VERB
ijpds-3865	6	8	and	and	CCONJ
ijpds-3865	6	9	demands	demand	VERB
ijpds-3865	6	10	immediate	immediate	ADJ
ijpds-3865	6	11	attention	attention	NOUN
ijpds-3865	6	12	.	.	PUNCT
ijpds-3865	7	1	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	7	2	resistance	resistance	PROPN
ijpds-3865	7	3	prevention	prevention	NOUN
ijpds-3865	7	4	mechanisms	mechanism	NOUN
ijpds-3865	7	5	must	must	AUX
ijpds-3865	7	6	be	be	AUX
ijpds-3865	7	7	strictly	strictly	ADV
ijpds-3865	7	8	enforced	enforce	VERB
ijpds-3865	7	9	.	.	PUNCT
ijpds-3865	8	1	the	the	DET
ijpds-3865	8	2	appropriate	appropriate	ADJ
ijpds-3865	8	3	drugs	drug	NOUN
ijpds-3865	8	4	should	should	AUX
ijpds-3865	8	5	be	be	AUX
ijpds-3865	8	6	chosen	choose	VERB
ijpds-3865	8	7	based	base	VERB
ijpds-3865	8	8	on	on	ADP
ijpds-3865	8	9	susceptibility	susceptibility	NOUN
ijpds-3865	8	10	patterns	pattern	NOUN
ijpds-3865	8	11	.	.	PUNCT
ijpds-3865	9	1	in	in	ADP
ijpds-3865	9	2	summary	summary	NOUN
ijpds-3865	9	3	,	,	PUNCT
ijpds-3865	9	4	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	9	5	should	should	AUX
ijpds-3865	9	6	be	be	AUX
ijpds-3865	9	7	considered	consider	VERB
ijpds-3865	9	8	in	in	ADP
ijpds-3865	9	9	the	the	DET
ijpds-3865	9	10	initial	initial	ADJ
ijpds-3865	9	11	treatment	treatment	NOUN
ijpds-3865	9	12	of	of	ADP
ijpds-3865	9	13	seriously	seriously	ADV
ijpds-3865	9	14	ill	ill	ADJ
ijpds-3865	9	15	patients	patient	NOUN
ijpds-3865	9	16	with	with	ADP
ijpds-3865	9	17	infections	infection	NOUN
ijpds-3865	9	18	of	of	ADP
ijpds-3865	9	19	unknown	unknown	ADJ
ijpds-3865	9	20	aetiology	aetiology	NOUN
ijpds-3865	9	21	when	when	SCONJ
ijpds-3865	9	22	gram	gram	NOUN
ijpds-3865	9	23	-	-	PUNCT
ijpds-3865	9	24	negative	negative	ADJ
ijpds-3865	9	25	aerobes	aerobe	NOUN
ijpds-3865	9	26	(	(	PUNCT
ijpds-3865	9	27	other	other	ADJ
ijpds-3865	9	28	than	than	ADP
ijpds-3865	9	29	pseudomonas	pseudomona	NOUN
ijpds-3865	9	30	species	specie	NOUN
ijpds-3865	9	31	)	)	PUNCT
ijpds-3865	9	32	are	be	AUX
ijpds-3865	9	33	the	the	DET
ijpds-3865	9	34	suspected	suspect	VERB
ijpds-3865	9	35	pathogens	pathogen	NOUN
ijpds-3865	9	36	,	,	PUNCT
ijpds-3865	9	37	and	and	CCONJ
ijpds-3865	9	38	in	in	ADP
ijpds-3865	9	39	patients	patient	NOUN
ijpds-3865	9	40	with	with	ADP
ijpds-3865	9	41	gram	gram	NOUN
ijpds-3865	9	42	-	-	PUNCT
ijpds-3865	9	43	negative	negative	ADJ
ijpds-3865	9	44	organisms	organism	NOUN
ijpds-3865	9	45	with	with	ADP
ijpds-3865	9	46	suspected	suspect	VERB
ijpds-3865	9	47	or	or	CCONJ
ijpds-3865	9	48	demonstrated	demonstrate	VERB
ijpds-3865	9	49	resistance	resistance	NOUN
ijpds-3865	9	50	to	to	ADP
ijpds-3865	9	51	other	other	ADJ
ijpds-3865	9	52	antibiotics	antibiotic	NOUN
ijpds-3865	9	53	.	.	PUNCT
ijpds-3865	10	1	this	this	DET
ijpds-3865	10	2	review	review	NOUN
ijpds-3865	10	3	summarizes	summarize	VERB
ijpds-3865	10	4	the	the	DET
ijpds-3865	10	5	advent	advent	NOUN
ijpds-3865	10	6	of	of	ADP
ijpds-3865	10	7	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	10	8	resistance	resistance	NOUN
ijpds-3865	10	9	among	among	ADP
ijpds-3865	10	10	various	various	ADJ
ijpds-3865	10	11	organisms	organism	NOUN
ijpds-3865	10	12	across	across	ADP
ijpds-3865	10	13	the	the	DET
ijpds-3865	10	14	globe	globe	NOUN
ijpds-3865	10	15	.	.	PUNCT
ijpds-3865	11	1	keywords	keyword	NOUN
ijpds-3865	11	2	–	–	PUNCT
ijpds-3865	11	3	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	11	4	,	,	PUNCT
ijpds-3865	11	5	resistance	resistance	NOUN
ijpds-3865	11	6	,	,	PUNCT
ijpds-3865	11	7	gonorrhoea	gonorrhoea	NOUN
ijpds-3865	11	8	,	,	PUNCT
ijpds-3865	11	9	salmonella	salmonella	NOUN
ijpds-3865	11	10	,	,	PUNCT
ijpds-3865	11	11	shigella	shigella	PROPN
ijpds-3865	11	12	,	,	PUNCT
ijpds-3865	11	13	aeromonas	aeromona	NOUN
ijpds-3865	11	14	,	,	PUNCT
ijpds-3865	11	15	enterobacter	enterobacter	NOUN
ijpds-3865	11	16	he	he	PRON
ijpds-3865	11	17	third	third	ADJ
ijpds-3865	11	18	-	-	PUNCT
ijpds-3865	11	19	generation	generation	NOUN
ijpds-3865	11	20	cephalosporin	cephalosporin	NOUN
ijpds-3865	11	21	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	11	22	has	have	VERB
ijpds-3865	11	23	good	good	ADJ
ijpds-3865	11	24	effectiveness	effectiveness	NOUN
ijpds-3865	11	25	against	against	ADP
ijpds-3865	11	26	numerous	numerous	ADJ
ijpds-3865	11	27	gram	gram	NOUN
ijpds-3865	11	28	-	-	PUNCT
ijpds-3865	11	29	negative	negative	ADJ
ijpds-3865	11	30	pathogens	pathogen	NOUN
ijpds-3865	11	31	and	and	CCONJ
ijpds-3865	11	32	excellent	excellent	ADJ
ijpds-3865	11	33	activity	activity	NOUN
ijpds-3865	11	34	against	against	ADP
ijpds-3865	11	35	the	the	DET
ijpds-3865	11	36	majority	majority	NOUN
ijpds-3865	11	37	of	of	ADP
ijpds-3865	11	38	gram	gram	NOUN
ijpds-3865	11	39	-	-	PUNCT
ijpds-3865	11	40	positive	positive	ADJ
ijpds-3865	11	41	infections	infection	NOUN
ijpds-3865	11	42	.	.	PUNCT
ijpds-3865	12	1	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	12	2	has	have	VERB
ijpds-3865	12	3	generally	generally	ADV
ijpds-3865	12	4	more	more	ADJ
ijpds-3865	12	5	antibacterial	antibacterial	ADJ
ijpds-3865	12	6	action	action	NOUN
ijpds-3865	12	7	against	against	ADP
ijpds-3865	12	8	gram	gram	NOUN
ijpds-3865	12	9	-	-	PUNCT
ijpds-3865	12	10	negative	negative	ADJ
ijpds-3865	12	11	bacteria	bacteria	NOUN
ijpds-3865	12	12	than	than	ADP
ijpds-3865	12	13	the	the	DET
ijpds-3865	12	14	"	"	PUNCT
ijpds-3865	12	15	first	first	ADJ
ijpds-3865	12	16	"	"	PUNCT
ijpds-3865	12	17	and	and	CCONJ
ijpds-3865	12	18	"	"	PUNCT
ijpds-3865	12	19	second	second	ADJ
ijpds-3865	12	20	generation	generation	NOUN
ijpds-3865	12	21	"	"	PUNCT
ijpds-3865	12	22	cephalosporins	cephalosporin	NOUN
ijpds-3865	12	23	,	,	PUNCT
ijpds-3865	12	24	but	but	CCONJ
ijpds-3865	12	25	less	less	ADV
ijpds-3865	12	26	antibacterial	antibacterial	ADJ
ijpds-3865	12	27	activity	activity	NOUN
ijpds-3865	12	28	than	than	ADP
ijpds-3865	12	29	the	the	DET
ijpds-3865	12	30	previous	previous	ADJ
ijpds-3865	12	31	generations	generation	NOUN
ijpds-3865	12	32	of	of	ADP
ijpds-3865	12	33	cephalosporins	cephalosporin	NOUN
ijpds-3865	12	34	against	against	ADP
ijpds-3865	12	35	numerous	numerous	ADJ
ijpds-3865	12	36	gram	gram	ADJ
ijpds-3865	12	37	-	-	PUNCT
ijpds-3865	12	38	positive	positive	ADJ
ijpds-3865	12	39	bacteria	bacteria	NOUN
ijpds-3865	12	40	.	.	PUNCT
ijpds-3865	13	1	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	13	2	has	have	VERB
ijpds-3865	13	3	a	a	DET
ijpds-3865	13	4	long	long	ADJ
ijpds-3865	13	5	elimination	elimination	NOUN
ijpds-3865	13	6	half	half	ADJ
ijpds-3865	13	7	-	-	PUNCT
ijpds-3865	13	8	life	life	NOUN
ijpds-3865	13	9	,	,	PUNCT
ijpds-3865	13	10	allowing	allow	VERB
ijpds-3865	13	11	for	for	ADP
ijpds-3865	13	12	twice	twice	ADV
ijpds-3865	13	13	and	and	CCONJ
ijpds-3865	13	14	once	once	ADV
ijpds-3865	13	15	-	-	PUNCT
ijpds-3865	13	16	daily	daily	ADJ
ijpds-3865	13	17	treatment	treatment	NOUN
ijpds-3865	13	18	,	,	PUNCT
ijpds-3865	13	19	the	the	DET
ijpds-3865	13	20	latter	latter	ADJ
ijpds-3865	13	21	of	of	ADP
ijpds-3865	13	22	which	which	PRON
ijpds-3865	13	23	may	may	AUX
ijpds-3865	13	24	result	result	VERB
ijpds-3865	13	25	in	in	ADP
ijpds-3865	13	26	significant	significant	ADJ
ijpds-3865	13	27	cost	cost	NOUN
ijpds-3865	13	28	savings	saving	NOUN
ijpds-3865	13	29	.	.	PUNCT
ijpds-3865	14	1	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	14	2	may	may	AUX
ijpds-3865	14	3	replace	replace	VERB
ijpds-3865	14	4	other	other	ADJ
ijpds-3865	14	5	thirdgeneration	thirdgeneration	NOUN
ijpds-3865	14	6	cephalosporins	cephalosporin	NOUN
ijpds-3865	14	7	as	as	ADP
ijpds-3865	14	8	the	the	DET
ijpds-3865	14	9	treatment	treatment	NOUN
ijpds-3865	14	10	of	of	ADP
ijpds-3865	14	11	choice	choice	NOUN
ijpds-3865	14	12	for	for	ADP
ijpds-3865	14	13	a	a	DET
ijpds-3865	14	14	range	range	NOUN
ijpds-3865	14	15	of	of	ADP
ijpds-3865	14	16	serious	serious	ADJ
ijpds-3865	14	17	infections	infection	NOUN
ijpds-3865	14	18	due	due	ADP
ijpds-3865	14	19	to	to	ADP
ijpds-3865	14	20	its	its	PRON
ijpds-3865	14	21	proven	prove	VERB
ijpds-3865	14	22	efficacy	efficacy	NOUN
ijpds-3865	14	23	,	,	PUNCT
ijpds-3865	14	24	safety	safety	NOUN
ijpds-3865	14	25	,	,	PUNCT
ijpds-3865	14	26	and	and	CCONJ
ijpds-3865	14	27	practical	practical	ADJ
ijpds-3865	14	28	dose	dose	NOUN
ijpds-3865	14	29	schedule	schedule	NOUN
ijpds-3865	14	30	[	[	X
ijpds-3865	14	31	1	1	NUM
ijpds-3865	14	32	]	]	PUNCT
ijpds-3865	14	33	.	.	PUNCT
ijpds-3865	15	1	in	in	ADP
ijpds-3865	15	2	patients	patient	NOUN
ijpds-3865	15	3	with	with	ADP
ijpds-3865	15	4	bacterial	bacterial	ADJ
ijpds-3865	15	5	meningitis	meningitis	NOUN
ijpds-3865	15	6	,	,	PUNCT
ijpds-3865	15	7	respiratory	respiratory	ADJ
ijpds-3865	15	8	tract	tract	NOUN
ijpds-3865	15	9	infections	infection	NOUN
ijpds-3865	15	10	,	,	PUNCT
ijpds-3865	15	11	urinary	urinary	ADJ
ijpds-3865	15	12	tract	tract	NOUN
ijpds-3865	15	13	infections	infection	NOUN
ijpds-3865	15	14	,	,	PUNCT
ijpds-3865	15	15	soft	soft	ADJ
ijpds-3865	15	16	tissue	tissue	NOUN
ijpds-3865	15	17	infections	infection	NOUN
ijpds-3865	15	18	of	of	ADP
ijpds-3865	15	19	the	the	DET
ijpds-3865	15	20	bone	bone	NOUN
ijpds-3865	15	21	and	and	CCONJ
ijpds-3865	15	22	joints	joint	NOUN
ijpds-3865	15	23	,	,	PUNCT
ijpds-3865	15	24	and	and	CCONJ
ijpds-3865	15	25	gonorrhoea	gonorrhoea	NOUN
ijpds-3865	15	26	,	,	PUNCT
ijpds-3865	15	27	clinical	clinical	ADJ
ijpds-3865	15	28	investigations	investigation	NOUN
ijpds-3865	15	29	have	have	AUX
ijpds-3865	15	30	shown	show	VERB
ijpds-3865	15	31	their	their	PRON
ijpds-3865	15	32	effectiveness	effectiveness	NOUN
ijpds-3865	15	33	and	and	CCONJ
ijpds-3865	15	34	safety	safety	NOUN
ijpds-3865	15	35	.	.	PUNCT
ijpds-3865	16	1	except	except	SCONJ
ijpds-3865	16	2	for	for	ADP
ijpds-3865	16	3	diarrhea	diarrhea	NOUN
ijpds-3865	16	4	,	,	PUNCT
ijpds-3865	16	5	which	which	PRON
ijpds-3865	16	6	has	have	AUX
ijpds-3865	16	7	often	often	ADV
ijpds-3865	16	8	not	not	PART
ijpds-3865	16	9	necessitated	necessitate	VERB
ijpds-3865	16	10	changing	change	VERB
ijpds-3865	16	11	the	the	DET
ijpds-3865	16	12	course	course	NOUN
ijpds-3865	16	13	of	of	ADP
ijpds-3865	16	14	treatment	treatment	NOUN
ijpds-3865	16	15	,	,	PUNCT
ijpds-3865	16	16	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	16	17	has	have	AUX
ijpds-3865	16	18	been	be	AUX
ijpds-3865	16	19	well	well	ADV
ijpds-3865	16	20	tolerated	tolerate	VERB
ijpds-3865	16	21	.	.	PUNCT
ijpds-3865	17	1	despite	despite	SCONJ
ijpds-3865	17	2	having	have	VERB
ijpds-3865	17	3	modest	modest	ADJ
ijpds-3865	17	4	action	action	NOUN
ijpds-3865	17	5	against	against	ADP
ijpds-3865	17	6	pseudomonas	pseudomona	NOUN
ijpds-3865	17	7	aeruginosa	aeruginosa	NOUN
ijpds-3865	17	8	,	,	PUNCT
ijpds-3865	17	9	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	17	10	is	be	AUX
ijpds-3865	17	11	not	not	PART
ijpds-3865	17	12	currently	currently	ADV
ijpds-3865	17	13	advised	advise	VERB
ijpds-3865	17	14	as	as	ADP
ijpds-3865	17	15	the	the	DET
ijpds-3865	17	16	only	only	ADJ
ijpds-3865	17	17	antibiotic	antibiotic	ADJ
ijpds-3865	17	18	therapy	therapy	NOUN
ijpds-3865	17	19	for	for	ADP
ijpds-3865	17	20	pseudomonal	pseudomonal	ADJ
ijpds-3865	17	21	infections	infection	NOUN
ijpds-3865	17	22	based	base	VERB
ijpds-3865	17	23	on	on	ADP
ijpds-3865	17	24	the	the	DET
ijpds-3865	17	25	available	available	ADJ
ijpds-3865	17	26	data	datum	NOUN
ijpds-3865	17	27	.	.	PUNCT
ijpds-3865	18	1	infections	infection	NOUN
ijpds-3865	18	2	caused	cause	VERB
ijpds-3865	18	3	by	by	ADP
ijpds-3865	18	4	other	other	ADJ
ijpds-3865	18	5	"	"	PUNCT
ijpds-3865	18	6	difficult	difficult	ADJ
ijpds-3865	18	7	"	"	PUNCT
ijpds-3865	18	8	organisms	organism	NOUN
ijpds-3865	18	9	,	,	PUNCT
ijpds-3865	18	10	such	such	ADJ
ijpds-3865	18	11	as	as	ADP
ijpds-3865	18	12	multidrugresistant	multidrugresistant	ADJ
ijpds-3865	18	13	enterobacteriaceae	enterobacteriaceae	PROPN
ijpds-3865	18	14	,	,	PUNCT
ijpds-3865	18	15	have	have	AUX
ijpds-3865	18	16	been	be	AUX
ijpds-3865	18	17	successfully	successfully	ADV
ijpds-3865	18	18	treated	treat	VERB
ijpds-3865	18	19	with	with	ADP
ijpds-3865	18	20	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	18	21	[	[	X
ijpds-3865	18	22	2	2	NUM
ijpds-3865	18	23	]	]	PUNCT
ijpds-3865	18	24	.	.	PUNCT
ijpds-3865	19	1	with	with	ADP
ijpds-3865	19	2	the	the	DET
ijpds-3865	19	3	discovery	discovery	NOUN
ijpds-3865	19	4	of	of	ADP
ijpds-3865	19	5	penicillin	penicillin	NOUN
ijpds-3865	19	6	by	by	ADP
ijpds-3865	19	7	sir	sir	PROPN
ijpds-3865	19	8	alexander	alexander	PROPN
ijpds-3865	19	9	fleming	fleming	PROPN
ijpds-3865	19	10	in	in	ADP
ijpds-3865	19	11	1928	1928	NUM
ijpds-3865	19	12	,	,	PUNCT
ijpds-3865	19	13	the	the	DET
ijpds-3865	19	14	modern	modern	ADJ
ijpds-3865	19	15	era	era	NOUN
ijpds-3865	19	16	of	of	ADP
ijpds-3865	19	17	antibiotics	antibiotic	NOUN
ijpds-3865	19	18	began	begin	VERB
ijpds-3865	19	19	[	[	X
ijpds-3865	19	20	3	3	NUM
ijpds-3865	19	21	]	]	PUNCT
ijpds-3865	19	22	.	.	PUNCT
ijpds-3865	20	1	since	since	SCONJ
ijpds-3865	20	2	that	that	DET
ijpds-3865	20	3	time	time	NOUN
ijpds-3865	20	4	,	,	PUNCT
ijpds-3865	20	5	antibiotics	antibiotic	NOUN
ijpds-3865	20	6	have	have	AUX
ijpds-3865	20	7	revolutionized	revolutionize	VERB
ijpds-3865	20	8	contemporary	contemporary	ADJ
ijpds-3865	20	9	medicine	medicine	NOUN
ijpds-3865	20	10	and	and	CCONJ
ijpds-3865	20	11	helped	help	VERB
ijpds-3865	20	12	save	save	VERB
ijpds-3865	20	13	countless	countless	ADJ
ijpds-3865	20	14	lives	life	NOUN
ijpds-3865	20	15	[	[	X
ijpds-3865	20	16	4	4	NUM
ijpds-3865	20	17	]	]	PUNCT
ijpds-3865	20	18	.	.	PUNCT
ijpds-3865	21	1	in	in	ADP
ijpds-3865	21	2	the	the	DET
ijpds-3865	21	3	1940s	1940	NOUN
ijpds-3865	21	4	,	,	PUNCT
ijpds-3865	21	5	doctors	doctor	NOUN
ijpds-3865	21	6	began	begin	VERB
ijpds-3865	21	7	using	use	VERB
ijpds-3865	21	8	antibiotics	antibiotic	NOUN
ijpds-3865	21	9	to	to	PART
ijpds-3865	21	10	treat	treat	VERB
ijpds-3865	21	11	severe	severe	ADJ
ijpds-3865	21	12	infections	infection	NOUN
ijpds-3865	21	13	.	.	PUNCT
ijpds-3865	22	1	unfortunately	unfortunately	ADV
ijpds-3865	22	2	,	,	PUNCT
ijpds-3865	22	3	almost	almost	ADV
ijpds-3865	22	4	all	all	DET
ijpds-3865	22	5	antibiotics	antibiotic	NOUN
ijpds-3865	22	6	that	that	PRON
ijpds-3865	22	7	have	have	AUX
ijpds-3865	22	8	been	be	AUX
ijpds-3865	22	9	produced	produce	VERB
ijpds-3865	22	10	have	have	AUX
ijpds-3865	22	11	eventually	eventually	ADV
ijpds-3865	22	12	been	be	AUX
ijpds-3865	22	13	associated	associate	VERB
ijpds-3865	22	14	with	with	ADP
ijpds-3865	22	15	resistance	resistance	NOUN
ijpds-3865	22	16	,	,	PUNCT
ijpds-3865	22	17	and	and	CCONJ
ijpds-3865	22	18	this	this	PRON
ijpds-3865	22	19	is	be	AUX
ijpds-3865	22	20	also	also	ADV
ijpds-3865	22	21	true	true	ADJ
ijpds-3865	22	22	of	of	ADP
ijpds-3865	22	23	cephalosporins	cephalosporin	NOUN
ijpds-3865	22	24	,	,	PUNCT
ijpds-3865	22	25	notably	notably	ADV
ijpds-3865	22	26	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	23	1	[	[	X
ijpds-3865	23	2	5	5	NUM
ijpds-3865	23	3	]	]	PUNCT
ijpds-3865	23	4	.	.	PUNCT
ijpds-3865	24	1	mechanism	mechanism	NOUN
ijpds-3865	24	2	of	of	ADP
ijpds-3865	24	3	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	24	4	resistance	resistance	PROPN
ijpds-3865	24	5	development	development	NOUN
ijpds-3865	24	6	there	there	PRON
ijpds-3865	24	7	are	be	VERB
ijpds-3865	24	8	multiple	multiple	ADJ
ijpds-3865	24	9	mechanisms	mechanism	NOUN
ijpds-3865	24	10	that	that	PRON
ijpds-3865	24	11	infectious	infectious	ADJ
ijpds-3865	24	12	agents	agent	NOUN
ijpds-3865	24	13	use	use	VERB
ijpds-3865	24	14	to	to	PART
ijpds-3865	24	15	resist	resist	VERB
ijpds-3865	24	16	the	the	DET
ijpds-3865	24	17	lethal	lethal	ADJ
ijpds-3865	24	18	action	action	NOUN
ijpds-3865	24	19	of	of	ADP
ijpds-3865	24	20	antibiotics	antibiotic	NOUN
ijpds-3865	24	21	such	such	ADJ
ijpds-3865	24	22	as	as	ADP
ijpds-3865	24	23	mutational	mutational	ADJ
ijpds-3865	24	24	resistance	resistance	NOUN
ijpds-3865	24	25	,	,	PUNCT
ijpds-3865	24	26	acquisition	acquisition	NOUN
ijpds-3865	24	27	of	of	ADP
ijpds-3865	24	28	genetic	genetic	ADJ
ijpds-3865	24	29	material	material	NOUN
ijpds-3865	24	30	,	,	PUNCT
ijpds-3865	24	31	increased	increase	VERB
ijpds-3865	24	32	drug	drug	NOUN
ijpds-3865	24	33	efflux	efflux	NOUN
ijpds-3865	24	34	or	or	CCONJ
ijpds-3865	24	35	,	,	PUNCT
ijpds-3865	24	36	decreased	decrease	VERB
ijpds-3865	24	37	drug	drug	NOUN
ijpds-3865	24	38	intake	intake	NOUN
ijpds-3865	25	1	[	[	X
ijpds-3865	25	2	6	6	NUM
ijpds-3865	25	3	]	]	PUNCT
ijpds-3865	25	4	.	.	PUNCT
ijpds-3865	26	1	other	other	ADJ
ijpds-3865	26	2	complex	complex	ADJ
ijpds-3865	26	3	mechanisms	mechanism	NOUN
ijpds-3865	26	4	involve	involve	VERB
ijpds-3865	26	5	are	be	AUX
ijpds-3865	26	6	biofilm	biofilm	NOUN
ijpds-3865	26	7	formation	formation	NOUN
ijpds-3865	26	8	and	and	CCONJ
ijpds-3865	26	9	quorum	quorum	NOUN
ijpds-3865	27	1	[	[	X
ijpds-3865	27	2	7	7	NUM
ijpds-3865	27	3	]	]	PUNCT
ijpds-3865	27	4	.	.	PUNCT
ijpds-3865	28	1	quorum	quorum	VERB
ijpds-3865	28	2	sensing	sense	VERB
ijpds-3865	28	3	and	and	CCONJ
ijpds-3865	28	4	biofilm	biofilm	NOUN
ijpds-3865	28	5	formation	formation	NOUN
ijpds-3865	28	6	is	be	AUX
ijpds-3865	28	7	the	the	DET
ijpds-3865	28	8	common	common	ADJ
ijpds-3865	28	9	mechanism	mechanism	NOUN
ijpds-3865	28	10	for	for	ADP
ijpds-3865	28	11	antibiotic	antibiotic	ADJ
ijpds-3865	28	12	resistance	resistance	NOUN
ijpds-3865	28	13	among	among	ADP
ijpds-3865	28	14	e.	e.	PROPN
ijpds-3865	28	15	coli	coli	PROPN
ijpds-3865	28	16	.	.	PUNCT
ijpds-3865	29	1	in	in	ADP
ijpds-3865	29	2	this	this	PRON
ijpds-3865	29	3	,	,	PUNCT
ijpds-3865	29	4	the	the	DET
ijpds-3865	29	5	cells	cell	NOUN
ijpds-3865	29	6	adhere	adhere	VERB
ijpds-3865	29	7	to	to	ADP
ijpds-3865	29	8	each	each	DET
ijpds-3865	29	9	other	other	ADJ
ijpds-3865	29	10	on	on	ADP
ijpds-3865	29	11	their	their	PRON
ijpds-3865	29	12	surface	surface	NOUN
ijpds-3865	29	13	using	use	VERB
ijpds-3865	29	14	a	a	DET
ijpds-3865	29	15	self	self	NOUN
ijpds-3865	29	16	-	-	PUNCT
ijpds-3865	29	17	produced	produce	VERB
ijpds-3865	29	18	matrix	matrix	NOUN
ijpds-3865	29	19	called	call	VERB
ijpds-3865	29	20	the	the	DET
ijpds-3865	29	21	extra	extra	ADJ
ijpds-3865	29	22	polymeric	polymeric	ADJ
ijpds-3865	29	23	substance	substance	NOUN
ijpds-3865	29	24	.	.	PUNCT
ijpds-3865	30	1	this	this	DET
ijpds-3865	30	2	extra	extra	ADJ
ijpds-3865	30	3	polymeric	polymeric	ADJ
ijpds-3865	30	4	substance	substance	NOUN
ijpds-3865	30	5	creates	create	VERB
ijpds-3865	30	6	a	a	DET
ijpds-3865	30	7	barrier	barrier	NOUN
ijpds-3865	30	8	for	for	ADP
ijpds-3865	30	9	the	the	DET
ijpds-3865	30	10	antibiotic	antibiotic	NOUN
ijpds-3865	30	11	to	to	PART
ijpds-3865	30	12	enter	enter	VERB
ijpds-3865	30	13	the	the	DET
ijpds-3865	30	14	bacteria	bacteria	NOUN
ijpds-3865	30	15	,	,	PUNCT
ijpds-3865	30	16	this	this	PRON
ijpds-3865	30	17	promotes	promote	VERB
ijpds-3865	30	18	the	the	DET
ijpds-3865	30	19	emergence	emergence	NOUN
ijpds-3865	30	20	of	of	ADP
ijpds-3865	30	21	antibiotic	antibiotic	ADJ
ijpds-3865	30	22	resistance	resistance	NOUN
ijpds-3865	30	23	and	and	CCONJ
ijpds-3865	30	24	this	this	PRON
ijpds-3865	30	25	is	be	AUX
ijpds-3865	30	26	referred	refer	VERB
ijpds-3865	30	27	to	to	ADP
ijpds-3865	30	28	as	as	ADP
ijpds-3865	30	29	quorum	quorum	NOUN
ijpds-3865	30	30	sensing	sense	VERB
ijpds-3865	30	31	[	[	X
ijpds-3865	30	32	8	8	NUM
ijpds-3865	30	33	]	]	PUNCT
ijpds-3865	30	34	.	.	PUNCT
ijpds-3865	31	1	however	however	ADV
ijpds-3865	31	2	,	,	PUNCT
ijpds-3865	31	3	this	this	DET
ijpds-3865	31	4	mechanism	mechanism	NOUN
ijpds-3865	31	5	may	may	AUX
ijpds-3865	31	6	not	not	PART
ijpds-3865	31	7	be	be	AUX
ijpds-3865	31	8	applicable	applicable	ADJ
ijpds-3865	31	9	to	to	AUX
ijpds-3865	31	10	gonococci	gonococci	VERB
ijpds-3865	31	11	.	.	PUNCT
ijpds-3865	32	1	gonococci	gonococci	PROPN
ijpds-3865	32	2	develop	develop	VERB
ijpds-3865	32	3	resistance	resistance	NOUN
ijpds-3865	32	4	to	to	ADP
ijpds-3865	32	5	beta	beta	NOUN
ijpds-3865	32	6	-	-	PUNCT
ijpds-3865	32	7	lactam	lactam	NOUN
ijpds-3865	32	8	antibiotics	antibiotic	NOUN
ijpds-3865	32	9	primarily	primarily	ADV
ijpds-3865	32	10	by	by	ADP
ijpds-3865	32	11	two	two	NUM
ijpds-3865	32	12	mechanisms	mechanism	NOUN
ijpds-3865	32	13	–	–	PUNCT
ijpds-3865	32	14	one	one	NOUN
ijpds-3865	32	15	that	that	PRON
ijpds-3865	32	16	is	be	AUX
ijpds-3865	32	17	quickly	quickly	ADV
ijpds-3865	32	18	acquired	acquire	VERB
ijpds-3865	32	19	through	through	ADP
ijpds-3865	32	20	the	the	DET
ijpds-3865	32	21	transfer	transfer	NOUN
ijpds-3865	32	22	of	of	ADP
ijpds-3865	32	23	resistance	resistance	NOUN
ijpds-3865	32	24	plasmid	plasmid	NOUN
ijpds-3865	32	25	that	that	PRON
ijpds-3865	32	26	produces	produce	VERB
ijpds-3865	32	27	betalactamases	betalactamase	NOUN
ijpds-3865	32	28	and	and	CCONJ
ijpds-3865	32	29	the	the	DET
ijpds-3865	32	30	second	second	ADJ
ijpds-3865	32	31	one	one	NOUN
ijpds-3865	32	32	is	be	AUX
ijpds-3865	32	33	the	the	DET
ijpds-3865	32	34	gradual	gradual	ADJ
ijpds-3865	32	35	acquisition	acquisition	NOUN
ijpds-3865	32	36	of	of	ADP
ijpds-3865	32	37	multiple	multiple	ADJ
ijpds-3865	32	38	resistance	resistance	NOUN
ijpds-3865	32	39	genes	gene	NOUN
ijpds-3865	32	40	that	that	PRON
ijpds-3865	32	41	promotes	promote	VERB
ijpds-3865	32	42	beta	beta	NOUN
ijpds-3865	32	43	-	-	PUNCT
ijpds-3865	32	44	lactam	lactam	NOUN
ijpds-3865	32	45	resistance	resistance	NOUN
ijpds-3865	33	1	[	[	X
ijpds-3865	33	2	9	9	NUM
ijpds-3865	33	3	]	]	PUNCT
ijpds-3865	33	4	.	.	PUNCT
ijpds-3865	34	1	the	the	DET
ijpds-3865	34	2	production	production	NOUN
ijpds-3865	34	3	of	of	ADP
ijpds-3865	34	4	extended	extend	VERB
ijpds-3865	34	5	-	-	PUNCT
ijpds-3865	34	6	spectrum	spectrum	NOUN
ijpds-3865	34	7	beta	beta	NOUN
ijpds-3865	34	8	-	-	PUNCT
ijpds-3865	34	9	lactamases	lactamase	NOUN
ijpds-3865	34	10	is	be	AUX
ijpds-3865	34	11	the	the	DET
ijpds-3865	34	12	most	most	ADV
ijpds-3865	34	13	commonly	commonly	ADV
ijpds-3865	34	14	attributed	attribute	VERB
ijpds-3865	34	15	mechanism	mechanism	NOUN
ijpds-3865	34	16	of	of	ADP
ijpds-3865	34	17	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	34	18	t	t	PROPN
ijpds-3865	34	19	mailto:janice.jacson@gmail.com	mailto:janice.jacson@gmail.com	PROPN
ijpds-3865	34	20	mandumpala	mandumpala	NOUN
ijpds-3865	34	21	a	a	DET
ijpds-3865	34	22	caution	caution	NOUN
ijpds-3865	34	23	for	for	ADP
ijpds-3865	34	24	judicial	judicial	ADJ
ijpds-3865	34	25	antibiotic	antibiotic	ADJ
ijpds-3865	34	26	use	use	NOUN
ijpds-3865	34	27	vol	vol	NOUN
ijpds-3865	34	28	2	2	NUM
ijpds-3865	34	29	|	|	NOUN
ijpds-3865	34	30	issue	issue	NOUN
ijpds-3865	34	31	1	1	NUM
ijpds-3865	34	32	|	|	ADV
ijpds-3865	34	33	jan	jan	PROPN
ijpds-3865	34	34	–	–	PUNCT
ijpds-3865	34	35	mar	mar	PROPN
ijpds-3865	34	36	2023	2023	NUM
ijpds-3865	34	37	indian	indian	PROPN
ijpds-3865	34	38	j	j	PROPN
ijpds-3865	34	39	pharm	pharm	PROPN
ijpds-3865	34	40	drug	drug	PROPN
ijpds-3865	34	41	studies	study	NOUN
ijpds-3865	34	42	|	|	ADV
ijpds-3865	34	43	12	12	NUM
ijpds-3865	34	44	resistance	resistance	NOUN
ijpds-3865	34	45	in	in	ADP
ijpds-3865	34	46	e.coli	e.coli	NOUN
ijpds-3865	34	47	[	[	X
ijpds-3865	34	48	10	10	NUM
ijpds-3865	34	49	]	]	PUNCT
ijpds-3865	34	50	.	.	PUNCT
ijpds-3865	35	1	additionally	additionally	ADV
ijpds-3865	35	2	,	,	PUNCT
ijpds-3865	35	3	a	a	DET
ijpds-3865	35	4	molecular	molecular	ADJ
ijpds-3865	35	5	analysis	analysis	NOUN
ijpds-3865	35	6	of	of	ADP
ijpds-3865	35	7	salmonella	salmonella	NOUN
ijpds-3865	35	8	isolates	isolate	NOUN
ijpds-3865	35	9	with	with	ADP
ijpds-3865	35	10	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	35	11	resistance	resistance	NOUN
ijpds-3865	35	12	has	have	AUX
ijpds-3865	35	13	demonstrated	demonstrate	VERB
ijpds-3865	35	14	a	a	DET
ijpds-3865	35	15	higher	high	ADJ
ijpds-3865	35	16	production	production	NOUN
ijpds-3865	35	17	of	of	ADP
ijpds-3865	35	18	the	the	DET
ijpds-3865	35	19	cmy-2	cmy-2	NOUN
ijpds-3865	35	20	and	and	CCONJ
ijpds-3865	35	21	the	the	DET
ijpds-3865	35	22	ctxm-3	ctxm-3	NUM
ijpds-3865	35	23	beta	beta	NOUN
ijpds-3865	35	24	-	-	PUNCT
ijpds-3865	35	25	lactamases	lactamase	NOUN
ijpds-3865	35	26	[	[	X
ijpds-3865	35	27	11	11	NUM
ijpds-3865	35	28	]	]	PUNCT
ijpds-3865	35	29	.	.	PUNCT
ijpds-3865	36	1	on	on	ADP
ijpds-3865	36	2	the	the	DET
ijpds-3865	36	3	other	other	ADJ
ijpds-3865	36	4	hand	hand	NOUN
ijpds-3865	36	5	,	,	PUNCT
ijpds-3865	36	6	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	36	7	resistance	resistance	NOUN
ijpds-3865	36	8	in	in	ADP
ijpds-3865	36	9	neisseria	neisseria	PROPN
ijpds-3865	36	10	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	36	11	is	be	AUX
ijpds-3865	36	12	a	a	DET
ijpds-3865	36	13	result	result	NOUN
ijpds-3865	36	14	of	of	ADP
ijpds-3865	36	15	chromosomally	chromosomally	ADV
ijpds-3865	36	16	mediated	mediate	VERB
ijpds-3865	36	17	mutations	mutation	NOUN
ijpds-3865	36	18	at	at	ADP
ijpds-3865	36	19	the	the	DET
ijpds-3865	36	20	three	three	NUM
ijpds-3865	36	21	loci	locus	NOUN
ijpds-3865	36	22	of	of	ADP
ijpds-3865	36	23	pena	pena	NOUN
ijpds-3865	36	24	,	,	PUNCT
ijpds-3865	36	25	mtrr	mtrr	NOUN
ijpds-3865	36	26	,	,	PUNCT
ijpds-3865	36	27	and	and	CCONJ
ijpds-3865	36	28	penb	penb	VERB
ijpds-3865	36	29	[	[	X
ijpds-3865	36	30	12	12	NUM
ijpds-3865	36	31	]	]	PUNCT
ijpds-3865	36	32	.	.	PUNCT
ijpds-3865	37	1	furthermore	furthermore	ADV
ijpds-3865	37	2	,	,	PUNCT
ijpds-3865	37	3	the	the	DET
ijpds-3865	37	4	production	production	NOUN
ijpds-3865	37	5	of	of	ADP
ijpds-3865	37	6	cephalosporinases	cephalosporinase	NOUN
ijpds-3865	37	7	also	also	ADV
ijpds-3865	37	8	degrades	degrade	VERB
ijpds-3865	37	9	cephalosporins	cephalosporin	NOUN
ijpds-3865	37	10	and	and	CCONJ
ijpds-3865	37	11	this	this	PRON
ijpds-3865	37	12	is	be	AUX
ijpds-3865	37	13	one	one	NUM
ijpds-3865	37	14	such	such	ADJ
ijpds-3865	37	15	mechanism	mechanism	NOUN
ijpds-3865	37	16	that	that	PRON
ijpds-3865	37	17	promoted	promote	VERB
ijpds-3865	37	18	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	37	19	resistance	resistance	NOUN
ijpds-3865	37	20	among	among	ADP
ijpds-3865	37	21	salmonella	salmonella	NOUN
ijpds-3865	37	22	species	specie	NOUN
ijpds-3865	37	23	.	.	PUNCT
ijpds-3865	38	1	since	since	SCONJ
ijpds-3865	38	2	extended	extend	VERB
ijpds-3865	38	3	-	-	PUNCT
ijpds-3865	38	4	spectrum	spectrum	NOUN
ijpds-3865	38	5	beta	beta	NOUN
ijpds-3865	38	6	-	-	PUNCT
ijpds-3865	38	7	lactamases	lactamase	NOUN
ijpds-3865	38	8	are	be	AUX
ijpds-3865	38	9	mobile	mobile	ADJ
ijpds-3865	38	10	genetic	genetic	ADJ
ijpds-3865	38	11	materials	material	NOUN
ijpds-3865	38	12	and	and	CCONJ
ijpds-3865	38	13	bacteria	bacteria	NOUN
ijpds-3865	38	14	can	can	AUX
ijpds-3865	38	15	acquire	acquire	VERB
ijpds-3865	38	16	them	they	PRON
ijpds-3865	38	17	through	through	ADP
ijpds-3865	38	18	horizontal	horizontal	ADJ
ijpds-3865	38	19	gene	gene	NOUN
ijpds-3865	38	20	transfer	transfer	NOUN
ijpds-3865	38	21	from	from	ADP
ijpds-3865	38	22	resistant	resistant	ADJ
ijpds-3865	38	23	bacteria	bacteria	NOUN
ijpds-3865	38	24	,	,	PUNCT
ijpds-3865	38	25	sensitive	sensitive	ADJ
ijpds-3865	38	26	bacteria	bacteria	NOUN
ijpds-3865	38	27	can	can	AUX
ijpds-3865	38	28	acquire	acquire	VERB
ijpds-3865	38	29	resistance	resistance	NOUN
ijpds-3865	38	30	to	to	ADP
ijpds-3865	38	31	cephalosporins	cephalosporin	NOUN
ijpds-3865	38	32	[	[	X
ijpds-3865	38	33	13	13	NUM
ijpds-3865	38	34	]	]	PUNCT
ijpds-3865	38	35	.	.	PUNCT
ijpds-3865	39	1	also	also	ADV
ijpds-3865	39	2	,	,	PUNCT
ijpds-3865	39	3	several	several	ADJ
ijpds-3865	39	4	studies	study	NOUN
ijpds-3865	39	5	on	on	ADP
ijpds-3865	39	6	the	the	DET
ijpds-3865	39	7	mechanism	mechanism	NOUN
ijpds-3865	39	8	of	of	ADP
ijpds-3865	39	9	resistance	resistance	NOUN
ijpds-3865	39	10	to	to	ADP
ijpds-3865	39	11	third	third	ADJ
ijpds-3865	39	12	-	-	PUNCT
ijpds-3865	39	13	generation	generation	NOUN
ijpds-3865	39	14	cephalosporins	cephalosporin	NOUN
ijpds-3865	39	15	,	,	PUNCT
ijpds-3865	39	16	particularly	particularly	ADV
ijpds-3865	39	17	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	39	18	have	have	AUX
ijpds-3865	39	19	suggested	suggest	VERB
ijpds-3865	39	20	that	that	SCONJ
ijpds-3865	39	21	clinical	clinical	ADJ
ijpds-3865	39	22	strains	strain	NOUN
ijpds-3865	39	23	of	of	ADP
ijpds-3865	39	24	enterobacter	enterobacter	ADJ
ijpds-3865	39	25	cloacae	cloacae	NOUN
ijpds-3865	39	26	are	be	AUX
ijpds-3865	39	27	linked	link	VERB
ijpds-3865	39	28	to	to	ADP
ijpds-3865	39	29	the	the	DET
ijpds-3865	39	30	excessive	excessive	ADJ
ijpds-3865	39	31	production	production	NOUN
ijpds-3865	39	32	of	of	ADP
ijpds-3865	39	33	chromosomal	chromosomal	ADJ
ijpds-3865	39	34	beta	beta	NOUN
ijpds-3865	39	35	-	-	PUNCT
ijpds-3865	39	36	lactamases	lactamase	NOUN
ijpds-3865	39	37	[	[	X
ijpds-3865	39	38	10	10	NUM
ijpds-3865	39	39	,	,	PUNCT
ijpds-3865	39	40	14	14	NUM
ijpds-3865	39	41	]	]	PUNCT
ijpds-3865	39	42	.	.	PUNCT
ijpds-3865	40	1	neisseria	neisseria	PROPN
ijpds-3865	40	2	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	40	3	antimicrobial	antimicrobial	ADJ
ijpds-3865	40	4	resistance	resistance	NOUN
ijpds-3865	40	5	in	in	ADP
ijpds-3865	40	6	neisseria	neisseria	PROPN
ijpds-3865	40	7	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	40	8	is	be	AUX
ijpds-3865	40	9	a	a	DET
ijpds-3865	40	10	major	major	ADJ
ijpds-3865	40	11	public	public	ADJ
ijpds-3865	40	12	health	health	NOUN
ijpds-3865	40	13	concern	concern	NOUN
ijpds-3865	40	14	globally	globally	ADV
ijpds-3865	40	15	.	.	PUNCT
ijpds-3865	41	1	the	the	DET
ijpds-3865	41	2	most	most	ADV
ijpds-3865	41	3	frequently	frequently	ADV
ijpds-3865	41	4	prescribed	prescribe	VERB
ijpds-3865	41	5	antibiotics	antibiotic	NOUN
ijpds-3865	41	6	for	for	ADP
ijpds-3865	41	7	gonorrhoea	gonorrhoea	NOUN
ijpds-3865	41	8	are	be	AUX
ijpds-3865	41	9	ceftriaxone	ceftriaxone	ADJ
ijpds-3865	41	10	,	,	PUNCT
ijpds-3865	41	11	cefixime	cefixime	NOUN
ijpds-3865	41	12	,	,	PUNCT
ijpds-3865	41	13	azithromycin	azithromycin	NOUN
ijpds-3865	41	14	,	,	PUNCT
ijpds-3865	41	15	spectinomycin	spectinomycin	PROPN
ijpds-3865	41	16	,	,	PUNCT
ijpds-3865	41	17	ciprofloxacin	ciprofloxacin	NOUN
ijpds-3865	41	18	,	,	PUNCT
ijpds-3865	41	19	and	and	CCONJ
ijpds-3865	41	20	ofloxacin	ofloxacin	PROPN
ijpds-3865	41	21	.	.	PUNCT
ijpds-3865	42	1	neisseria	neisseria	PROPN
ijpds-3865	42	2	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	42	3	was	be	AUX
ijpds-3865	42	4	initially	initially	ADV
ijpds-3865	42	5	susceptible	susceptible	ADJ
ijpds-3865	42	6	to	to	ADP
ijpds-3865	42	7	the	the	DET
ijpds-3865	42	8	majority	majority	NOUN
ijpds-3865	42	9	of	of	ADP
ijpds-3865	42	10	antimicrobials	antimicrobial	NOUN
ijpds-3865	42	11	since	since	SCONJ
ijpds-3865	42	12	the	the	DET
ijpds-3865	42	13	mid-1930s	mid-1930s	NUM
ijpds-3865	42	14	[	[	X
ijpds-3865	42	15	15	15	NUM
ijpds-3865	42	16	,	,	PUNCT
ijpds-3865	42	17	16	16	NUM
ijpds-3865	42	18	]	]	PUNCT
ijpds-3865	42	19	.	.	PUNCT
ijpds-3865	43	1	but	but	CCONJ
ijpds-3865	43	2	recently	recently	ADV
ijpds-3865	43	3	the	the	DET
ijpds-3865	43	4	resistant	resistant	ADJ
ijpds-3865	43	5	patterns	pattern	NOUN
ijpds-3865	43	6	in	in	ADP
ijpds-3865	43	7	neisseria	neisseria	PROPN
ijpds-3865	43	8	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	43	9	have	have	AUX
ijpds-3865	43	10	developed	develop	VERB
ijpds-3865	43	11	owing	owe	VERB
ijpds-3865	43	12	to	to	ADP
ijpds-3865	43	13	its	its	PRON
ijpds-3865	43	14	ability	ability	NOUN
ijpds-3865	43	15	to	to	PART
ijpds-3865	43	16	develop	develop	VERB
ijpds-3865	43	17	or	or	CCONJ
ijpds-3865	43	18	acquire	acquire	VERB
ijpds-3865	43	19	antimicrobial	antimicrobial	ADJ
ijpds-3865	43	20	resistance	resistance	NOUN
ijpds-3865	43	21	through	through	ADP
ijpds-3865	43	22	most	most	ADJ
ijpds-3865	43	23	of	of	ADP
ijpds-3865	43	24	the	the	DET
ijpds-3865	43	25	existing	exist	VERB
ijpds-3865	43	26	mechanisms	mechanism	NOUN
ijpds-3865	43	27	.	.	PUNCT
ijpds-3865	44	1	a	a	DET
ijpds-3865	44	2	few	few	ADJ
ijpds-3865	44	3	examples	example	NOUN
ijpds-3865	44	4	of	of	ADP
ijpds-3865	44	5	the	the	DET
ijpds-3865	44	6	mechanisms	mechanism	NOUN
ijpds-3865	44	7	neisseria	neisseria	X
ijpds-3865	44	8	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	44	9	undergo	undergo	VERB
ijpds-3865	44	10	to	to	PART
ijpds-3865	44	11	cater	cater	VERB
ijpds-3865	44	12	to	to	ADP
ijpds-3865	44	13	antimicrobial	antimicrobial	ADJ
ijpds-3865	44	14	resistance	resistance	NOUN
ijpds-3865	44	15	are	be	AUX
ijpds-3865	44	16	as	as	SCONJ
ijpds-3865	44	17	follows	follow	VERB
ijpds-3865	44	18	–	–	PUNCT
ijpds-3865	44	19	inactivation	inactivation	NOUN
ijpds-3865	44	20	,	,	PUNCT
ijpds-3865	44	21	degradation	degradation	NOUN
ijpds-3865	44	22	of	of	ADP
ijpds-3865	44	23	antimicrobials	antimicrobial	NOUN
ijpds-3865	44	24	,	,	PUNCT
ijpds-3865	44	25	alteration	alteration	NOUN
ijpds-3865	44	26	of	of	ADP
ijpds-3865	44	27	the	the	DET
ijpds-3865	44	28	target	target	NOUN
ijpds-3865	44	29	antimicrobial	antimicrobial	ADJ
ijpds-3865	44	30	,	,	PUNCT
ijpds-3865	44	31	decreased	decrease	VERB
ijpds-3865	44	32	antimicrobial	antimicrobial	ADJ
ijpds-3865	44	33	influx	influx	NOUN
ijpds-3865	44	34	,	,	PUNCT
ijpds-3865	44	35	and	and	CCONJ
ijpds-3865	44	36	increased	increase	VERB
ijpds-3865	44	37	generation	generation	NOUN
ijpds-3865	44	38	of	of	ADP
ijpds-3865	44	39	efflux	efflux	ADJ
ijpds-3865	44	40	transporters	transporter	NOUN
ijpds-3865	44	41	.	.	PUNCT
ijpds-3865	45	1	resistance	resistance	NOUN
ijpds-3865	45	2	of	of	ADP
ijpds-3865	45	3	neisseria	neisseria	PROPN
ijpds-3865	45	4	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	45	5	to	to	ADP
ijpds-3865	45	6	fluoroquinolones	fluoroquinolone	NOUN
ijpds-3865	45	7	and	and	CCONJ
ijpds-3865	45	8	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	45	9	came	come	VERB
ijpds-3865	45	10	into	into	ADP
ijpds-3865	45	11	prominence	prominence	NOUN
ijpds-3865	45	12	after	after	ADP
ijpds-3865	45	13	its	its	PRON
ijpds-3865	45	14	first	first	ADJ
ijpds-3865	45	15	appearance	appearance	NOUN
ijpds-3865	45	16	in	in	ADP
ijpds-3865	45	17	japan	japan	PROPN
ijpds-3865	45	18	which	which	PRON
ijpds-3865	45	19	then	then	ADV
ijpds-3865	45	20	further	far	ADV
ijpds-3865	45	21	spread	spread	VERB
ijpds-3865	45	22	globally	globally	ADV
ijpds-3865	45	23	[	[	X
ijpds-3865	45	24	17	17	NUM
ijpds-3865	45	25	-	-	SYM
ijpds-3865	45	26	20	20	NUM
ijpds-3865	45	27	]	]	PUNCT
ijpds-3865	45	28	.	.	PUNCT
ijpds-3865	46	1	furthermore	furthermore	ADV
ijpds-3865	46	2	,	,	PUNCT
ijpds-3865	46	3	the	the	DET
ijpds-3865	46	4	first	first	ADJ
ijpds-3865	46	5	global	global	ADJ
ijpds-3865	46	6	failure	failure	NOUN
ijpds-3865	46	7	for	for	ADP
ijpds-3865	46	8	treating	treat	VERB
ijpds-3865	46	9	pharyngeal	pharyngeal	ADJ
ijpds-3865	46	10	gonorrhoea	gonorrhoea	NOUN
ijpds-3865	46	11	with	with	ADP
ijpds-3865	46	12	dual	dual	ADJ
ijpds-3865	46	13	antibiotics	antibiotic	NOUN
ijpds-3865	46	14	(	(	PUNCT
ijpds-3865	46	15	both	both	PRON
ijpds-3865	46	16	500	500	NUM
ijpds-3865	46	17	mg	mg	PROPN
ijpds-3865	46	18	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	46	19	and	and	CCONJ
ijpds-3865	46	20	1	1	NUM
ijpds-3865	46	21	g	g	NOUN
ijpds-3865	46	22	azithromycin	azithromycin	NOUN
ijpds-3865	46	23	)	)	PUNCT
ijpds-3865	46	24	was	be	AUX
ijpds-3865	46	25	first	first	ADV
ijpds-3865	46	26	reported	report	VERB
ijpds-3865	46	27	in	in	ADP
ijpds-3865	46	28	the	the	DET
ijpds-3865	46	29	united	united	ADJ
ijpds-3865	46	30	kingdom	kingdom	NOUN
ijpds-3865	46	31	in	in	ADP
ijpds-3865	46	32	2016	2016	NUM
ijpds-3865	46	33	[	[	X
ijpds-3865	46	34	21	21	NUM
ijpds-3865	46	35	]	]	PUNCT
ijpds-3865	46	36	.	.	PUNCT
ijpds-3865	47	1	dual	dual	ADJ
ijpds-3865	47	2	therapy	therapy	NOUN
ijpds-3865	47	3	has	have	AUX
ijpds-3865	47	4	been	be	AUX
ijpds-3865	47	5	instituted	institute	VERB
ijpds-3865	47	6	due	due	ADP
ijpds-3865	47	7	to	to	ADP
ijpds-3865	47	8	the	the	DET
ijpds-3865	47	9	emerging	emerge	VERB
ijpds-3865	47	10	resistance	resistance	NOUN
ijpds-3865	47	11	patterns	pattern	NOUN
ijpds-3865	47	12	,	,	PUNCT
ijpds-3865	47	13	but	but	CCONJ
ijpds-3865	47	14	countries	country	NOUN
ijpds-3865	47	15	such	such	ADJ
ijpds-3865	47	16	as	as	ADP
ijpds-3865	47	17	japan	japan	PROPN
ijpds-3865	47	18	,	,	PUNCT
ijpds-3865	47	19	china	china	PROPN
ijpds-3865	47	20	,	,	PUNCT
ijpds-3865	47	21	azerbaijan	azerbaijan	PROPN
ijpds-3865	47	22	,	,	PUNCT
ijpds-3865	47	23	netherlands	netherlands	PROPN
ijpds-3865	47	24	,	,	PUNCT
ijpds-3865	47	25	belarus	belarus	PROPN
ijpds-3865	47	26	,	,	PUNCT
ijpds-3865	47	27	and	and	CCONJ
ijpds-3865	47	28	ukraine	ukraine	NOUN
ijpds-3865	47	29	still	still	ADV
ijpds-3865	47	30	use	use	VERB
ijpds-3865	47	31	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	47	32	500mg-1	500mg-1	NUM
ijpds-3865	47	33	g	g	NOUN
ijpds-3865	47	34	as	as	ADP
ijpds-3865	47	35	empirical	empirical	ADJ
ijpds-3865	47	36	mono	mono	NOUN
ijpds-3865	47	37	-	-	PUNCT
ijpds-3865	47	38	therapy	therapy	NOUN
ijpds-3865	47	39	[	[	X
ijpds-3865	47	40	22	22	NUM
ijpds-3865	47	41	-	-	SYM
ijpds-3865	47	42	24	24	NUM
ijpds-3865	47	43	]	]	PUNCT
ijpds-3865	47	44	.	.	PUNCT
ijpds-3865	48	1	with	with	ADP
ijpds-3865	48	2	the	the	DET
ijpds-3865	48	3	evolving	evolve	VERB
ijpds-3865	48	4	resistance	resistance	NOUN
ijpds-3865	48	5	patterns	pattern	NOUN
ijpds-3865	48	6	,	,	PUNCT
ijpds-3865	48	7	what	what	PRON
ijpds-3865	48	8	are	be	AUX
ijpds-3865	48	9	the	the	DET
ijpds-3865	48	10	options	option	NOUN
ijpds-3865	48	11	available	available	ADJ
ijpds-3865	48	12	to	to	ADP
ijpds-3865	48	13	the	the	DET
ijpds-3865	48	14	medical	medical	ADJ
ijpds-3865	48	15	community	community	NOUN
ijpds-3865	48	16	?	?	PUNCT
ijpds-3865	49	1	repurposing	repurpose	VERB
ijpds-3865	49	2	the	the	DET
ijpds-3865	49	3	old	old	ADJ
ijpds-3865	49	4	antimicrobials	antimicrobial	NOUN
ijpds-3865	49	5	,	,	PUNCT
ijpds-3865	49	6	use	use	NOUN
ijpds-3865	49	7	of	of	ADP
ijpds-3865	49	8	newer	new	ADJ
ijpds-3865	49	9	antimicrobials	antimicrobial	NOUN
ijpds-3865	49	10	with	with	ADP
ijpds-3865	49	11	mainly	mainly	ADV
ijpds-3865	49	12	nonhuman	nonhuman	ADJ
ijpds-3865	49	13	or	or	CCONJ
ijpds-3865	49	14	invitro	invitro	ADJ
ijpds-3865	49	15	data	datum	NOUN
ijpds-3865	49	16	availability	availability	NOUN
ijpds-3865	49	17	,	,	PUNCT
ijpds-3865	49	18	and	and	CCONJ
ijpds-3865	49	19	novel	novel	ADJ
ijpds-3865	49	20	antibiotics	antibiotic	NOUN
ijpds-3865	49	21	in	in	ADP
ijpds-3865	49	22	clinical	clinical	ADJ
ijpds-3865	49	23	trials	trial	NOUN
ijpds-3865	49	24	.	.	PUNCT
ijpds-3865	50	1	spectinomycin	spectinomycin	PROPN
ijpds-3865	50	2	is	be	AUX
ijpds-3865	50	3	a	a	DET
ijpds-3865	50	4	long	long	ADV
ijpds-3865	50	5	-	-	PUNCT
ijpds-3865	50	6	used	use	VERB
ijpds-3865	50	7	antimicrobial	antimicrobial	NOUN
ijpds-3865	50	8	for	for	ADP
ijpds-3865	50	9	gonorrhoea	gonorrhoea	NOUN
ijpds-3865	50	10	with	with	ADP
ijpds-3865	50	11	excellent	excellent	ADJ
ijpds-3865	50	12	susceptibility	susceptibility	NOUN
ijpds-3865	50	13	,	,	PUNCT
ijpds-3865	50	14	but	but	CCONJ
ijpds-3865	50	15	relatively	relatively	ADV
ijpds-3865	50	16	lower	low	ADJ
ijpds-3865	50	17	success	success	NOUN
ijpds-3865	50	18	in	in	ADP
ijpds-3865	50	19	treating	treat	VERB
ijpds-3865	50	20	pharyngeal	pharyngeal	ADJ
ijpds-3865	50	21	gonorrhoea	gonorrhoea	NOUN
ijpds-3865	50	22	[	[	X
ijpds-3865	50	23	25	25	NUM
ijpds-3865	50	24	]	]	PUNCT
ijpds-3865	50	25	.	.	PUNCT
ijpds-3865	51	1	therefore	therefore	ADV
ijpds-3865	51	2	,	,	PUNCT
ijpds-3865	51	3	spectinomycin	spectinomycin	PROPN
ijpds-3865	51	4	can	can	AUX
ijpds-3865	51	5	be	be	AUX
ijpds-3865	51	6	used	use	VERB
ijpds-3865	51	7	as	as	ADP
ijpds-3865	51	8	a	a	DET
ijpds-3865	51	9	part	part	NOUN
ijpds-3865	51	10	of	of	ADP
ijpds-3865	51	11	the	the	DET
ijpds-3865	51	12	dual	dual	ADJ
ijpds-3865	51	13	regimen	regiman	NOUN
ijpds-3865	51	14	along	along	ADP
ijpds-3865	51	15	with	with	ADP
ijpds-3865	51	16	azithromycin	azithromycin	PROPN
ijpds-3865	51	17	to	to	PART
ijpds-3865	51	18	prevent	prevent	VERB
ijpds-3865	51	19	the	the	DET
ijpds-3865	51	20	emergence	emergence	NOUN
ijpds-3865	51	21	of	of	ADP
ijpds-3865	51	22	antimicrobialresistant	antimicrobialresistant	ADJ
ijpds-3865	51	23	strains	strain	NOUN
ijpds-3865	51	24	[	[	X
ijpds-3865	51	25	26	26	NUM
ijpds-3865	51	26	]	]	PUNCT
ijpds-3865	51	27	.	.	PUNCT
ijpds-3865	52	1	new	new	ADJ
ijpds-3865	52	2	antimicrobials	antimicrobial	NOUN
ijpds-3865	52	3	with	with	ADP
ijpds-3865	52	4	only	only	ADJ
ijpds-3865	52	5	non	non	ADJ
ijpds-3865	52	6	-	-	ADJ
ijpds-3865	52	7	human	human	ADJ
ijpds-3865	52	8	evidence	evidence	NOUN
ijpds-3865	52	9	have	have	AUX
ijpds-3865	52	10	demonstrated	demonstrate	VERB
ijpds-3865	52	11	relative	relative	ADJ
ijpds-3865	52	12	potency	potency	NOUN
ijpds-3865	52	13	against	against	ADP
ijpds-3865	52	14	neisseria	neisseria	NOUN
ijpds-3865	52	15	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	52	16	and	and	CCONJ
ijpds-3865	52	17	include	include	VERB
ijpds-3865	52	18	avarofloxacin	avarofloxacin	ADP
ijpds-3865	52	19	,	,	PUNCT
ijpds-3865	52	20	delafloxacin	delafloxacin	PROPN
ijpds-3865	52	21	,	,	PUNCT
ijpds-3865	52	22	sitafloxacin	sitafloxacin	PROPN
ijpds-3865	52	23	,	,	PUNCT
ijpds-3865	52	24	tigecycline	tigecycline	ADV
ijpds-3865	52	25	,	,	PUNCT
ijpds-3865	52	26	2	2	NUM
ijpds-3865	52	27	-	-	PUNCT
ijpds-3865	52	28	acyl	acyl	NOUN
ijpds-3865	52	29	carbapenems	carbapenem	NOUN
ijpds-3865	52	30	and	and	CCONJ
ijpds-3865	52	31	many	many	ADJ
ijpds-3865	52	32	others	other	NOUN
ijpds-3865	52	33	which	which	PRON
ijpds-3865	52	34	have	have	AUX
ijpds-3865	52	35	been	be	AUX
ijpds-3865	52	36	reviewed	review	VERB
ijpds-3865	52	37	elsewhere	elsewhere	ADV
ijpds-3865	52	38	[	[	X
ijpds-3865	52	39	27	27	NUM
ijpds-3865	52	40	-	-	SYM
ijpds-3865	52	41	29	29	NUM
ijpds-3865	52	42	]	]	PUNCT
ijpds-3865	52	43	.	.	PUNCT
ijpds-3865	53	1	however	however	ADV
ijpds-3865	53	2	,	,	PUNCT
ijpds-3865	53	3	many	many	ADJ
ijpds-3865	53	4	of	of	ADP
ijpds-3865	53	5	them	they	PRON
ijpds-3865	53	6	are	be	AUX
ijpds-3865	53	7	in	in	ADP
ijpds-3865	53	8	stages	stage	NOUN
ijpds-3865	53	9	of	of	ADP
ijpds-3865	53	10	early	early	ADJ
ijpds-3865	53	11	development	development	NOUN
ijpds-3865	53	12	thus	thus	ADV
ijpds-3865	53	13	posing	pose	VERB
ijpds-3865	53	14	a	a	DET
ijpds-3865	53	15	challenge	challenge	NOUN
ijpds-3865	53	16	for	for	ADP
ijpds-3865	53	17	their	their	PRON
ijpds-3865	53	18	use	use	NOUN
ijpds-3865	53	19	within	within	ADP
ijpds-3865	53	20	the	the	DET
ijpds-3865	53	21	clinical	clinical	ADJ
ijpds-3865	53	22	setting	setting	NOUN
ijpds-3865	53	23	.	.	PUNCT
ijpds-3865	54	1	three	three	NUM
ijpds-3865	54	2	antimicrobials	antimicrobial	NOUN
ijpds-3865	54	3	solithromycin	solithromycin	NOUN
ijpds-3865	54	4	,	,	PUNCT
ijpds-3865	54	5	zoliflodacin	zoliflodacin	PROPN
ijpds-3865	54	6	,	,	PUNCT
ijpds-3865	54	7	and	and	CCONJ
ijpds-3865	54	8	gepotidacin	gepotidacin	PROPN
ijpds-3865	54	9	are	be	AUX
ijpds-3865	54	10	novel	novel	NOUN
ijpds-3865	54	11	orally	orally	ADV
ijpds-3865	54	12	administered	administer	VERB
ijpds-3865	54	13	drugs	drug	NOUN
ijpds-3865	54	14	in	in	ADP
ijpds-3865	54	15	clinical	clinical	ADJ
ijpds-3865	54	16	evaluation	evaluation	NOUN
ijpds-3865	54	17	for	for	ADP
ijpds-3865	54	18	uncomplicated	uncomplicated	ADJ
ijpds-3865	54	19	gonorrhoea	gonorrhoea	NOUN
ijpds-3865	54	20	and	and	CCONJ
ijpds-3865	54	21	particularly	particularly	ADV
ijpds-3865	54	22	zoliflodacin	zoliflodacin	PROPN
ijpds-3865	54	23	appears	appear	VERB
ijpds-3865	54	24	very	very	ADV
ijpds-3865	54	25	promising	promising	ADJ
ijpds-3865	54	26	and	and	CCONJ
ijpds-3865	54	27	requires	require	VERB
ijpds-3865	54	28	attention	attention	NOUN
ijpds-3865	54	29	[	[	X
ijpds-3865	54	30	30	30	NUM
ijpds-3865	54	31	]	]	SYM
ijpds-3865	54	32	.	.	PUNCT
ijpds-3865	55	1	until	until	ADP
ijpds-3865	55	2	a	a	DET
ijpds-3865	55	3	promising	promising	ADJ
ijpds-3865	55	4	new	new	ADJ
ijpds-3865	55	5	effective	effective	ADJ
ijpds-3865	55	6	treatments	treatment	NOUN
ijpds-3865	55	7	,	,	PUNCT
ijpds-3865	55	8	rational	rational	ADJ
ijpds-3865	55	9	use	use	NOUN
ijpds-3865	55	10	of	of	ADP
ijpds-3865	55	11	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	55	12	and	and	CCONJ
ijpds-3865	55	13	azithromycin	azithromycin	PROPN
ijpds-3865	55	14	will	will	AUX
ijpds-3865	55	15	help	help	VERB
ijpds-3865	55	16	treat	treat	VERB
ijpds-3865	55	17	gonorrhoea	gonorrhoea	NOUN
ijpds-3865	55	18	with	with	ADP
ijpds-3865	55	19	its	its	PRON
ijpds-3865	55	20	severe	severe	ADJ
ijpds-3865	55	21	complications	complication	NOUN
ijpds-3865	55	22	.	.	PUNCT
ijpds-3865	56	1	aeromonas	aeromonas	PROPN
ijpds-3865	56	2	spp	spp	PROPN
ijpds-3865	56	3	.	.	PUNCT
ijpds-3865	57	1	aeromonas	aeromonas	PROPN
ijpds-3865	57	2	species	species	PROPN
ijpds-3865	57	3	can	can	AUX
ijpds-3865	57	4	cause	cause	VERB
ijpds-3865	57	5	a	a	DET
ijpds-3865	57	6	wide	wide	ADJ
ijpds-3865	57	7	spectrum	spectrum	NOUN
ijpds-3865	57	8	of	of	ADP
ijpds-3865	57	9	intestinal	intestinal	ADJ
ijpds-3865	57	10	and	and	CCONJ
ijpds-3865	57	11	extra	extra	ADJ
ijpds-3865	57	12	-	-	ADJ
ijpds-3865	57	13	intestinal	intestinal	ADJ
ijpds-3865	57	14	infections	infection	NOUN
ijpds-3865	57	15	(	(	PUNCT
ijpds-3865	57	16	gastrointestinal	gastrointestinal	ADJ
ijpds-3865	57	17	tract	tract	NOUN
ijpds-3865	57	18	syndromes	syndrome	NOUN
ijpds-3865	57	19	,	,	PUNCT
ijpds-3865	57	20	wound	wound	NOUN
ijpds-3865	57	21	and	and	CCONJ
ijpds-3865	57	22	soft	soft	ADJ
ijpds-3865	57	23	tissue	tissue	NOUN
ijpds-3865	57	24	infections	infection	NOUN
ijpds-3865	57	25	,	,	PUNCT
ijpds-3865	57	26	urinary	urinary	ADJ
ijpds-3865	57	27	tract	tract	NOUN
ijpds-3865	57	28	infections	infection	NOUN
ijpds-3865	57	29	,	,	PUNCT
ijpds-3865	57	30	and	and	CCONJ
ijpds-3865	57	31	rarely	rarely	ADV
ijpds-3865	57	32	septicaemia	septicaemia	NOUN
ijpds-3865	57	33	)	)	PUNCT
ijpds-3865	58	1	[	[	X
ijpds-3865	58	2	31	31	NUM
ijpds-3865	58	3	]	]	PUNCT
ijpds-3865	58	4	.	.	PUNCT
ijpds-3865	59	1	they	they	PRON
ijpds-3865	59	2	are	be	AUX
ijpds-3865	59	3	gram	gram	NOUN
ijpds-3865	59	4	-	-	PUNCT
ijpds-3865	59	5	negative	negative	ADJ
ijpds-3865	59	6	rods	rod	NOUN
ijpds-3865	59	7	,	,	PUNCT
ijpds-3865	59	8	facultative	facultative	ADJ
ijpds-3865	59	9	anaerobes	anaerobe	NOUN
ijpds-3865	59	10	and	and	CCONJ
ijpds-3865	59	11	oxidase	oxidase	NOUN
ijpds-3865	59	12	-	-	PUNCT
ijpds-3865	59	13	positive	positive	ADJ
ijpds-3865	59	14	.	.	PUNCT
ijpds-3865	60	1	aeromonas	aeromonas	PROPN
ijpds-3865	60	2	species	specie	VERB
ijpds-3865	60	3	that	that	PRON
ijpds-3865	60	4	are	be	AUX
ijpds-3865	60	5	pathogenic	pathogenic	ADJ
ijpds-3865	60	6	for	for	ADP
ijpds-3865	60	7	humans	human	NOUN
ijpds-3865	60	8	include	include	VERB
ijpds-3865	60	9	aeromonas	aeromonas	PROPN
ijpds-3865	60	10	hydrophila	hydrophila	PROPN
ijpds-3865	60	11	,	,	PUNCT
ijpds-3865	60	12	aeromonas	aeromonas	PROPN
ijpds-3865	60	13	sobria	sobria	PROPN
ijpds-3865	60	14	,	,	PUNCT
ijpds-3865	60	15	aeromonas	aeromonas	PROPN
ijpds-3865	60	16	trota	trota	NOUN
ijpds-3865	60	17	,	,	PUNCT
ijpds-3865	60	18	and	and	CCONJ
ijpds-3865	60	19	aeromonas	aeromonas	PROPN
ijpds-3865	60	20	caviae	caviae	NOUN
ijpds-3865	60	21	and	and	CCONJ
ijpds-3865	60	22	are	be	AUX
ijpds-3865	60	23	most	most	ADV
ijpds-3865	60	24	commonly	commonly	ADV
ijpds-3865	60	25	found	find	VERB
ijpds-3865	60	26	in	in	ADP
ijpds-3865	60	27	the	the	DET
ijpds-3865	60	28	aquactic	aquactic	ADJ
ijpds-3865	60	29	life	life	NOUN
ijpds-3865	60	30	forms	form	NOUN
ijpds-3865	60	31	particularly	particularly	ADV
ijpds-3865	60	32	fishes	fish	NOUN
ijpds-3865	60	33	[	[	X
ijpds-3865	60	34	32	32	NUM
ijpds-3865	60	35	,	,	PUNCT
ijpds-3865	60	36	33	33	NUM
ijpds-3865	60	37	]	]	PUNCT
ijpds-3865	60	38	.	.	PUNCT
ijpds-3865	61	1	the	the	DET
ijpds-3865	61	2	sensitivity	sensitivity	NOUN
ijpds-3865	61	3	of	of	ADP
ijpds-3865	61	4	aeromonas	aeromonas	PROPN
ijpds-3865	61	5	can	can	AUX
ijpds-3865	61	6	vary	vary	VERB
ijpds-3865	61	7	based	base	VERB
ijpds-3865	61	8	on	on	ADP
ijpds-3865	61	9	geographical	geographical	ADJ
ijpds-3865	61	10	location	location	NOUN
ijpds-3865	61	11	and	and	CCONJ
ijpds-3865	61	12	diversity	diversity	NOUN
ijpds-3865	61	13	.	.	PUNCT
ijpds-3865	62	1	the	the	DET
ijpds-3865	62	2	most	most	ADV
ijpds-3865	62	3	common	common	ADJ
ijpds-3865	62	4	antibiotics	antibiotic	NOUN
ijpds-3865	62	5	employed	employ	VERB
ijpds-3865	62	6	for	for	ADP
ijpds-3865	62	7	aeromonas	aeromonas	PROPN
ijpds-3865	62	8	infections	infection	NOUN
ijpds-3865	62	9	are	be	AUX
ijpds-3865	62	10	fluoroquinolones	fluoroquinolone	NOUN
ijpds-3865	62	11	and	and	CCONJ
ijpds-3865	62	12	tetracyclines	tetracycline	NOUN
ijpds-3865	62	13	.	.	PUNCT
ijpds-3865	63	1	furthermore	furthermore	ADV
ijpds-3865	63	2	,	,	PUNCT
ijpds-3865	63	3	thirdgeneration	thirdgeneration	NOUN
ijpds-3865	63	4	cephalosporins	cephalosporin	NOUN
ijpds-3865	63	5	have	have	AUX
ijpds-3865	63	6	also	also	ADV
ijpds-3865	63	7	been	be	AUX
ijpds-3865	63	8	recommended	recommend	VERB
ijpds-3865	63	9	but	but	CCONJ
ijpds-3865	63	10	in	in	ADP
ijpds-3865	63	11	recent	recent	ADJ
ijpds-3865	63	12	years	year	NOUN
ijpds-3865	63	13	,	,	PUNCT
ijpds-3865	63	14	there	there	PRON
ijpds-3865	63	15	has	have	AUX
ijpds-3865	63	16	been	be	AUX
ijpds-3865	63	17	an	an	DET
ijpds-3865	63	18	upward	upward	ADJ
ijpds-3865	63	19	trend	trend	NOUN
ijpds-3865	63	20	for	for	ADP
ijpds-3865	63	21	resistance	resistance	NOUN
ijpds-3865	63	22	to	to	ADP
ijpds-3865	63	23	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	63	24	attributed	attribute	VERB
ijpds-3865	63	25	to	to	ADP
ijpds-3865	63	26	the	the	DET
ijpds-3865	63	27	beta	beta	NOUN
ijpds-3865	63	28	-	-	PUNCT
ijpds-3865	63	29	lactamase	lactamase	NOUN
ijpds-3865	63	30	activity	activity	NOUN
ijpds-3865	63	31	of	of	ADP
ijpds-3865	63	32	aeromonas	aeromonas	PROPN
ijpds-3865	63	33	[	[	X
ijpds-3865	63	34	34	34	NUM
ijpds-3865	63	35	]	]	PUNCT
ijpds-3865	63	36	.	.	PUNCT
ijpds-3865	64	1	aeromonas	aeromonas	PROPN
ijpds-3865	64	2	has	have	AUX
ijpds-3865	64	3	been	be	AUX
ijpds-3865	64	4	linked	link	VERB
ijpds-3865	64	5	to	to	ADP
ijpds-3865	64	6	the	the	DET
ijpds-3865	64	7	development	development	NOUN
ijpds-3865	64	8	of	of	ADP
ijpds-3865	64	9	betalactamases	betalactamase	NOUN
ijpds-3865	64	10	(	(	PUNCT
ijpds-3865	64	11	esbls	esbls	PROPN
ijpds-3865	64	12	,	,	PUNCT
ijpds-3865	64	13	ampcbls	ampcbls	ADJ
ijpds-3865	64	14	,	,	PUNCT
ijpds-3865	64	15	and	and	CCONJ
ijpds-3865	64	16	carbapenemases	carbapenemase	NOUN
ijpds-3865	64	17	)	)	PUNCT
ijpds-3865	64	18	,	,	PUNCT
ijpds-3865	64	19	efflux	efflux	VERB
ijpds-3865	64	20	pumps	pump	NOUN
ijpds-3865	64	21	,	,	PUNCT
ijpds-3865	64	22	and	and	CCONJ
ijpds-3865	64	23	changes	change	NOUN
ijpds-3865	64	24	in	in	ADP
ijpds-3865	64	25	the	the	DET
ijpds-3865	64	26	outer	outer	ADJ
ijpds-3865	64	27	membrane	membrane	NOUN
ijpds-3865	64	28	that	that	PRON
ijpds-3865	64	29	result	result	VERB
ijpds-3865	64	30	in	in	ADP
ijpds-3865	64	31	decreased	decrease	VERB
ijpds-3865	64	32	permeability	permeability	NOUN
ijpds-3865	64	33	as	as	ADP
ijpds-3865	64	34	the	the	DET
ijpds-3865	64	35	mechanisms	mechanism	NOUN
ijpds-3865	64	36	of	of	ADP
ijpds-3865	64	37	resistance	resistance	NOUN
ijpds-3865	64	38	to	to	ADP
ijpds-3865	64	39	third	third	ADJ
ijpds-3865	64	40	-	-	PUNCT
ijpds-3865	64	41	generation	generation	NOUN
ijpds-3865	64	42	cephalosporins	cephalosporin	NOUN
ijpds-3865	64	43	.	.	PUNCT
ijpds-3865	65	1	aeromonas	aeromonas	PROPN
ijpds-3865	65	2	is	be	AUX
ijpds-3865	65	3	known	know	VERB
ijpds-3865	65	4	to	to	PART
ijpds-3865	65	5	carry	carry	VERB
ijpds-3865	65	6	various	various	ADJ
ijpds-3865	65	7	drug	drug	NOUN
ijpds-3865	65	8	-	-	PUNCT
ijpds-3865	65	9	resistance	resistance	NOUN
ijpds-3865	65	10	genes	gene	NOUN
ijpds-3865	65	11	and	and	CCONJ
ijpds-3865	65	12	has	have	AUX
ijpds-3865	65	13	also	also	ADV
ijpds-3865	65	14	demonstrated	demonstrate	VERB
ijpds-3865	65	15	the	the	DET
ijpds-3865	65	16	ability	ability	NOUN
ijpds-3865	65	17	to	to	PART
ijpds-3865	65	18	transfer	transfer	VERB
ijpds-3865	65	19	such	such	ADJ
ijpds-3865	65	20	genes	gene	NOUN
ijpds-3865	65	21	to	to	ADP
ijpds-3865	65	22	various	various	ADJ
ijpds-3865	65	23	gram	gram	NOUN
ijpds-3865	65	24	-	-	PUNCT
ijpds-3865	65	25	negative	negative	ADJ
ijpds-3865	65	26	bacteria	bacteria	NOUN
ijpds-3865	65	27	.	.	PUNCT
ijpds-3865	66	1	multiple	multiple	ADJ
ijpds-3865	66	2	drug	drug	NOUN
ijpds-3865	66	3	resistance	resistance	NOUN
ijpds-3865	66	4	among	among	ADP
ijpds-3865	66	5	aeromonas	aeromonas	PROPN
ijpds-3865	66	6	spp	spp	PROPN
ijpds-3865	66	7	.	.	PUNCT
ijpds-3865	66	8	have	have	AUX
ijpds-3865	66	9	been	be	AUX
ijpds-3865	66	10	reported	report	VERB
ijpds-3865	66	11	from	from	ADP
ijpds-3865	66	12	many	many	ADJ
ijpds-3865	66	13	parts	part	NOUN
ijpds-3865	66	14	of	of	ADP
ijpds-3865	66	15	the	the	DET
ijpds-3865	66	16	world	world	NOUN
ijpds-3865	66	17	as	as	ADV
ijpds-3865	66	18	well	well	ADV
ijpds-3865	66	19	.	.	PUNCT
ijpds-3865	67	1	also	also	ADV
ijpds-3865	67	2	,	,	PUNCT
ijpds-3865	67	3	a	a	DET
ijpds-3865	67	4	concerning	concern	VERB
ijpds-3865	67	5	aspect	aspect	NOUN
ijpds-3865	67	6	of	of	ADP
ijpds-3865	67	7	drug	drug	NOUN
ijpds-3865	67	8	resistance	resistance	NOUN
ijpds-3865	67	9	among	among	ADP
ijpds-3865	67	10	the	the	DET
ijpds-3865	67	11	aeromonas	aeromonas	PROPN
ijpds-3865	67	12	spp	spp	PROPN
ijpds-3865	67	13	.	.	PROPN
ijpds-3865	67	14	is	be	AUX
ijpds-3865	67	15	the	the	DET
ijpds-3865	67	16	ability	ability	NOUN
ijpds-3865	67	17	to	to	PART
ijpds-3865	67	18	bring	bring	VERB
ijpds-3865	67	19	about	about	ADP
ijpds-3865	67	20	extra	extra	ADJ
ijpds-3865	67	21	-	-	ADJ
ijpds-3865	67	22	intestinal	intestinal	ADJ
ijpds-3865	67	23	infections	infection	NOUN
ijpds-3865	67	24	that	that	PRON
ijpds-3865	67	25	can	can	AUX
ijpds-3865	67	26	be	be	AUX
ijpds-3865	67	27	fatal	fatal	ADJ
ijpds-3865	67	28	with	with	ADP
ijpds-3865	67	29	the	the	DET
ijpds-3865	67	30	existing	exist	VERB
ijpds-3865	67	31	multiple	multiple	ADJ
ijpds-3865	67	32	drugresistance	drugresistance	NOUN
ijpds-3865	67	33	genes	gene	NOUN
ijpds-3865	67	34	[	[	X
ijpds-3865	67	35	35	35	NUM
ijpds-3865	67	36	]	]	PUNCT
ijpds-3865	67	37	.	.	PUNCT
ijpds-3865	68	1	a	a	DET
ijpds-3865	68	2	plausible	plausible	ADJ
ijpds-3865	68	3	cause	cause	NOUN
ijpds-3865	68	4	for	for	ADP
ijpds-3865	68	5	such	such	ADJ
ijpds-3865	68	6	increased	increase	VERB
ijpds-3865	68	7	spread	spread	NOUN
ijpds-3865	68	8	of	of	ADP
ijpds-3865	68	9	antibiotic	antibiotic	ADJ
ijpds-3865	68	10	resistance	resistance	NOUN
ijpds-3865	68	11	is	be	AUX
ijpds-3865	68	12	rapid	rapid	ADJ
ijpds-3865	68	13	urbanization	urbanization	NOUN
ijpds-3865	68	14	and	and	CCONJ
ijpds-3865	68	15	the	the	DET
ijpds-3865	68	16	evolution	evolution	NOUN
ijpds-3865	68	17	of	of	ADP
ijpds-3865	68	18	bacteria	bacteria	NOUN
ijpds-3865	68	19	to	to	PART
ijpds-3865	68	20	survive	survive	VERB
ijpds-3865	68	21	such	such	ADJ
ijpds-3865	68	22	threats	threat	NOUN
ijpds-3865	68	23	[	[	X
ijpds-3865	68	24	36	36	NUM
ijpds-3865	68	25	]	]	PUNCT
ijpds-3865	68	26	.	.	PUNCT
ijpds-3865	69	1	mandumpala	mandumpala	NOUN
ijpds-3865	69	2	a	a	DET
ijpds-3865	69	3	caution	caution	NOUN
ijpds-3865	69	4	for	for	ADP
ijpds-3865	69	5	judicial	judicial	ADJ
ijpds-3865	69	6	antibiotic	antibiotic	ADJ
ijpds-3865	69	7	use	use	NOUN
ijpds-3865	69	8	vol	vol	NOUN
ijpds-3865	69	9	2	2	NUM
ijpds-3865	69	10	|	|	NOUN
ijpds-3865	69	11	issue	issue	NOUN
ijpds-3865	69	12	1	1	NUM
ijpds-3865	70	1	|	|	ADV
ijpds-3865	70	2	jan	jan	PROPN
ijpds-3865	70	3	–	–	PUNCT
ijpds-3865	71	1	mar	mar	PROPN
ijpds-3865	71	2	2023	2023	NUM
ijpds-3865	71	3	indian	indian	PROPN
ijpds-3865	71	4	j	j	PROPN
ijpds-3865	71	5	pharm	pharm	PROPN
ijpds-3865	71	6	drug	drug	PROPN
ijpds-3865	71	7	studies	study	NOUN
ijpds-3865	71	8	|	|	ADV
ijpds-3865	71	9	13	13	NUM
ijpds-3865	71	10	salmonella	salmonella	NOUN
ijpds-3865	71	11	spp	spp	NOUN
ijpds-3865	71	12	.	.	PUNCT
ijpds-3865	72	1	an	an	DET
ijpds-3865	72	2	alarming	alarming	ADJ
ijpds-3865	72	3	health	health	NOUN
ijpds-3865	72	4	issue	issue	NOUN
ijpds-3865	72	5	that	that	PRON
ijpds-3865	72	6	exists	exist	VERB
ijpds-3865	72	7	everywhere	everywhere	ADV
ijpds-3865	72	8	is	be	AUX
ijpds-3865	72	9	salmonella	salmonella	NOUN
ijpds-3865	72	10	infection	infection	NOUN
ijpds-3865	72	11	.	.	PUNCT
ijpds-3865	73	1	effective	effective	ADJ
ijpds-3865	73	2	steps	step	NOUN
ijpds-3865	73	3	should	should	AUX
ijpds-3865	73	4	be	be	AUX
ijpds-3865	73	5	taken	take	VERB
ijpds-3865	73	6	to	to	PART
ijpds-3865	73	7	stop	stop	VERB
ijpds-3865	73	8	the	the	DET
ijpds-3865	73	9	issue	issue	NOUN
ijpds-3865	73	10	from	from	ADP
ijpds-3865	73	11	getting	get	VERB
ijpds-3865	73	12	worse	bad	ADJ
ijpds-3865	73	13	[	[	X
ijpds-3865	73	14	11	11	NUM
ijpds-3865	73	15	]	]	PUNCT
ijpds-3865	73	16	.	.	PUNCT
ijpds-3865	74	1	the	the	DET
ijpds-3865	74	2	preferred	preferred	ADJ
ijpds-3865	74	3	treatment	treatment	NOUN
ijpds-3865	74	4	for	for	ADP
ijpds-3865	74	5	typhoid	typhoid	NOUN
ijpds-3865	74	6	fever	fever	NOUN
ijpds-3865	74	7	is	be	AUX
ijpds-3865	74	8	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	74	9	,	,	PUNCT
ijpds-3865	74	10	however	however	ADV
ijpds-3865	74	11	,	,	PUNCT
ijpds-3865	74	12	the	the	DET
ijpds-3865	74	13	introduction	introduction	NOUN
ijpds-3865	74	14	of	of	ADP
ijpds-3865	74	15	salmonella	salmonella	NOUN
ijpds-3865	74	16	typhi	typhi	NOUN
ijpds-3865	74	17	which	which	PRON
ijpds-3865	74	18	is	be	AUX
ijpds-3865	74	19	resistant	resistant	ADJ
ijpds-3865	74	20	to	to	ADP
ijpds-3865	74	21	it	it	PRON
ijpds-3865	74	22	creates	create	VERB
ijpds-3865	74	23	serious	serious	ADJ
ijpds-3865	74	24	treatment	treatment	NOUN
ijpds-3865	74	25	problems	problem	NOUN
ijpds-3865	74	26	.	.	PUNCT
ijpds-3865	75	1	there	there	PRON
ijpds-3865	75	2	are	be	VERB
ijpds-3865	75	3	more	more	ADV
ijpds-3865	75	4	and	and	CCONJ
ijpds-3865	75	5	more	more	ADV
ijpds-3865	75	6	sporadic	sporadic	ADJ
ijpds-3865	75	7	instances	instance	NOUN
ijpds-3865	75	8	of	of	ADP
ijpds-3865	75	9	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	75	10	-	-	PUNCT
ijpds-3865	75	11	resistant	resistant	ADJ
ijpds-3865	75	12	s.	s.	PROPN
ijpds-3865	75	13	typhi	typhi	NOUN
ijpds-3865	75	14	,	,	PUNCT
ijpds-3865	75	15	therefore	therefore	ADV
ijpds-3865	75	16	reducing	reduce	VERB
ijpds-3865	75	17	the	the	DET
ijpds-3865	75	18	chance	chance	NOUN
ijpds-3865	75	19	that	that	SCONJ
ijpds-3865	75	20	the	the	DET
ijpds-3865	75	21	patient	patient	NOUN
ijpds-3865	75	22	wo	will	AUX
ijpds-3865	75	23	n't	not	PART
ijpds-3865	75	24	respond	respond	VERB
ijpds-3865	75	25	to	to	ADP
ijpds-3865	75	26	therapy	therapy	NOUN
ijpds-3865	75	27	and	and	CCONJ
ijpds-3865	75	28	that	that	SCONJ
ijpds-3865	75	29	outbreaks	outbreak	NOUN
ijpds-3865	75	30	will	will	AUX
ijpds-3865	75	31	spread	spread	VERB
ijpds-3865	75	32	throughout	throughout	ADP
ijpds-3865	75	33	the	the	DET
ijpds-3865	75	34	neighbourhood	neighbourhood	NOUN
ijpds-3865	75	35	must	must	AUX
ijpds-3865	75	36	take	take	VERB
ijpds-3865	75	37	precedence	precedence	NOUN
ijpds-3865	75	38	.	.	PUNCT
ijpds-3865	76	1	since	since	SCONJ
ijpds-3865	76	2	1988	1988	NUM
ijpds-3865	76	3	,	,	PUNCT
ijpds-3865	76	4	salmonella	salmonella	NOUN
ijpds-3865	76	5	resistant	resistant	ADJ
ijpds-3865	76	6	to	to	ADP
ijpds-3865	76	7	extended	extend	VERB
ijpds-3865	76	8	-	-	PUNCT
ijpds-3865	76	9	spectrum	spectrum	NOUN
ijpds-3865	76	10	cephalosporins	cephalosporin	NOUN
ijpds-3865	76	11	has	have	AUX
ijpds-3865	76	12	become	become	VERB
ijpds-3865	76	13	an	an	DET
ijpds-3865	76	14	international	international	ADJ
ijpds-3865	76	15	problem	problem	NOUN
ijpds-3865	76	16	.	.	PUNCT
ijpds-3865	77	1	this	this	DET
ijpds-3865	77	2	public	public	ADJ
ijpds-3865	77	3	health	health	NOUN
ijpds-3865	77	4	issue	issue	NOUN
ijpds-3865	77	5	had	have	AUX
ijpds-3865	77	6	been	be	AUX
ijpds-3865	77	7	reported	report	VERB
ijpds-3865	77	8	in	in	ADP
ijpds-3865	77	9	43	43	NUM
ijpds-3865	77	10	countries	country	NOUN
ijpds-3865	77	11	by	by	ADP
ijpds-3865	77	12	2004	2004	NUM
ijpds-3865	77	13	.	.	PUNCT
ijpds-3865	78	1	traditional	traditional	ADJ
ijpds-3865	78	2	extendedspectrum	extendedspectrum	CCONJ
ijpds-3865	78	3	beta	beta	NOUN
ijpds-3865	78	4	-	-	PUNCT
ijpds-3865	78	5	lactamases	lactamase	NOUN
ijpds-3865	78	6	,	,	PUNCT
ijpds-3865	78	7	plasmid	plasmid	NOUN
ijpds-3865	78	8	-	-	PUNCT
ijpds-3865	78	9	mediated	mediate	VERB
ijpds-3865	78	10	cephalosporinases	cephalosporinase	NOUN
ijpds-3865	78	11	,	,	PUNCT
ijpds-3865	78	12	and	and	CCONJ
ijpds-3865	78	13	most	most	ADV
ijpds-3865	78	14	recently	recently	ADV
ijpds-3865	78	15	a	a	DET
ijpds-3865	78	16	class	class	NOUN
ijpds-3865	78	17	a	a	DET
ijpds-3865	78	18	carbapenemase	carbapenemase	NOUN
ijpds-3865	78	19	were	be	AUX
ijpds-3865	78	20	responsible	responsible	ADJ
ijpds-3865	78	21	for	for	ADP
ijpds-3865	78	22	mediating	mediate	VERB
ijpds-3865	78	23	resistance	resistance	NOUN
ijpds-3865	78	24	.	.	PUNCT
ijpds-3865	79	1	the	the	DET
ijpds-3865	79	2	most	most	ADV
ijpds-3865	79	3	extensively	extensively	ADV
ijpds-3865	79	4	distributed	distribute	VERB
ijpds-3865	79	5	of	of	ADP
ijpds-3865	79	6	them	they	PRON
ijpds-3865	79	7	is	be	AUX
ijpds-3865	79	8	cmy-2	cmy-2	VERB
ijpds-3865	79	9	.	.	PUNCT
ijpds-3865	80	1	the	the	DET
ijpds-3865	80	2	two	two	NUM
ijpds-3865	80	3	most	most	ADV
ijpds-3865	80	4	prevalent	prevalent	ADJ
ijpds-3865	80	5	serovars	serovar	NOUN
ijpds-3865	80	6	connected	connect	VERB
ijpds-3865	80	7	to	to	ADP
ijpds-3865	80	8	extended	extend	VERB
ijpds-3865	80	9	-	-	PUNCT
ijpds-3865	80	10	spectrum	spectrum	NOUN
ijpds-3865	80	11	cephalosporins	cephalosporin	NOUN
ijpds-3865	80	12	resistance	resistance	NOUN
ijpds-3865	80	13	in	in	ADP
ijpds-3865	80	14	human	human	ADJ
ijpds-3865	80	15	infections	infection	NOUN
ijpds-3865	80	16	are	be	AUX
ijpds-3865	80	17	salmonella	salmonella	PROPN
ijpds-3865	80	18	enterica	enterica	PROPN
ijpds-3865	80	19	serotype	serotype	PROPN
ijpds-3865	80	20	typhimurium	typhimurium	PROPN
ijpds-3865	80	21	and	and	CCONJ
ijpds-3865	80	22	salmonella	salmonella	PROPN
ijpds-3865	80	23	enterica	enterica	PROPN
ijpds-3865	80	24	serotype	serotype	ADJ
ijpds-3865	80	25	enteritidis	enteritidi	NOUN
ijpds-3865	80	26	[	[	X
ijpds-3865	80	27	37	37	NUM
ijpds-3865	80	28	]	]	PUNCT
ijpds-3865	80	29	.	.	PUNCT
ijpds-3865	81	1	the	the	DET
ijpds-3865	81	2	invasive	invasive	ADJ
ijpds-3865	81	3	infection	infection	NOUN
ijpds-3865	81	4	caused	cause	VERB
ijpds-3865	81	5	by	by	ADP
ijpds-3865	81	6	salmonella	salmonella	PROPN
ijpds-3865	81	7	enterica	enterica	PROPN
ijpds-3865	81	8	serotype	serotype	PROPN
ijpds-3865	81	9	choleraesuis	choleraesuis	NOUN
ijpds-3865	81	10	is	be	AUX
ijpds-3865	81	11	usually	usually	ADV
ijpds-3865	81	12	typical	typical	ADJ
ijpds-3865	81	13	.	.	PUNCT
ijpds-3865	82	1	most	most	ADV
ijpds-3865	82	2	often	often	ADV
ijpds-3865	82	3	extendedspectrum	extendedspectrum	ADP
ijpds-3865	82	4	cephalosporins	cephalosporin	NOUN
ijpds-3865	82	5	or	or	CCONJ
ijpds-3865	82	6	fluoroquinolones	fluoroquinolone	NOUN
ijpds-3865	82	7	are	be	AUX
ijpds-3865	82	8	utilized	utilize	VERB
ijpds-3865	82	9	to	to	PART
ijpds-3865	82	10	treat	treat	VERB
ijpds-3865	82	11	resistant	resistant	ADJ
ijpds-3865	82	12	salmonella	salmonella	NOUN
ijpds-3865	82	13	infections	infection	NOUN
ijpds-3865	83	1	[	[	X
ijpds-3865	83	2	38	38	NUM
ijpds-3865	83	3	]	]	PUNCT
ijpds-3865	83	4	.	.	PUNCT
ijpds-3865	84	1	however	however	ADV
ijpds-3865	84	2	,	,	PUNCT
ijpds-3865	84	3	there	there	PRON
ijpds-3865	84	4	are	be	VERB
ijpds-3865	84	5	increasing	increase	VERB
ijpds-3865	84	6	reports	report	NOUN
ijpds-3865	84	7	of	of	ADP
ijpds-3865	84	8	fluoroquinolone	fluoroquinolone	NOUN
ijpds-3865	84	9	resistance	resistance	NOUN
ijpds-3865	84	10	in	in	ADP
ijpds-3865	84	11	the	the	DET
ijpds-3865	84	12	invasive	invasive	ADJ
ijpds-3865	84	13	serotype	serotype	NOUN
ijpds-3865	84	14	of	of	ADP
ijpds-3865	84	15	salmonella	salmonella	NOUN
ijpds-3865	84	16	.	.	PUNCT
ijpds-3865	85	1	in	in	ADP
ijpds-3865	85	2	sc	sc	PROPN
ijpds-3865	85	3	-	-	PUNCT
ijpds-3865	85	4	b67	b67	NOUN
ijpds-3865	85	5	,	,	PUNCT
ijpds-3865	85	6	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	85	7	resistance	resistance	NOUN
ijpds-3865	85	8	was	be	AUX
ijpds-3865	85	9	linked	link	VERB
ijpds-3865	85	10	to	to	ADP
ijpds-3865	85	11	a	a	DET
ijpds-3865	85	12	plasmid	plasmid	NOUN
ijpds-3865	85	13	-	-	PUNCT
ijpds-3865	85	14	mediated	mediate	VERB
ijpds-3865	85	15	blacmy-2	blacmy-2	NUM
ijpds-3865	85	16	that	that	PRON
ijpds-3865	85	17	is	be	AUX
ijpds-3865	85	18	commonly	commonly	ADV
ijpds-3865	85	19	present	present	ADJ
ijpds-3865	85	20	on	on	ADP
ijpds-3865	85	21	a	a	DET
ijpds-3865	85	22	particular	particular	ADJ
ijpds-3865	85	23	isecp1	isecp1	NOUN
ijpds-3865	85	24	-	-	PUNCT
ijpds-3865	85	25	blacmy-2	blacmy-2	NOUN
ijpds-3865	85	26	-	-	PUNCT
ijpds-3865	85	27	blc	blc	NOUN
ijpds-3865	85	28	-	-	PUNCT
ijpds-3865	85	29	suge	suge	NOUN
ijpds-3865	85	30	structure	structure	NOUN
ijpds-3865	86	1	[	[	X
ijpds-3865	86	2	39	39	NUM
ijpds-3865	86	3	]	]	PUNCT
ijpds-3865	86	4	.	.	PUNCT
ijpds-3865	87	1	this	this	PRON
ijpds-3865	87	2	conserved	conserve	VERB
ijpds-3865	87	3	dna	dna	PROPN
ijpds-3865	87	4	segment	segment	NOUN
ijpds-3865	87	5	,	,	PUNCT
ijpds-3865	87	6	later	later	ADV
ijpds-3865	87	7	given	give	VERB
ijpds-3865	87	8	the	the	DET
ijpds-3865	87	9	designation	designation	NOUN
ijpds-3865	87	10	tn6092	tn6092	NOUN
ijpds-3865	87	11	,	,	PUNCT
ijpds-3865	87	12	has	have	AUX
ijpds-3865	87	13	been	be	AUX
ijpds-3865	87	14	identified	identify	VERB
ijpds-3865	87	15	in	in	ADP
ijpds-3865	87	16	numerous	numerous	ADJ
ijpds-3865	87	17	enterobacteriaceae	enterobacteriaceae	NOUN
ijpds-3865	87	18	and	and	CCONJ
ijpds-3865	87	19	salmonella	salmonella	NOUN
ijpds-3865	87	20	serotypes	serotype	NOUN
ijpds-3865	87	21	from	from	ADP
ijpds-3865	87	22	across	across	ADP
ijpds-3865	87	23	the	the	DET
ijpds-3865	87	24	globe	globe	NOUN
ijpds-3865	88	1	[	[	X
ijpds-3865	88	2	40	40	NUM
ijpds-3865	88	3	,	,	PUNCT
ijpds-3865	88	4	41	41	NUM
ijpds-3865	88	5	]	]	PUNCT
ijpds-3865	88	6	.	.	PUNCT
ijpds-3865	89	1	in	in	ADP
ijpds-3865	89	2	addition	addition	NOUN
ijpds-3865	89	3	,	,	PUNCT
ijpds-3865	89	4	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	89	5	-	-	PUNCT
ijpds-3865	89	6	resistant	resistant	ADJ
ijpds-3865	89	7	serotype	serotype	ADJ
ijpds-3865	89	8	salmonella	salmonella	NOUN
ijpds-3865	89	9	typhimurium	typhimurium	NOUN
ijpds-3865	89	10	infections	infection	NOUN
ijpds-3865	89	11	,	,	PUNCT
ijpds-3865	89	12	which	which	PRON
ijpds-3865	89	13	were	be	AUX
ijpds-3865	89	14	previously	previously	ADV
ijpds-3865	89	15	uncommon	uncommon	ADJ
ijpds-3865	89	16	in	in	ADP
ijpds-3865	89	17	western	western	ADJ
ijpds-3865	89	18	kenya	kenya	PROPN
ijpds-3865	89	19	,	,	PUNCT
ijpds-3865	89	20	appeared	appear	VERB
ijpds-3865	89	21	quickly	quickly	ADV
ijpds-3865	89	22	between	between	ADP
ijpds-3865	89	23	2009	2009	NUM
ijpds-3865	89	24	and	and	CCONJ
ijpds-3865	89	25	2014	2014	NUM
ijpds-3865	89	26	in	in	ADP
ijpds-3865	89	27	countries	country	NOUN
ijpds-3865	89	28	in	in	ADP
ijpds-3865	89	29	western	western	ADJ
ijpds-3865	89	30	kenya	kenya	NOUN
ijpds-3865	89	31	,	,	PUNCT
ijpds-3865	89	32	restricting	restrict	VERB
ijpds-3865	89	33	the	the	DET
ijpds-3865	89	34	range	range	NOUN
ijpds-3865	89	35	of	of	ADP
ijpds-3865	89	36	available	available	ADJ
ijpds-3865	89	37	treatments	treatment	NOUN
ijpds-3865	89	38	for	for	ADP
ijpds-3865	89	39	serious	serious	ADJ
ijpds-3865	89	40	infections	infection	NOUN
ijpds-3865	89	41	.	.	PUNCT
ijpds-3865	90	1	in	in	ADP
ijpds-3865	90	2	order	order	NOUN
ijpds-3865	90	3	to	to	PART
ijpds-3865	90	4	direct	direct	VERB
ijpds-3865	90	5	proper	proper	ADJ
ijpds-3865	90	6	therapy	therapy	NOUN
ijpds-3865	90	7	in	in	ADP
ijpds-3865	90	8	diverse	diverse	ADJ
ijpds-3865	90	9	asian	asian	ADJ
ijpds-3865	90	10	and	and	CCONJ
ijpds-3865	90	11	african	african	ADJ
ijpds-3865	90	12	nations	nation	NOUN
ijpds-3865	90	13	,	,	PUNCT
ijpds-3865	90	14	there	there	PRON
ijpds-3865	90	15	is	be	VERB
ijpds-3865	90	16	an	an	DET
ijpds-3865	90	17	urgent	urgent	ADJ
ijpds-3865	90	18	need	need	NOUN
ijpds-3865	90	19	for	for	ADP
ijpds-3865	90	20	increased	increase	VERB
ijpds-3865	90	21	microbiologic	microbiologic	ADJ
ijpds-3865	90	22	diagnostic	diagnostic	ADJ
ijpds-3865	90	23	capability	capability	NOUN
ijpds-3865	90	24	in	in	ADP
ijpds-3865	90	25	clinical	clinical	ADJ
ijpds-3865	90	26	settings	setting	NOUN
ijpds-3865	90	27	[	[	X
ijpds-3865	90	28	42	42	NUM
ijpds-3865	90	29	]	]	PUNCT
ijpds-3865	90	30	.	.	PUNCT
ijpds-3865	91	1	extended	extend	VERB
ijpds-3865	91	2	-	-	PUNCT
ijpds-3865	91	3	spectrum	spectrum	NOUN
ijpds-3865	91	4	–	–	PUNCT
ijpds-3865	91	5	lactamases	lactamase	NOUN
ijpds-3865	91	6	whose	whose	DET
ijpds-3865	91	7	genetic	genetic	ADJ
ijpds-3865	91	8	elements	element	NOUN
ijpds-3865	91	9	can	can	AUX
ijpds-3865	91	10	be	be	AUX
ijpds-3865	91	11	found	find	VERB
ijpds-3865	91	12	in	in	ADP
ijpds-3865	91	13	plasmids	plasmid	NOUN
ijpds-3865	91	14	or	or	CCONJ
ijpds-3865	91	15	the	the	DET
ijpds-3865	91	16	chromosome	chromosome	NOUN
ijpds-3865	91	17	,	,	PUNCT
ijpds-3865	91	18	are	be	AUX
ijpds-3865	91	19	typically	typically	ADV
ijpds-3865	91	20	responsible	responsible	ADJ
ijpds-3865	91	21	for	for	ADP
ijpds-3865	91	22	the	the	DET
ijpds-3865	91	23	creation	creation	NOUN
ijpds-3865	91	24	of	of	ADP
ijpds-3865	91	25	resistance	resistance	NOUN
ijpds-3865	91	26	to	to	ADP
ijpds-3865	91	27	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	91	28	.	.	PUNCT
ijpds-3865	92	1	organisms	organism	NOUN
ijpds-3865	92	2	that	that	PRON
ijpds-3865	92	3	produce	produce	VERB
ijpds-3865	92	4	ctx	ctx	NOUN
ijpds-3865	92	5	-	-	ADJ
ijpds-3865	92	6	m	m	NOUN
ijpds-3865	92	7	-	-	PUNCT
ijpds-3865	92	8	type	type	NOUN
ijpds-3865	92	9	esbls	esbls	NOUN
ijpds-3865	92	10	constitute	constitute	VERB
ijpds-3865	92	11	a	a	DET
ijpds-3865	92	12	particularly	particularly	ADV
ijpds-3865	92	13	major	major	ADJ
ijpds-3865	92	14	public	public	ADJ
ijpds-3865	92	15	health	health	NOUN
ijpds-3865	92	16	danger	danger	NOUN
ijpds-3865	92	17	globally	globally	ADV
ijpds-3865	92	18	among	among	ADP
ijpds-3865	92	19	the	the	DET
ijpds-3865	92	20	variety	variety	NOUN
ijpds-3865	92	21	of	of	ADP
ijpds-3865	92	22	antibiotic	antibiotic	ADJ
ijpds-3865	92	23	-	-	PUNCT
ijpds-3865	92	24	resistant	resistant	ADJ
ijpds-3865	92	25	gram	gram	NOUN
ijpds-3865	92	26	-	-	PUNCT
ijpds-3865	92	27	negative	negative	ADJ
ijpds-3865	92	28	bacteria	bacteria	NOUN
ijpds-3865	92	29	pathogens	pathogen	NOUN
ijpds-3865	92	30	that	that	PRON
ijpds-3865	92	31	are	be	AUX
ijpds-3865	92	32	currently	currently	ADV
ijpds-3865	92	33	recognised	recognise	VERB
ijpds-3865	92	34	[	[	X
ijpds-3865	92	35	43	43	NUM
ijpds-3865	92	36	]	]	PUNCT
ijpds-3865	92	37	.	.	PUNCT
ijpds-3865	93	1	an	an	DET
ijpds-3865	93	2	extremely	extremely	ADV
ijpds-3865	93	3	invasive	invasive	ADJ
ijpds-3865	93	4	zoonotic	zoonotic	ADJ
ijpds-3865	93	5	bacterium	bacterium	NOUN
ijpds-3865	93	6	called	call	VERB
ijpds-3865	93	7	s.	s.	PROPN
ijpds-3865	93	8	choleraesuis	choleraesuis	PROPN
ijpds-3865	93	9	produces	produce	VERB
ijpds-3865	93	10	a	a	DET
ijpds-3865	93	11	devastating	devastating	ADJ
ijpds-3865	93	12	systemic	systemic	ADJ
ijpds-3865	93	13	infection	infection	NOUN
ijpds-3865	93	14	in	in	ADP
ijpds-3865	93	15	people	people	NOUN
ijpds-3865	93	16	.	.	PUNCT
ijpds-3865	94	1	a	a	DET
ijpds-3865	94	2	significant	significant	ADJ
ijpds-3865	94	3	treatment	treatment	NOUN
ijpds-3865	94	4	issue	issue	NOUN
ijpds-3865	94	5	has	have	AUX
ijpds-3865	94	6	arisen	arise	VERB
ijpds-3865	94	7	due	due	ADP
ijpds-3865	94	8	to	to	ADP
ijpds-3865	94	9	the	the	DET
ijpds-3865	94	10	emergence	emergence	NOUN
ijpds-3865	94	11	and	and	CCONJ
ijpds-3865	94	12	growth	growth	NOUN
ijpds-3865	94	13	of	of	ADP
ijpds-3865	94	14	s.	s.	PROPN
ijpds-3865	94	15	choleraesuis	choleraesuis	PROPN
ijpds-3865	94	16	resistance	resistance	NOUN
ijpds-3865	94	17	to	to	ADP
ijpds-3865	94	18	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	94	19	and	and	CCONJ
ijpds-3865	94	20	ciprofloxacin	ciprofloxacin	PROPN
ijpds-3865	94	21	.	.	PUNCT
ijpds-3865	95	1	sirirat	sirirat	PROPN
ijpds-3865	95	2	et	et	PROPN
ijpds-3865	95	3	al	al	PROPN
ijpds-3865	95	4	have	have	AUX
ijpds-3865	95	5	demonstrated	demonstrate	VERB
ijpds-3865	95	6	high	high	ADJ
ijpds-3865	95	7	frequency	frequency	NOUN
ijpds-3865	95	8	of	of	ADP
ijpds-3865	95	9	antimicrobial	antimicrobial	ADJ
ijpds-3865	95	10	resistance	resistance	NOUN
ijpds-3865	95	11	in	in	ADP
ijpds-3865	95	12	salmonella	salmonella	PROPN
ijpds-3865	95	13	choleraesuis	choleraesuis	NOUN
ijpds-3865	95	14	among	among	ADP
ijpds-3865	95	15	414	414	NUM
ijpds-3865	95	16	nontyphoidal	nontyphoidal	ADJ
ijpds-3865	95	17	salmonella	salmonella	NOUN
ijpds-3865	95	18	isolates	isolate	NOUN
ijpds-3865	95	19	from	from	ADP
ijpds-3865	95	20	bacteremic	bacteremic	ADJ
ijpds-3865	95	21	patients	patient	NOUN
ijpds-3865	95	22	in	in	ADP
ijpds-3865	95	23	thailand	thailand	PROPN
ijpds-3865	95	24	.	.	PUNCT
ijpds-3865	96	1	s.	s.	PROPN
ijpds-3865	96	2	choleraesuis	choleraesuis	PROPN
ijpds-3865	96	3	isolates	isolate	NOUN
ijpds-3865	96	4	had	have	VERB
ijpds-3865	96	5	high	high	ADJ
ijpds-3865	96	6	rates	rate	NOUN
ijpds-3865	96	7	of	of	ADP
ijpds-3865	96	8	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	96	9	(	(	PUNCT
ijpds-3865	96	10	58.3	58.3	NUM
ijpds-3865	96	11	%	%	NOUN
ijpds-3865	96	12	)	)	PUNCT
ijpds-3865	96	13	and	and	CCONJ
ijpds-3865	96	14	ciprofloxacin	ciprofloxacin	NOUN
ijpds-3865	96	15	(	(	PUNCT
ijpds-3865	96	16	19.6	19.6	NUM
ijpds-3865	96	17	%	%	NOUN
ijpds-3865	96	18	)	)	PUNCT
ijpds-3865	96	19	resistance	resistance	NOUN
ijpds-3865	96	20	.	.	PUNCT
ijpds-3865	97	1	the	the	DET
ijpds-3865	97	2	clonal	clonal	ADJ
ijpds-3865	97	3	spread	spread	NOUN
ijpds-3865	97	4	of	of	ADP
ijpds-3865	97	5	s.	s.	PROPN
ijpds-3865	97	6	choleraesuis	choleraesuis	PROPN
ijpds-3865	97	7	isolates	isolate	NOUN
ijpds-3865	97	8	harbouring	harbour	VERB
ijpds-3865	97	9	blacmy-2	blacmy-2	NOUN
ijpds-3865	97	10	as	as	ADV
ijpds-3865	97	11	well	well	ADV
ijpds-3865	97	12	as	as	ADP
ijpds-3865	97	13	the	the	DET
ijpds-3865	97	14	dissemination	dissemination	NOUN
ijpds-3865	97	15	of	of	ADP
ijpds-3865	97	16	the	the	DET
ijpds-3865	97	17	self	self	NOUN
ijpds-3865	97	18	-	-	PUNCT
ijpds-3865	97	19	transferable	transferable	NOUN
ijpds-3865	97	20	blactx	blactx	NOUN
ijpds-3865	97	21	-	-	PUNCT
ijpds-3865	97	22	m-14	m-14	NOUN
ijpds-3865	97	23	-	-	PUNCT
ijpds-3865	97	24	carrying	carry	VERB
ijpds-3865	97	25	incfiis	incfiis	NOUN
ijpds-3865	97	26	,	,	PUNCT
ijpds-3865	97	27	incfii	incfii	NOUN
ijpds-3865	97	28	,	,	PUNCT
ijpds-3865	97	29	and	and	CCONJ
ijpds-3865	97	30	inci1	inci1	ADJ
ijpds-3865	97	31	plasmids	plasmid	NOUN
ijpds-3865	97	32	and	and	CCONJ
ijpds-3865	97	33	the	the	DET
ijpds-3865	97	34	blacmy-2	blacmy-2	NOUN
ijpds-3865	97	35	-	-	PUNCT
ijpds-3865	97	36	carrying	carry	VERB
ijpds-3865	97	37	inca	inca	NOUN
ijpds-3865	97	38	/	/	SYM
ijpds-3865	97	39	c	c	NOUN
ijpds-3865	97	40	plasmid	plasmid	NOUN
ijpds-3865	97	41	as	as	ADV
ijpds-3865	97	42	well	well	ADV
ijpds-3865	97	43	as	as	ADP
ijpds-3865	97	44	the	the	DET
ijpds-3865	97	45	high	high	ADJ
ijpds-3865	97	46	frequency	frequency	NOUN
ijpds-3865	97	47	of	of	ADP
ijpds-3865	97	48	resistance	resistance	NOUN
ijpds-3865	97	49	to	to	ADP
ijpds-3865	97	50	extended	extend	VERB
ijpds-3865	97	51	-	-	PUNCT
ijpds-3865	97	52	spectrum	spectrum	NOUN
ijpds-3865	97	53	cephalosporins	cephalosporin	NOUN
ijpds-3865	97	54	(	(	PUNCT
ijpds-3865	97	55	3rd	3rd	ADJ
ijpds-3865	97	56	and	and	CCONJ
ijpds-3865	97	57	4th	4th	ADJ
ijpds-3865	97	58	generation	generation	NOUN
ijpds-3865	97	59	cephalosporins	cephalosporin	NOUN
ijpds-3865	97	60	)	)	PUNCT
ijpds-3865	97	61	.	.	PUNCT
ijpds-3865	98	1	the	the	DET
ijpds-3865	98	2	first	first	ADJ
ijpds-3865	98	3	occurrence	occurrence	NOUN
ijpds-3865	98	4	of	of	ADP
ijpds-3865	98	5	ceftazidime	ceftazidime	NOUN
ijpds-3865	98	6	-	-	PUNCT
ijpds-3865	98	7	hydrolyzing	hydrolyzing	NOUN
ijpds-3865	98	8	ctx	ctx	NOUN
ijpds-3865	98	9	-	-	NOUN
ijpds-3865	98	10	m-55	m-55	VERB
ijpds-3865	98	11	in	in	ADP
ijpds-3865	98	12	s.	s.	PROPN
ijpds-3865	98	13	choleraesuis	choleraesuis	PROPN
ijpds-3865	98	14	isolates	isolate	NOUN
ijpds-3865	98	15	has	have	AUX
ijpds-3865	98	16	been	be	AUX
ijpds-3865	98	17	documented	document	VERB
ijpds-3865	98	18	;	;	PUNCT
ijpds-3865	98	19	between	between	ADP
ijpds-3865	98	20	2012	2012	NUM
ijpds-3865	98	21	and	and	CCONJ
ijpds-3865	98	22	2016	2016	NUM
ijpds-3865	98	23	,	,	PUNCT
ijpds-3865	98	24	this	this	DET
ijpds-3865	98	25	variant	variant	NOUN
ijpds-3865	98	26	's	's	PART
ijpds-3865	98	27	abundance	abundance	NOUN
ijpds-3865	98	28	among	among	ADP
ijpds-3865	98	29	esc	esc	NOUN
ijpds-3865	98	30	-	-	PUNCT
ijpds-3865	98	31	resistant	resistant	ADJ
ijpds-3865	98	32	s.	s.	PROPN
ijpds-3865	98	33	choleraesuis	choleraesuis	PROPN
ijpds-3865	98	34	isolates	isolate	NOUN
ijpds-3865	98	35	grew	grow	VERB
ijpds-3865	98	36	rapidly	rapidly	ADV
ijpds-3865	98	37	.	.	PUNCT
ijpds-3865	99	1	the	the	DET
ijpds-3865	99	2	dispersion	dispersion	NOUN
ijpds-3865	99	3	of	of	ADP
ijpds-3865	99	4	inca	inca	PROPN
ijpds-3865	99	5	/	/	SYM
ijpds-3865	99	6	c	c	NOUN
ijpds-3865	99	7	plasmids	plasmid	NOUN
ijpds-3865	99	8	carrying	carry	VERB
ijpds-3865	99	9	both	both	DET
ijpds-3865	99	10	blactx	blactx	NOUN
ijpds-3865	99	11	-	-	PUNCT
ijpds-3865	99	12	m-55	m-55	PROPN
ijpds-3865	99	13	and	and	CCONJ
ijpds-3865	99	14	qnrs1	qnrs1	NOUN
ijpds-3865	99	15	among	among	ADP
ijpds-3865	99	16	ciprofloxacin	ciprofloxacin	NOUN
ijpds-3865	99	17	-	-	PUNCT
ijpds-3865	99	18	resistant	resistant	ADJ
ijpds-3865	99	19	s.	s.	PROPN
ijpds-3865	99	20	choleraesuis	choleraesuis	PROPN
ijpds-3865	99	21	isolates	isolate	NOUN
ijpds-3865	99	22	expressing	express	VERB
ijpds-3865	99	23	d87	d87	NOUN
ijpds-3865	99	24	g	g	PROPN
ijpds-3865	99	25	in	in	ADP
ijpds-3865	99	26	gyra	gyra	PROPN
ijpds-3865	99	27	was	be	AUX
ijpds-3865	99	28	the	the	DET
ijpds-3865	99	29	cause	cause	NOUN
ijpds-3865	99	30	of	of	ADP
ijpds-3865	99	31	the	the	DET
ijpds-3865	99	32	spread	spread	NOUN
ijpds-3865	99	33	of	of	ADP
ijpds-3865	99	34	clone	clone	NOUN
ijpds-3865	99	35	pulsotype	pulsotype	NOUN
ijpds-3865	99	36	b3	b3	PROPN
ijpds-3865	99	37	.	.	PUNCT
ijpds-3865	100	1	the	the	DET
ijpds-3865	100	2	high	high	ADJ
ijpds-3865	100	3	frequencies	frequency	NOUN
ijpds-3865	100	4	of	of	ADP
ijpds-3865	100	5	co	co	NOUN
ijpds-3865	100	6	-	-	NOUN
ijpds-3865	100	7	resistance	resistance	NOUN
ijpds-3865	100	8	to	to	ADP
ijpds-3865	100	9	escs	esc	NOUN
ijpds-3865	100	10	and	and	CCONJ
ijpds-3865	100	11	ciprofloxacin	ciprofloxacin	NOUN
ijpds-3865	100	12	(	(	PUNCT
ijpds-3865	100	13	51.3	51.3	NUM
ijpds-3865	100	14	%	%	NOUN
ijpds-3865	100	15	)	)	PUNCT
ijpds-3865	100	16	from	from	ADP
ijpds-3865	100	17	2012	2012	NUM
ijpds-3865	100	18	to	to	ADP
ijpds-3865	100	19	2016	2016	NUM
ijpds-3865	100	20	were	be	AUX
ijpds-3865	100	21	reportedly	reportedly	ADV
ijpds-3865	100	22	caused	cause	VERB
ijpds-3865	100	23	by	by	ADP
ijpds-3865	100	24	these	these	DET
ijpds-3865	100	25	isolates	isolate	NOUN
ijpds-3865	100	26	.	.	PUNCT
ijpds-3865	101	1	as	as	ADP
ijpds-3865	101	2	a	a	DET
ijpds-3865	101	3	result	result	NOUN
ijpds-3865	101	4	of	of	ADP
ijpds-3865	101	5	travel	travel	NOUN
ijpds-3865	101	6	and	and	CCONJ
ijpds-3865	101	7	commerce	commerce	NOUN
ijpds-3865	101	8	in	in	ADP
ijpds-3865	101	9	animal	animal	NOUN
ijpds-3865	101	10	food	food	NOUN
ijpds-3865	101	11	items	item	NOUN
ijpds-3865	101	12	,	,	PUNCT
ijpds-3865	101	13	this	this	DET
ijpds-3865	101	14	study	study	NOUN
ijpds-3865	101	15	highlights	highlight	VERB
ijpds-3865	101	16	the	the	DET
ijpds-3865	101	17	significance	significance	NOUN
ijpds-3865	101	18	of	of	ADP
ijpds-3865	101	19	having	have	VERB
ijpds-3865	101	20	an	an	DET
ijpds-3865	101	21	action	action	NOUN
ijpds-3865	101	22	plan	plan	NOUN
ijpds-3865	101	23	to	to	PART
ijpds-3865	101	24	prevent	prevent	VERB
ijpds-3865	101	25	the	the	DET
ijpds-3865	101	26	spread	spread	NOUN
ijpds-3865	101	27	of	of	ADP
ijpds-3865	101	28	antibiotic	antibiotic	ADJ
ijpds-3865	101	29	resistance	resistance	NOUN
ijpds-3865	101	30	in	in	ADP
ijpds-3865	101	31	s.	s.	PROPN
ijpds-3865	101	32	choleraesuis	choleraesuis	PROPN
ijpds-3865	102	1	[	[	X
ijpds-3865	102	2	44	44	NUM
ijpds-3865	102	3	-	-	SYM
ijpds-3865	102	4	46	46	NUM
ijpds-3865	102	5	]	]	PUNCT
ijpds-3865	102	6	.	.	PUNCT
ijpds-3865	103	1	shigella	shigella	PROPN
ijpds-3865	103	2	spp	spp	PROPN
ijpds-3865	103	3	.	.	PUNCT
ijpds-3865	104	1	in	in	ADP
ijpds-3865	104	2	the	the	DET
ijpds-3865	104	3	underdeveloped	underdeveloped	ADJ
ijpds-3865	104	4	world	world	NOUN
ijpds-3865	104	5	,	,	PUNCT
ijpds-3865	104	6	shigellosis	shigellosis	NOUN
ijpds-3865	104	7	is	be	AUX
ijpds-3865	104	8	one	one	NUM
ijpds-3865	104	9	of	of	ADP
ijpds-3865	104	10	the	the	DET
ijpds-3865	104	11	major	major	ADJ
ijpds-3865	104	12	causes	cause	NOUN
ijpds-3865	104	13	of	of	ADP
ijpds-3865	104	14	diarrheal	diarrheal	ADJ
ijpds-3865	104	15	illnesses	illness	NOUN
ijpds-3865	104	16	.	.	PUNCT
ijpds-3865	105	1	an	an	DET
ijpds-3865	105	2	estimated	estimate	VERB
ijpds-3865	105	3	165	165	NUM
ijpds-3865	105	4	million	million	NUM
ijpds-3865	105	5	cases	case	NOUN
ijpds-3865	105	6	and	and	CCONJ
ijpds-3865	105	7	1.1	1.1	NUM
ijpds-3865	105	8	million	million	NUM
ijpds-3865	105	9	fatalities	fatality	NOUN
ijpds-3865	105	10	worldwide	worldwide	ADV
ijpds-3865	105	11	(	(	PUNCT
ijpds-3865	105	12	mainly	mainly	ADV
ijpds-3865	105	13	in	in	ADP
ijpds-3865	105	14	underdeveloped	underdeveloped	ADJ
ijpds-3865	105	15	nations	nation	NOUN
ijpds-3865	105	16	)	)	PUNCT
ijpds-3865	105	17	occur	occur	VERB
ijpds-3865	105	18	each	each	DET
ijpds-3865	105	19	year	year	NOUN
ijpds-3865	105	20	.	.	PUNCT
ijpds-3865	106	1	shigellosis	shigellosis	NOUN
ijpds-3865	106	2	patients	patient	NOUN
ijpds-3865	106	3	have	have	AUX
ijpds-3865	106	4	been	be	AUX
ijpds-3865	106	5	advised	advise	VERB
ijpds-3865	106	6	to	to	PART
ijpds-3865	106	7	have	have	VERB
ijpds-3865	106	8	antibiotic	antibiotic	ADJ
ijpds-3865	106	9	therapy	therapy	NOUN
ijpds-3865	106	10	because	because	SCONJ
ijpds-3865	106	11	it	it	PRON
ijpds-3865	106	12	can	can	AUX
ijpds-3865	106	13	shorten	shorten	VERB
ijpds-3865	106	14	the	the	DET
ijpds-3865	106	15	duration	duration	NOUN
ijpds-3865	106	16	of	of	ADP
ijpds-3865	106	17	the	the	DET
ijpds-3865	106	18	causative	causative	ADJ
ijpds-3865	106	19	organism	organism	NOUN
ijpds-3865	106	20	's	's	PART
ijpds-3865	106	21	faecal	faecal	ADJ
ijpds-3865	106	22	excretion	excretion	NOUN
ijpds-3865	106	23	and	and	CCONJ
ijpds-3865	106	24	limit	limit	VERB
ijpds-3865	106	25	the	the	DET
ijpds-3865	106	26	clinical	clinical	ADJ
ijpds-3865	106	27	course	course	NOUN
ijpds-3865	106	28	of	of	ADP
ijpds-3865	106	29	the	the	DET
ijpds-3865	106	30	illness	illness	NOUN
ijpds-3865	106	31	,	,	PUNCT
ijpds-3865	106	32	lowering	lower	VERB
ijpds-3865	106	33	the	the	DET
ijpds-3865	106	34	risk	risk	NOUN
ijpds-3865	106	35	of	of	ADP
ijpds-3865	106	36	complications	complication	NOUN
ijpds-3865	106	37	and	and	CCONJ
ijpds-3865	106	38	infection	infection	NOUN
ijpds-3865	106	39	transmission	transmission	NOUN
ijpds-3865	107	1	[	[	X
ijpds-3865	107	2	47	47	NUM
ijpds-3865	107	3	,	,	PUNCT
ijpds-3865	107	4	48	48	NUM
ijpds-3865	107	5	]	]	PUNCT
ijpds-3865	107	6	.	.	PUNCT
ijpds-3865	108	1	the	the	DET
ijpds-3865	108	2	growing	grow	VERB
ijpds-3865	108	3	resistance	resistance	NOUN
ijpds-3865	108	4	of	of	ADP
ijpds-3865	108	5	shigella	shigella	PROPN
ijpds-3865	108	6	spp	spp	PROPN
ijpds-3865	108	7	.	.	PUNCT
ijpds-3865	109	1	to	to	ADP
ijpds-3865	109	2	effective	effective	ADJ
ijpds-3865	109	3	antimicrobial	antimicrobial	ADJ
ijpds-3865	109	4	treatments	treatment	NOUN
ijpds-3865	109	5	,	,	PUNCT
ijpds-3865	109	6	however	however	ADV
ijpds-3865	109	7	,	,	PUNCT
ijpds-3865	109	8	is	be	AUX
ijpds-3865	109	9	a	a	DET
ijpds-3865	109	10	significant	significant	ADJ
ijpds-3865	109	11	issue	issue	NOUN
ijpds-3865	109	12	[	[	X
ijpds-3865	109	13	49	49	NUM
ijpds-3865	109	14	]	]	PUNCT
ijpds-3865	109	15	.	.	PUNCT
ijpds-3865	110	1	shigella	shigella	PROPN
ijpds-3865	110	2	isolates	isolate	NOUN
ijpds-3865	110	3	that	that	PRON
ijpds-3865	110	4	are	be	AUX
ijpds-3865	110	5	resistant	resistant	ADJ
ijpds-3865	110	6	to	to	ADP
ijpds-3865	110	7	a	a	DET
ijpds-3865	110	8	variety	variety	NOUN
ijpds-3865	110	9	of	of	ADP
ijpds-3865	110	10	medications	medication	NOUN
ijpds-3865	110	11	,	,	PUNCT
ijpds-3865	110	12	including	include	VERB
ijpds-3865	110	13	sulphonamides	sulphonamide	NOUN
ijpds-3865	110	14	,	,	PUNCT
ijpds-3865	110	15	tetracyclines	tetracycline	NOUN
ijpds-3865	110	16	,	,	PUNCT
ijpds-3865	110	17	ampicillin	ampicillin	PROPN
ijpds-3865	110	18	,	,	PUNCT
ijpds-3865	110	19	trimethoprim	trimethoprim	NOUN
ijpds-3865	110	20	-	-	PUNCT
ijpds-3865	110	21	sulphamethoxazole	sulphamethoxazole	NOUN
ijpds-3865	110	22	(	(	PUNCT
ijpds-3865	110	23	sxt	sxt	PROPN
ijpds-3865	110	24	)	)	PUNCT
ijpds-3865	110	25	,	,	PUNCT
ijpds-3865	110	26	and	and	CCONJ
ijpds-3865	110	27	nalidixic	nalidixic	ADJ
ijpds-3865	110	28	acid	acid	NOUN
ijpds-3865	110	29	,	,	PUNCT
ijpds-3865	110	30	have	have	AUX
ijpds-3865	110	31	been	be	AUX
ijpds-3865	110	32	reported	report	VERB
ijpds-3865	110	33	from	from	ADP
ijpds-3865	110	34	many	many	ADJ
ijpds-3865	110	35	different	different	ADJ
ijpds-3865	110	36	nations	nation	NOUN
ijpds-3865	110	37	over	over	ADP
ijpds-3865	110	38	the	the	DET
ijpds-3865	110	39	years	year	NOUN
ijpds-3865	111	1	[	[	X
ijpds-3865	111	2	50	50	NUM
ijpds-3865	111	3	]	]	PUNCT
ijpds-3865	111	4	.	.	PUNCT
ijpds-3865	112	1	azithromycin	azithromycin	PROPN
ijpds-3865	112	2	,	,	PUNCT
ijpds-3865	112	3	mecillinam	mecillinam	PROPN
ijpds-3865	112	4	,	,	PUNCT
ijpds-3865	112	5	ciprofloxacin	ciprofloxacin	NOUN
ijpds-3865	112	6	,	,	PUNCT
ijpds-3865	112	7	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	112	8	,	,	PUNCT
ijpds-3865	112	9	and	and	CCONJ
ijpds-3865	112	10	cefixime	cefixime	NOUN
ijpds-3865	112	11	are	be	AUX
ijpds-3865	112	12	examples	example	NOUN
ijpds-3865	112	13	of	of	ADP
ijpds-3865	112	14	novel	novel	ADJ
ijpds-3865	112	15	antimicrobials	antimicrobial	NOUN
ijpds-3865	112	16	that	that	PRON
ijpds-3865	112	17	have	have	AUX
ijpds-3865	112	18	been	be	AUX
ijpds-3865	112	19	proven	prove	VERB
ijpds-3865	112	20	to	to	PART
ijpds-3865	112	21	be	be	AUX
ijpds-3865	112	22	successful	successful	ADJ
ijpds-3865	112	23	in	in	ADP
ijpds-3865	112	24	treating	treat	VERB
ijpds-3865	112	25	multidrug	multidrug	NOUN
ijpds-3865	112	26	-	-	PUNCT
ijpds-3865	112	27	resistant	resistant	ADJ
ijpds-3865	112	28	shigellaassociated	shigellaassociate	VERB
ijpds-3865	112	29	illnesses	illness	NOUN
ijpds-3865	112	30	.	.	PUNCT
ijpds-3865	113	1	however	however	ADV
ijpds-3865	113	2	,	,	PUNCT
ijpds-3865	113	3	shigella	shigella	PROPN
ijpds-3865	113	4	strains	strain	NOUN
ijpds-3865	113	5	resistant	resistant	ADJ
ijpds-3865	113	6	to	to	ADP
ijpds-3865	113	7	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	113	8	have	have	AUX
ijpds-3865	113	9	emerged	emerge	VERB
ijpds-3865	113	10	[	[	X
ijpds-3865	113	11	51	51	NUM
ijpds-3865	113	12	,	,	PUNCT
ijpds-3865	113	13	52	52	NUM
ijpds-3865	113	14	]	]	PUNCT
ijpds-3865	113	15	.	.	PUNCT
ijpds-3865	114	1	fluoroquinolones	fluoroquinolone	NOUN
ijpds-3865	114	2	are	be	AUX
ijpds-3865	114	3	the	the	DET
ijpds-3865	114	4	sole	sole	ADJ
ijpds-3865	114	5	available	available	ADJ
ijpds-3865	114	6	antibiotic	antibiotic	ADJ
ijpds-3865	114	7	therapy	therapy	NOUN
ijpds-3865	114	8	for	for	ADP
ijpds-3865	114	9	such	such	ADJ
ijpds-3865	114	10	mdr	mdr	PROPN
ijpds-3865	114	11	shigellaassociated	shigellaassociate	VERB
ijpds-3865	114	12	illnesses	illness	NOUN
ijpds-3865	114	13	due	due	ADJ
ijpds-3865	114	14	to	to	ADP
ijpds-3865	114	15	the	the	DET
ijpds-3865	114	16	dearth	dearth	NOUN
ijpds-3865	114	17	of	of	ADP
ijpds-3865	114	18	other	other	ADJ
ijpds-3865	114	19	options	option	NOUN
ijpds-3865	114	20	.	.	PUNCT
ijpds-3865	115	1	fluoroquinolones	fluoroquinolone	NOUN
ijpds-3865	115	2	must	must	AUX
ijpds-3865	115	3	be	be	AUX
ijpds-3865	115	4	used	use	VERB
ijpds-3865	115	5	carefully	carefully	ADV
ijpds-3865	115	6	and	and	CCONJ
ijpds-3865	115	7	wisely	wisely	ADV
ijpds-3865	115	8	to	to	PART
ijpds-3865	115	9	prevent	prevent	VERB
ijpds-3865	115	10	the	the	DET
ijpds-3865	115	11	rapid	rapid	ADJ
ijpds-3865	115	12	emergence	emergence	NOUN
ijpds-3865	115	13	and	and	CCONJ
ijpds-3865	115	14	spread	spread	VERB
ijpds-3865	115	15	of	of	ADP
ijpds-3865	115	16	resistance	resistance	NOUN
ijpds-3865	115	17	,	,	PUNCT
ijpds-3865	115	18	as	as	SCONJ
ijpds-3865	115	19	evidenced	evidence	VERB
ijpds-3865	115	20	by	by	ADP
ijpds-3865	115	21	the	the	DET
ijpds-3865	115	22	discovery	discovery	NOUN
ijpds-3865	115	23	of	of	ADP
ijpds-3865	115	24	decreased	decrease	VERB
ijpds-3865	115	25	susceptibility	susceptibility	NOUN
ijpds-3865	115	26	to	to	ADP
ijpds-3865	115	27	fluoroquinolones	fluoroquinolone	NOUN
ijpds-3865	115	28	in	in	ADP
ijpds-3865	115	29	a	a	DET
ijpds-3865	115	30	significant	significant	ADJ
ijpds-3865	115	31	fraction	fraction	NOUN
ijpds-3865	115	32	of	of	ADP
ijpds-3865	115	33	shigella	shigella	PROPN
ijpds-3865	115	34	strains	strain	NOUN
ijpds-3865	115	35	and	and	CCONJ
ijpds-3865	115	36	completely	completely	ADV
ijpds-3865	115	37	fluoroquinolone	fluoroquinolone	NOUN
ijpds-3865	115	38	-	-	PUNCT
ijpds-3865	115	39	resistant	resistant	ADJ
ijpds-3865	115	40	s.	s.	PROPN
ijpds-3865	115	41	dysenteriae	dysenteriae	PROPN
ijpds-3865	115	42	type	type	VERB
ijpds-3865	115	43	1	1	NUM
ijpds-3865	116	1	[	[	X
ijpds-3865	116	2	53	53	NUM
ijpds-3865	116	3	,	,	PUNCT
ijpds-3865	116	4	54	54	NUM
ijpds-3865	116	5	]	]	PUNCT
ijpds-3865	116	6	.	.	PUNCT
ijpds-3865	117	1	according	accord	VERB
ijpds-3865	117	2	to	to	ADP
ijpds-3865	117	3	a	a	DET
ijpds-3865	117	4	study	study	NOUN
ijpds-3865	117	5	conducted	conduct	VERB
ijpds-3865	117	6	by	by	ADP
ijpds-3865	117	7	gu	gu	PROPN
ijpds-3865	117	8	b	b	PROPN
ijpds-3865	117	9	et	et	PROPN
ijpds-3865	117	10	al	al	PROPN
ijpds-3865	117	11	,	,	PUNCT
ijpds-3865	117	12	a	a	DET
ijpds-3865	117	13	lower	low	ADJ
ijpds-3865	117	14	average	average	ADJ
ijpds-3865	117	15	mandumpala	mandumpala	NOUN
ijpds-3865	117	16	a	a	DET
ijpds-3865	117	17	caution	caution	NOUN
ijpds-3865	117	18	for	for	ADP
ijpds-3865	117	19	judicial	judicial	ADJ
ijpds-3865	117	20	antibiotic	antibiotic	ADJ
ijpds-3865	117	21	use	use	NOUN
ijpds-3865	117	22	vol	vol	NOUN
ijpds-3865	117	23	2	2	NUM
ijpds-3865	117	24	|	|	NOUN
ijpds-3865	117	25	issue	issue	NOUN
ijpds-3865	117	26	1	1	NUM
ijpds-3865	117	27	|	|	ADV
ijpds-3865	117	28	jan	jan	PROPN
ijpds-3865	117	29	–	–	PUNCT
ijpds-3865	117	30	mar	mar	PROPN
ijpds-3865	117	31	2023	2023	NUM
ijpds-3865	117	32	indian	indian	PROPN
ijpds-3865	117	33	j	j	PROPN
ijpds-3865	117	34	pharm	pharm	PROPN
ijpds-3865	117	35	drug	drug	PROPN
ijpds-3865	117	36	studies	study	NOUN
ijpds-3865	117	37	|	|	ADV
ijpds-3865	117	38	14	14	NUM
ijpds-3865	117	39	prevalence	prevalence	NOUN
ijpds-3865	117	40	of	of	ADP
ijpds-3865	117	41	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	117	42	resistance	resistance	NOUN
ijpds-3865	117	43	among	among	ADP
ijpds-3865	117	44	shigella	shigella	PROPN
ijpds-3865	117	45	spp	spp	PROPN
ijpds-3865	117	46	.	.	PROPN
ijpds-3865	117	47	was	be	AUX
ijpds-3865	117	48	found	find	VERB
ijpds-3865	117	49	in	in	ADP
ijpds-3865	117	50	europe	europe	PROPN
ijpds-3865	117	51	-	-	PUNCT
ijpds-3865	117	52	america	america	PROPN
ijpds-3865	117	53	countries	country	NOUN
ijpds-3865	117	54	.	.	PUNCT
ijpds-3865	118	1	in	in	ADP
ijpds-3865	118	2	contrast	contrast	NOUN
ijpds-3865	118	3	,	,	PUNCT
ijpds-3865	118	4	asia	asia	PROPN
ijpds-3865	118	5	and	and	CCONJ
ijpds-3865	118	6	africa	africa	PROPN
ijpds-3865	118	7	saw	see	VERB
ijpds-3865	118	8	a	a	DET
ijpds-3865	118	9	clear	clear	ADJ
ijpds-3865	118	10	increasing	increase	VERB
ijpds-3865	118	11	trend	trend	NOUN
ijpds-3865	118	12	in	in	ADP
ijpds-3865	118	13	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	118	14	resistance	resistance	NOUN
ijpds-3865	118	15	,	,	PUNCT
ijpds-3865	118	16	especially	especially	ADV
ijpds-3865	118	17	after	after	ADP
ijpds-3865	118	18	2007	2007	NUM
ijpds-3865	118	19	.	.	PUNCT
ijpds-3865	119	1	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	119	2	resistance	resistance	PROPN
ijpds-3865	119	3	was	be	AUX
ijpds-3865	119	4	present	present	ADJ
ijpds-3865	119	5	on	on	ADP
ijpds-3865	119	6	average	average	ADJ
ijpds-3865	119	7	at	at	ADP
ijpds-3865	119	8	a	a	DET
ijpds-3865	119	9	rate	rate	NOUN
ijpds-3865	119	10	of	of	ADP
ijpds-3865	119	11	5	5	NUM
ijpds-3865	119	12	%	%	NOUN
ijpds-3865	119	13	in	in	ADP
ijpds-3865	119	14	asia	asia	PROPN
ijpds-3865	119	15	and	and	CCONJ
ijpds-3865	119	16	africa	africa	PROPN
ijpds-3865	119	17	,	,	PUNCT
ijpds-3865	119	18	which	which	PRON
ijpds-3865	119	19	is	be	AUX
ijpds-3865	119	20	6	6	NUM
ijpds-3865	119	21	times	time	NOUN
ijpds-3865	119	22	higher	high	ADJ
ijpds-3865	119	23	than	than	ADP
ijpds-3865	119	24	that	that	PRON
ijpds-3865	119	25	of	of	ADP
ijpds-3865	119	26	europe	europe	PROPN
ijpds-3865	119	27	and	and	CCONJ
ijpds-3865	119	28	north	north	PROPN
ijpds-3865	119	29	america	america	PROPN
ijpds-3865	119	30	.	.	PUNCT
ijpds-3865	120	1	in	in	ADP
ijpds-3865	120	2	addition	addition	NOUN
ijpds-3865	120	3	,	,	PUNCT
ijpds-3865	120	4	asia	asia	PROPN
ijpds-3865	120	5	-	-	PUNCT
ijpds-3865	120	6	africa	africa	PROPN
ijpds-3865	120	7	had	have	VERB
ijpds-3865	120	8	resistance	resistance	NOUN
ijpds-3865	120	9	rates	rate	NOUN
ijpds-3865	120	10	to	to	ADP
ijpds-3865	120	11	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	120	12	,	,	PUNCT
ijpds-3865	120	13	cefotaxime	cefotaxime	NOUN
ijpds-3865	120	14	,	,	PUNCT
ijpds-3865	120	15	and	and	CCONJ
ijpds-3865	120	16	ceftazidime	ceftazidime	NOUN
ijpds-3865	120	17	that	that	PRON
ijpds-3865	120	18	were	be	AUX
ijpds-3865	120	19	up	up	ADP
ijpds-3865	120	20	to	to	ADP
ijpds-3865	120	21	142	142	NUM
ijpds-3865	120	22	%	%	NOUN
ijpds-3865	120	23	,	,	PUNCT
ijpds-3865	120	24	226	226	NUM
ijpds-3865	120	25	%	%	NOUN
ijpds-3865	120	26	,	,	PUNCT
ijpds-3865	120	27	and	and	CCONJ
ijpds-3865	120	28	62	62	NUM
ijpds-3865	120	29	%	%	NOUN
ijpds-3865	120	30	,	,	PUNCT
ijpds-3865	120	31	respectively	respectively	ADV
ijpds-3865	120	32	,	,	PUNCT
ijpds-3865	120	33	between	between	ADP
ijpds-3865	120	34	2010	2010	NUM
ijpds-3865	120	35	and	and	CCONJ
ijpds-3865	120	36	2012	2012	NUM
ijpds-3865	120	37	.	.	PUNCT
ijpds-3865	121	1	this	this	DET
ijpds-3865	121	2	warrants	warrant	NOUN
ijpds-3865	121	3	rapid	rapid	ADJ
ijpds-3865	121	4	action	action	NOUN
ijpds-3865	121	5	[	[	X
ijpds-3865	121	6	55	55	NUM
ijpds-3865	121	7	]	]	PUNCT
ijpds-3865	121	8	.	.	PUNCT
ijpds-3865	122	1	this	this	DET
ijpds-3865	122	2	phenomenon	phenomenon	NOUN
ijpds-3865	122	3	could	could	AUX
ijpds-3865	122	4	have	have	VERB
ijpds-3865	122	5	a	a	DET
ijpds-3865	122	6	number	number	NOUN
ijpds-3865	122	7	of	of	ADP
ijpds-3865	122	8	explanations	explanation	NOUN
ijpds-3865	122	9	.	.	PUNCT
ijpds-3865	123	1	the	the	DET
ijpds-3865	123	2	major	major	ADJ
ijpds-3865	123	3	cause	cause	NOUN
ijpds-3865	123	4	is	be	AUX
ijpds-3865	123	5	regional	regional	ADJ
ijpds-3865	123	6	variations	variation	NOUN
ijpds-3865	123	7	,	,	PUNCT
ijpds-3865	123	8	which	which	PRON
ijpds-3865	123	9	have	have	VERB
ijpds-3865	123	10	a	a	DET
ijpds-3865	123	11	direct	direct	ADJ
ijpds-3865	123	12	impact	impact	NOUN
ijpds-3865	123	13	on	on	ADP
ijpds-3865	123	14	socioeconomic	socioeconomic	ADJ
ijpds-3865	123	15	position	position	NOUN
ijpds-3865	123	16	.	.	PUNCT
ijpds-3865	124	1	individuals	individual	NOUN
ijpds-3865	124	2	in	in	ADP
ijpds-3865	124	3	more	more	ADV
ijpds-3865	124	4	developed	developed	ADJ
ijpds-3865	124	5	regions	region	NOUN
ijpds-3865	124	6	(	(	PUNCT
ijpds-3865	124	7	such	such	ADJ
ijpds-3865	124	8	as	as	ADP
ijpds-3865	124	9	europe	europe	PROPN
ijpds-3865	124	10	and	and	CCONJ
ijpds-3865	124	11	america	america	PROPN
ijpds-3865	124	12	)	)	PUNCT
ijpds-3865	124	13	typically	typically	ADV
ijpds-3865	124	14	receive	receive	VERB
ijpds-3865	124	15	better	well	ADJ
ijpds-3865	124	16	care	care	NOUN
ijpds-3865	124	17	after	after	ADP
ijpds-3865	124	18	contracting	contract	VERB
ijpds-3865	124	19	an	an	DET
ijpds-3865	124	20	infection	infection	NOUN
ijpds-3865	124	21	than	than	ADP
ijpds-3865	124	22	people	people	NOUN
ijpds-3865	124	23	in	in	ADP
ijpds-3865	124	24	less	less	ADJ
ijpds-3865	124	25	developed	developed	ADJ
ijpds-3865	124	26	nations	nation	NOUN
ijpds-3865	124	27	(	(	PUNCT
ijpds-3865	124	28	asia	asia	PROPN
ijpds-3865	124	29	-	-	PUNCT
ijpds-3865	124	30	africa	africa	PROPN
ijpds-3865	124	31	)	)	PUNCT
ijpds-3865	124	32	.	.	PUNCT
ijpds-3865	125	1	second	second	ADJ
ijpds-3865	125	2	,	,	PUNCT
ijpds-3865	125	3	flaws	flaw	NOUN
ijpds-3865	125	4	in	in	ADP
ijpds-3865	125	5	medical	medical	ADJ
ijpds-3865	125	6	infrastructure	infrastructure	NOUN
ijpds-3865	125	7	and	and	CCONJ
ijpds-3865	125	8	facilities	facility	NOUN
ijpds-3865	125	9	are	be	AUX
ijpds-3865	125	10	also	also	ADV
ijpds-3865	125	11	significant	significant	ADJ
ijpds-3865	125	12	factors	factor	NOUN
ijpds-3865	125	13	.	.	PUNCT
ijpds-3865	126	1	pakistan	pakistan	PROPN
ijpds-3865	126	2	and	and	CCONJ
ijpds-3865	126	3	other	other	ADJ
ijpds-3865	126	4	asian	asian	ADJ
ijpds-3865	126	5	-	-	PUNCT
ijpds-3865	126	6	african	african	ADJ
ijpds-3865	126	7	nations	nation	NOUN
ijpds-3865	126	8	lack	lack	VERB
ijpds-3865	126	9	the	the	DET
ijpds-3865	126	10	infrastructure	infrastructure	NOUN
ijpds-3865	126	11	necessary	necessary	ADJ
ijpds-3865	126	12	to	to	PART
ijpds-3865	126	13	track	track	VERB
ijpds-3865	126	14	antimicrobial	antimicrobial	ADJ
ijpds-3865	126	15	resistance	resistance	NOUN
ijpds-3865	126	16	on	on	ADP
ijpds-3865	126	17	a	a	DET
ijpds-3865	126	18	national	national	ADJ
ijpds-3865	126	19	scale	scale	NOUN
ijpds-3865	126	20	[	[	X
ijpds-3865	126	21	56	56	NUM
ijpds-3865	126	22	]	]	PUNCT
ijpds-3865	126	23	.	.	PUNCT
ijpds-3865	127	1	in	in	ADP
ijpds-3865	127	2	addition	addition	NOUN
ijpds-3865	127	3	,	,	PUNCT
ijpds-3865	127	4	cheap	cheap	ADJ
ijpds-3865	127	5	antibiotics	antibiotic	NOUN
ijpds-3865	127	6	are	be	AUX
ijpds-3865	127	7	widely	widely	ADV
ijpds-3865	127	8	accessible	accessible	ADJ
ijpds-3865	127	9	from	from	ADP
ijpds-3865	127	10	both	both	CCONJ
ijpds-3865	127	11	licensed	licensed	ADJ
ijpds-3865	127	12	and	and	CCONJ
ijpds-3865	127	13	unlicensed	unlicensed	ADJ
ijpds-3865	127	14	sources	source	NOUN
ijpds-3865	127	15	in	in	ADP
ijpds-3865	127	16	many	many	ADJ
ijpds-3865	127	17	asian	asian	ADJ
ijpds-3865	127	18	and	and	CCONJ
ijpds-3865	127	19	african	african	ADJ
ijpds-3865	127	20	nations	nation	NOUN
ijpds-3865	127	21	,	,	PUNCT
ijpds-3865	127	22	which	which	PRON
ijpds-3865	127	23	contributes	contribute	VERB
ijpds-3865	127	24	to	to	ADP
ijpds-3865	127	25	drug	drug	NOUN
ijpds-3865	127	26	addiction	addiction	NOUN
ijpds-3865	127	27	and	and	CCONJ
ijpds-3865	127	28	a	a	DET
ijpds-3865	127	29	high	high	ADJ
ijpds-3865	127	30	rate	rate	NOUN
ijpds-3865	127	31	of	of	ADP
ijpds-3865	127	32	resistance	resistance	NOUN
ijpds-3865	127	33	[	[	X
ijpds-3865	127	34	57	57	NUM
ijpds-3865	127	35	]	]	PUNCT
ijpds-3865	127	36	.	.	PUNCT
ijpds-3865	128	1	third	third	ADJ
ijpds-3865	128	2	,	,	PUNCT
ijpds-3865	128	3	the	the	DET
ijpds-3865	128	4	lack	lack	NOUN
ijpds-3865	128	5	of	of	ADP
ijpds-3865	128	6	access	access	NOUN
ijpds-3865	128	7	to	to	ADP
ijpds-3865	128	8	safe	safe	ADJ
ijpds-3865	128	9	drinking	drinking	NOUN
ijpds-3865	128	10	water	water	NOUN
ijpds-3865	128	11	and	and	CCONJ
ijpds-3865	128	12	inadequate	inadequate	ADJ
ijpds-3865	128	13	sanitation	sanitation	NOUN
ijpds-3865	128	14	lead	lead	NOUN
ijpds-3865	128	15	to	to	ADP
ijpds-3865	128	16	the	the	DET
ijpds-3865	128	17	emergence	emergence	NOUN
ijpds-3865	128	18	of	of	ADP
ijpds-3865	128	19	mdr	mdr	PROPN
ijpds-3865	128	20	strains	strain	NOUN
ijpds-3865	128	21	of	of	ADP
ijpds-3865	128	22	shigella	shigella	PROPN
ijpds-3865	128	23	.	.	PUNCT
ijpds-3865	129	1	malnutrition	malnutrition	NOUN
ijpds-3865	129	2	is	be	AUX
ijpds-3865	129	3	one	one	NUM
ijpds-3865	129	4	of	of	ADP
ijpds-3865	129	5	the	the	DET
ijpds-3865	129	6	underlying	underlie	VERB
ijpds-3865	129	7	factors	factor	NOUN
ijpds-3865	129	8	that	that	PRON
ijpds-3865	129	9	raise	raise	VERB
ijpds-3865	129	10	the	the	DET
ijpds-3865	129	11	risk	risk	NOUN
ijpds-3865	129	12	of	of	ADP
ijpds-3865	129	13	diarrhoea	diarrhoea	NOUN
ijpds-3865	129	14	and	and	CCONJ
ijpds-3865	129	15	is	be	AUX
ijpds-3865	129	16	widespread	widespread	ADJ
ijpds-3865	129	17	in	in	ADP
ijpds-3865	129	18	asian	asian	ADJ
ijpds-3865	129	19	and	and	CCONJ
ijpds-3865	129	20	african	african	ADJ
ijpds-3865	129	21	nations	nation	NOUN
ijpds-3865	129	22	[	[	X
ijpds-3865	129	23	58	58	NUM
ijpds-3865	129	24	]	]	PUNCT
ijpds-3865	129	25	.	.	PUNCT
ijpds-3865	130	1	enterobacter	enterobacter	ADJ
ijpds-3865	130	2	cloacae	cloacae	NOUN
ijpds-3865	130	3	the	the	DET
ijpds-3865	130	4	environmental	environmental	ADJ
ijpds-3865	130	5	pathogen	pathogen	NOUN
ijpds-3865	130	6	enterobacter	enterobacter	ADJ
ijpds-3865	130	7	cloacae	cloacae	NOUN
ijpds-3865	130	8	complex	complex	NOUN
ijpds-3865	130	9	(	(	PUNCT
ijpds-3865	130	10	ecc	ecc	PROPN
ijpds-3865	130	11	)	)	PUNCT
ijpds-3865	130	12	,	,	PUNCT
ijpds-3865	130	13	which	which	PRON
ijpds-3865	130	14	is	be	AUX
ijpds-3865	130	15	common	common	ADJ
ijpds-3865	130	16	,	,	PUNCT
ijpds-3865	130	17	is	be	AUX
ijpds-3865	130	18	a	a	DET
ijpds-3865	130	19	significant	significant	ADJ
ijpds-3865	130	20	cause	cause	NOUN
ijpds-3865	130	21	of	of	ADP
ijpds-3865	130	22	nosocomial	nosocomial	ADJ
ijpds-3865	130	23	infections	infection	NOUN
ijpds-3865	130	24	.	.	PUNCT
ijpds-3865	131	1	the	the	DET
ijpds-3865	131	2	therapeutic	therapeutic	ADJ
ijpds-3865	131	3	importance	importance	NOUN
ijpds-3865	131	4	of	of	ADP
ijpds-3865	131	5	each	each	DET
ijpds-3865	131	6	species	specie	NOUN
ijpds-3865	131	7	within	within	ADP
ijpds-3865	131	8	ecc	ecc	PROPN
ijpds-3865	131	9	is	be	AUX
ijpds-3865	131	10	less	less	ADV
ijpds-3865	131	11	understood	understand	VERB
ijpds-3865	131	12	since	since	SCONJ
ijpds-3865	131	13	standard	standard	ADJ
ijpds-3865	131	14	techniques	technique	NOUN
ijpds-3865	131	15	used	use	VERB
ijpds-3865	131	16	in	in	ADP
ijpds-3865	131	17	clinical	clinical	ADJ
ijpds-3865	131	18	laboratories	laboratory	NOUN
ijpds-3865	131	19	can	can	AUX
ijpds-3865	131	20	not	not	PART
ijpds-3865	131	21	distinguish	distinguish	VERB
ijpds-3865	131	22	between	between	ADP
ijpds-3865	131	23	species	specie	NOUN
ijpds-3865	131	24	within	within	ADP
ijpds-3865	131	25	ecc.gram	ecc.gram	NOUN
ijpds-3865	131	26	-	-	PUNCT
ijpds-3865	131	27	negative	negative	ADJ
ijpds-3865	131	28	rods	rod	NOUN
ijpds-3865	131	29	resistant	resistant	ADJ
ijpds-3865	131	30	to	to	ADP
ijpds-3865	131	31	third	third	ADJ
ijpds-3865	131	32	-	-	PUNCT
ijpds-3865	131	33	generation	generation	NOUN
ijpds-3865	131	34	cephalosporins	cephalosporin	NOUN
ijpds-3865	131	35	are	be	AUX
ijpds-3865	131	36	included	include	VERB
ijpds-3865	131	37	in	in	ADP
ijpds-3865	131	38	the	the	DET
ijpds-3865	131	39	broad	broad	ADJ
ijpds-3865	131	40	spectrum	spectrum	NOUN
ijpds-3865	131	41	of	of	ADP
ijpds-3865	131	42	antibacterial	antibacterial	ADJ
ijpds-3865	131	43	activity	activity	NOUN
ijpds-3865	131	44	of	of	ADP
ijpds-3865	131	45	carbapenems	carbapenem	NOUN
ijpds-3865	131	46	.	.	PUNCT
ijpds-3865	132	1	the	the	DET
ijpds-3865	132	2	main	main	ADJ
ijpds-3865	132	3	cause	cause	NOUN
ijpds-3865	132	4	of	of	ADP
ijpds-3865	132	5	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	132	6	resistance	resistance	NOUN
ijpds-3865	132	7	is	be	AUX
ijpds-3865	132	8	the	the	DET
ijpds-3865	132	9	pre	pre	ADJ
ijpds-3865	132	10	-	-	ADJ
ijpds-3865	132	11	existing	exist	VERB
ijpds-3865	132	12	presence	presence	NOUN
ijpds-3865	132	13	of	of	ADP
ijpds-3865	132	14	resistant	resistant	ADJ
ijpds-3865	132	15	clones	clone	NOUN
ijpds-3865	132	16	(	(	PUNCT
ijpds-3865	132	17	also	also	ADV
ijpds-3865	132	18	known	know	VERB
ijpds-3865	132	19	as	as	ADP
ijpds-3865	132	20	"	"	PUNCT
ijpds-3865	132	21	derepressed	derepresse	VERB
ijpds-3865	132	22	mutants	mutant	NOUN
ijpds-3865	132	23	"	"	PUNCT
ijpds-3865	132	24	)	)	PUNCT
ijpds-3865	132	25	in	in	ADP
ijpds-3865	132	26	the	the	DET
ijpds-3865	132	27	enterobacter	enterobacter	ADJ
ijpds-3865	132	28	populations	population	NOUN
ijpds-3865	132	29	.	.	PUNCT
ijpds-3865	133	1	the	the	DET
ijpds-3865	133	2	majority	majority	NOUN
ijpds-3865	133	3	of	of	ADP
ijpds-3865	133	4	resistant	resistant	ADJ
ijpds-3865	133	5	clones	clone	NOUN
ijpds-3865	133	6	generate	generate	VERB
ijpds-3865	133	7	substantial	substantial	ADJ
ijpds-3865	133	8	levels	level	NOUN
ijpds-3865	133	9	of	of	ADP
ijpds-3865	133	10	beta	beta	NOUN
ijpds-3865	133	11	-	-	PUNCT
ijpds-3865	133	12	lactamases	lactamase	NOUN
ijpds-3865	133	13	,	,	PUNCT
ijpds-3865	133	14	and	and	CCONJ
ijpds-3865	133	15	some	some	PRON
ijpds-3865	133	16	of	of	ADP
ijpds-3865	133	17	them	they	PRON
ijpds-3865	133	18	exhibit	exhibit	NOUN
ijpds-3865	133	19	decreased	decrease	VERB
ijpds-3865	133	20	porin	porin	PROPN
ijpds-3865	133	21	f	f	PROPN
ijpds-3865	133	22	expression	expression	NOUN
ijpds-3865	133	23	together	together	ADV
ijpds-3865	133	24	with	with	ADP
ijpds-3865	133	25	enhanced	enhanced	ADJ
ijpds-3865	133	26	porin	porin	PROPN
ijpds-3865	133	27	c	c	PROPN
ijpds-3865	133	28	expression	expression	NOUN
ijpds-3865	133	29	.	.	PUNCT
ijpds-3865	134	1	in	in	ADP
ijpds-3865	134	2	a	a	DET
ijpds-3865	134	3	hplc	hplc	NOUN
ijpds-3865	134	4	-	-	PUNCT
ijpds-3865	134	5	based	base	VERB
ijpds-3865	134	6	approach	approach	NOUN
ijpds-3865	134	7	conducted	conduct	VERB
ijpds-3865	134	8	by	by	ADP
ijpds-3865	134	9	pechere	pechere	PROPN
ijpds-3865	134	10	et	et	PROPN
ijpds-3865	134	11	al	al	PROPN
ijpds-3865	134	12	the	the	DET
ijpds-3865	134	13	author	author	NOUN
ijpds-3865	134	14	used	use	VERB
ijpds-3865	134	15	hplc	hplc	PROPN
ijpds-3865	134	16	to	to	PART
ijpds-3865	134	17	determine	determine	VERB
ijpds-3865	134	18	the	the	DET
ijpds-3865	134	19	outer	outer	ADJ
ijpds-3865	134	20	membrane	membrane	NOUN
ijpds-3865	134	21	permeability	permeability	NOUN
ijpds-3865	134	22	in	in	ADP
ijpds-3865	134	23	intact	intact	ADJ
ijpds-3865	134	24	cells	cell	NOUN
ijpds-3865	134	25	,	,	PUNCT
ijpds-3865	134	26	and	and	CCONJ
ijpds-3865	134	27	the	the	DET
ijpds-3865	134	28	results	result	NOUN
ijpds-3865	134	29	revealed	reveal	VERB
ijpds-3865	134	30	that	that	SCONJ
ijpds-3865	134	31	imipenem	imipenem	PROPN
ijpds-3865	134	32	penetrated	penetrate	VERB
ijpds-3865	134	33	three	three	NUM
ijpds-3865	134	34	times	time	NOUN
ijpds-3865	134	35	more	more	ADV
ijpds-3865	134	36	quickly	quickly	ADV
ijpds-3865	134	37	than	than	ADP
ijpds-3865	134	38	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	134	39	.	.	PUNCT
ijpds-3865	135	1	furthermore	furthermore	ADV
ijpds-3865	135	2	,	,	PUNCT
ijpds-3865	135	3	imipenem	imipenem	ADJ
ijpds-3865	135	4	penetration	penetration	NOUN
ijpds-3865	135	5	was	be	AUX
ijpds-3865	135	6	unaffected	unaffected	ADJ
ijpds-3865	135	7	in	in	ADP
ijpds-3865	135	8	a	a	DET
ijpds-3865	135	9	porin	porin	NOUN
ijpds-3865	135	10	f	f	PROPN
ijpds-3865	135	11	defective	defective	ADJ
ijpds-3865	135	12	mutant	mutant	NOUN
ijpds-3865	135	13	,	,	PUNCT
ijpds-3865	135	14	in	in	ADP
ijpds-3865	135	15	contrast	contrast	NOUN
ijpds-3865	135	16	to	to	ADP
ijpds-3865	135	17	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	135	18	.	.	PUNCT
ijpds-3865	136	1	this	this	PRON
ijpds-3865	136	2	implied	imply	VERB
ijpds-3865	136	3	that	that	SCONJ
ijpds-3865	136	4	imipenem	imipenem	PROPN
ijpds-3865	136	5	has	have	VERB
ijpds-3865	136	6	a	a	DET
ijpds-3865	136	7	different	different	ADJ
ijpds-3865	136	8	route	route	NOUN
ijpds-3865	136	9	,	,	PUNCT
ijpds-3865	137	1	possibly	possibly	ADV
ijpds-3865	137	2	porin	porin	PROPN
ijpds-3865	137	3	c	c	PROPN
ijpds-3865	137	4	,	,	PUNCT
ijpds-3865	137	5	then	then	ADV
ijpds-3865	137	6	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	137	7	.	.	PUNCT
ijpds-3865	138	1	the	the	DET
ijpds-3865	138	2	affinity	affinity	NOUN
ijpds-3865	138	3	for	for	ADP
ijpds-3865	138	4	pbps	pbps	NOUN
ijpds-3865	138	5	,	,	PUNCT
ijpds-3865	138	6	as	as	SCONJ
ijpds-3865	138	7	determined	determine	VERB
ijpds-3865	138	8	by	by	ADP
ijpds-3865	138	9	computation	computation	NOUN
ijpds-3865	138	10	,	,	PUNCT
ijpds-3865	138	11	and	and	CCONJ
ijpds-3865	138	12	the	the	DET
ijpds-3865	138	13	rate	rate	NOUN
ijpds-3865	138	14	of	of	ADP
ijpds-3865	138	15	beta	beta	NOUN
ijpds-3865	138	16	-	-	PUNCT
ijpds-3865	138	17	lactamase	lactamase	NOUN
ijpds-3865	138	18	hydrolysis	hydrolysis	NOUN
ijpds-3865	138	19	under	under	ADP
ijpds-3865	138	20	experimental	experimental	ADJ
ijpds-3865	138	21	settings	setting	NOUN
ijpds-3865	138	22	that	that	PRON
ijpds-3865	138	23	were	be	AUX
ijpds-3865	138	24	believed	believe	VERB
ijpds-3865	138	25	to	to	PART
ijpds-3865	138	26	be	be	AUX
ijpds-3865	138	27	physiologically	physiologically	ADV
ijpds-3865	138	28	relevant	relevant	ADJ
ijpds-3865	138	29	were	be	AUX
ijpds-3865	138	30	comparable	comparable	ADJ
ijpds-3865	138	31	for	for	ADP
ijpds-3865	138	32	the	the	DET
ijpds-3865	138	33	two	two	NUM
ijpds-3865	138	34	antibiotics	antibiotic	NOUN
ijpds-3865	138	35	.	.	PUNCT
ijpds-3865	139	1	thus	thus	ADV
ijpds-3865	139	2	,	,	PUNCT
ijpds-3865	139	3	selective	selective	ADJ
ijpds-3865	139	4	permeability	permeability	NOUN
ijpds-3865	139	5	of	of	ADP
ijpds-3865	139	6	the	the	DET
ijpds-3865	139	7	outer	outer	ADJ
ijpds-3865	139	8	membrane	membrane	NOUN
ijpds-3865	139	9	appears	appear	VERB
ijpds-3865	139	10	to	to	PART
ijpds-3865	139	11	be	be	AUX
ijpds-3865	139	12	the	the	DET
ijpds-3865	139	13	main	main	ADJ
ijpds-3865	139	14	cause	cause	NOUN
ijpds-3865	139	15	of	of	ADP
ijpds-3865	139	16	imipenem	imipenem	PROPN
ijpds-3865	139	17	's	's	PART
ijpds-3865	139	18	action	action	NOUN
ijpds-3865	139	19	against	against	ADP
ijpds-3865	139	20	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	139	21	-	-	PUNCT
ijpds-3865	139	22	resistant	resistant	ADJ
ijpds-3865	139	23	e.	e.	PROPN
ijpds-3865	139	24	cloacae	cloacae	PROPN
ijpds-3865	140	1	[	[	X
ijpds-3865	140	2	59	59	NUM
ijpds-3865	140	3	]	]	PUNCT
ijpds-3865	140	4	.	.	PUNCT
ijpds-3865	141	1	because	because	SCONJ
ijpds-3865	141	2	ecc	ecc	PROPN
ijpds-3865	141	3	isolates	isolate	NOUN
ijpds-3865	141	4	display	display	VERB
ijpds-3865	141	5	intrinsic	intrinsic	ADJ
ijpds-3865	141	6	ampc	ampc	PROPN
ijpds-3865	141	7	-lactamases	-lactamase	NOUN
ijpds-3865	141	8	,	,	PUNCT
ijpds-3865	141	9	such	such	ADJ
ijpds-3865	141	10	as	as	ADP
ijpds-3865	141	11	cmh	cmh	PROPN
ijpds-3865	141	12	,	,	PUNCT
ijpds-3865	141	13	act	act	PROPN
ijpds-3865	141	14	,	,	PUNCT
ijpds-3865	141	15	and	and	CCONJ
ijpds-3865	141	16	mir	mir	NOUN
ijpds-3865	141	17	with	with	ADP
ijpds-3865	141	18	numerous	numerous	ADJ
ijpds-3865	141	19	variations	variation	NOUN
ijpds-3865	141	20	,	,	PUNCT
ijpds-3865	141	21	they	they	PRON
ijpds-3865	141	22	are	be	AUX
ijpds-3865	141	23	innately	innately	ADV
ijpds-3865	141	24	resistant	resistant	ADJ
ijpds-3865	141	25	to	to	ADP
ijpds-3865	141	26	ampicillin	ampicillin	PROPN
ijpds-3865	141	27	,	,	PUNCT
ijpds-3865	141	28	amoxicillin	amoxicillin	NOUN
ijpds-3865	141	29	-	-	PUNCT
ijpds-3865	141	30	clavulanate	clavulanate	NOUN
ijpds-3865	141	31	,	,	PUNCT
ijpds-3865	141	32	and	and	CCONJ
ijpds-3865	141	33	first	first	ADV
ijpds-3865	141	34	and	and	CCONJ
ijpds-3865	141	35	secondgeneration	secondgeneration	NOUN
ijpds-3865	141	36	cephalosporins	cephalosporin	NOUN
ijpds-3865	141	37	[	[	X
ijpds-3865	141	38	60	60	NUM
ijpds-3865	141	39	]	]	PUNCT
ijpds-3865	141	40	.	.	PUNCT
ijpds-3865	142	1	antibiotic	antibiotic	ADJ
ijpds-3865	142	2	usage	usage	NOUN
ijpds-3865	142	3	has	have	AUX
ijpds-3865	142	4	led	lead	VERB
ijpds-3865	142	5	to	to	ADP
ijpds-3865	142	6	the	the	DET
ijpds-3865	142	7	emergence	emergence	NOUN
ijpds-3865	142	8	and	and	CCONJ
ijpds-3865	142	9	global	global	ADJ
ijpds-3865	142	10	spread	spread	NOUN
ijpds-3865	142	11	of	of	ADP
ijpds-3865	142	12	multidrug	multidrug	NOUN
ijpds-3865	142	13	resistant	resistant	ADJ
ijpds-3865	142	14	(	(	PUNCT
ijpds-3865	142	15	mdr	mdr	PROPN
ijpds-3865	142	16	)	)	PUNCT
ijpds-3865	142	17	ecc	ecc	PROPN
ijpds-3865	142	18	strains	strain	VERB
ijpds-3865	142	19	[	[	X
ijpds-3865	142	20	61	61	NUM
ijpds-3865	142	21	]	]	PUNCT
ijpds-3865	142	22	.	.	PUNCT
ijpds-3865	143	1	third	third	ADJ
ijpds-3865	143	2	-	-	PUNCT
ijpds-3865	143	3	generation	generation	NOUN
ijpds-3865	143	4	cephalosporin	cephalosporin	NOUN
ijpds-3865	143	5	resistance	resistance	NOUN
ijpds-3865	143	6	is	be	AUX
ijpds-3865	143	7	also	also	ADV
ijpds-3865	143	8	brought	bring	VERB
ijpds-3865	143	9	on	on	ADP
ijpds-3865	143	10	by	by	ADP
ijpds-3865	143	11	the	the	DET
ijpds-3865	143	12	acquisition	acquisition	NOUN
ijpds-3865	143	13	of	of	ADP
ijpds-3865	143	14	genes	gene	NOUN
ijpds-3865	143	15	encoding	encode	VERB
ijpds-3865	143	16	extended	extend	VERB
ijpds-3865	143	17	spectrum	spectrum	NOUN
ijpds-3865	143	18	-lactamase	-lactamase	NOUN
ijpds-3865	143	19	(	(	PUNCT
ijpds-3865	143	20	esbl	esbl	NOUN
ijpds-3865	143	21	)	)	PUNCT
ijpds-3865	143	22	.	.	PUNCT
ijpds-3865	144	1	additionally	additionally	ADV
ijpds-3865	144	2	,	,	PUNCT
ijpds-3865	144	3	treatment	treatment	NOUN
ijpds-3865	144	4	is	be	AUX
ijpds-3865	144	5	becoming	becoming	AUX
ijpds-3865	144	6	challenging	challenge	VERB
ijpds-3865	144	7	due	due	ADJ
ijpds-3865	144	8	to	to	ADP
ijpds-3865	144	9	the	the	DET
ijpds-3865	144	10	advent	advent	NOUN
ijpds-3865	144	11	and	and	CCONJ
ijpds-3865	144	12	rising	rise	VERB
ijpds-3865	144	13	prevalence	prevalence	NOUN
ijpds-3865	144	14	of	of	ADP
ijpds-3865	144	15	carbapenem	carbapenem	NOUN
ijpds-3865	144	16	-	-	PUNCT
ijpds-3865	144	17	resistant	resistant	ADJ
ijpds-3865	144	18	ecc	ecc	PROPN
ijpds-3865	144	19	.	.	PUNCT
ijpds-3865	145	1	mdr	mdr	PROPN
ijpds-3865	145	2	strain	strain	PROPN
ijpds-3865	145	3	infections	infection	NOUN
ijpds-3865	145	4	typically	typically	ADV
ijpds-3865	145	5	result	result	VERB
ijpds-3865	145	6	in	in	ADP
ijpds-3865	145	7	increased	increase	VERB
ijpds-3865	145	8	mortality	mortality	NOUN
ijpds-3865	145	9	,	,	PUNCT
ijpds-3865	145	10	lengthier	lengthy	ADJ
ijpds-3865	145	11	hospital	hospital	NOUN
ijpds-3865	145	12	stays	stay	NOUN
ijpds-3865	145	13	,	,	PUNCT
ijpds-3865	145	14	and	and	CCONJ
ijpds-3865	145	15	higher	high	ADJ
ijpds-3865	145	16	expenses	expense	NOUN
ijpds-3865	145	17	,	,	PUNCT
ijpds-3865	145	18	having	have	VERB
ijpds-3865	145	19	a	a	DET
ijpds-3865	145	20	significant	significant	ADJ
ijpds-3865	145	21	influence	influence	NOUN
ijpds-3865	145	22	on	on	ADP
ijpds-3865	145	23	worldwide	worldwide	ADJ
ijpds-3865	145	24	public	public	ADJ
ijpds-3865	145	25	health	health	NOUN
ijpds-3865	146	1	[	[	X
ijpds-3865	146	2	62	62	NUM
ijpds-3865	146	3	]	]	PUNCT
ijpds-3865	146	4	.	.	PUNCT
ijpds-3865	147	1	conclusion	conclusion	NOUN
ijpds-3865	147	2	antibiotic	antibiotic	ADJ
ijpds-3865	147	3	resistance	resistance	NOUN
ijpds-3865	147	4	should	should	AUX
ijpds-3865	147	5	be	be	AUX
ijpds-3865	147	6	prevented	prevent	VERB
ijpds-3865	147	7	by	by	ADP
ijpds-3865	147	8	reducing	reduce	VERB
ijpds-3865	147	9	the	the	DET
ijpds-3865	147	10	irrational	irrational	ADJ
ijpds-3865	147	11	misuse	misuse	NOUN
ijpds-3865	147	12	of	of	ADP
ijpds-3865	147	13	antibiotics	antibiotic	NOUN
ijpds-3865	147	14	,	,	PUNCT
ijpds-3865	147	15	but	but	CCONJ
ijpds-3865	147	16	designing	design	VERB
ijpds-3865	147	17	successful	successful	ADJ
ijpds-3865	147	18	interventions	intervention	NOUN
ijpds-3865	147	19	to	to	PART
ijpds-3865	147	20	do	do	VERB
ijpds-3865	147	21	so	so	ADV
ijpds-3865	147	22	will	will	AUX
ijpds-3865	147	23	require	require	VERB
ijpds-3865	147	24	a	a	DET
ijpds-3865	147	25	greater	great	ADJ
ijpds-3865	147	26	knowledge	knowledge	NOUN
ijpds-3865	147	27	of	of	ADP
ijpds-3865	147	28	the	the	DET
ijpds-3865	147	29	practices	practice	NOUN
ijpds-3865	147	30	and	and	CCONJ
ijpds-3865	147	31	financial	financial	ADJ
ijpds-3865	147	32	incentives	incentive	NOUN
ijpds-3865	147	33	associated	associate	VERB
ijpds-3865	147	34	with	with	ADP
ijpds-3865	147	35	antibiotic	antibiotic	ADJ
ijpds-3865	147	36	administration	administration	NOUN
ijpds-3865	147	37	.	.	PUNCT
ijpds-3865	148	1	although	although	SCONJ
ijpds-3865	148	2	increased	increase	VERB
ijpds-3865	148	3	cephalosporin	cephalosporin	NOUN
ijpds-3865	148	4	resistance	resistance	NOUN
ijpds-3865	148	5	is	be	AUX
ijpds-3865	148	6	frequently	frequently	ADV
ijpds-3865	148	7	attributed	attribute	VERB
ijpds-3865	148	8	to	to	ADP
ijpds-3865	148	9	a	a	DET
ijpds-3865	148	10	single	single	ADJ
ijpds-3865	148	11	factor	factor	NOUN
ijpds-3865	148	12	(	(	PUNCT
ijpds-3865	148	13	pbp	pbp	NOUN
ijpds-3865	148	14	modification	modification	NOUN
ijpds-3865	148	15	,	,	PUNCT
ijpds-3865	148	16	betalactamase	betalactamase	NOUN
ijpds-3865	148	17	action	action	NOUN
ijpds-3865	148	18	,	,	PUNCT
ijpds-3865	148	19	or	or	CCONJ
ijpds-3865	148	20	impermeability	impermeability	NOUN
ijpds-3865	148	21	)	)	PUNCT
ijpds-3865	148	22	,	,	PUNCT
ijpds-3865	148	23	an	an	DET
ijpds-3865	148	24	organism	organism	NOUN
ijpds-3865	148	25	's	's	PART
ijpds-3865	148	26	response	response	NOUN
ijpds-3865	148	27	to	to	ADP
ijpds-3865	148	28	a	a	DET
ijpds-3865	148	29	drug	drug	NOUN
ijpds-3865	148	30	frequently	frequently	ADV
ijpds-3865	148	31	reflects	reflect	VERB
ijpds-3865	148	32	the	the	DET
ijpds-3865	148	33	interaction	interaction	NOUN
ijpds-3865	148	34	of	of	ADP
ijpds-3865	148	35	several	several	ADJ
ijpds-3865	148	36	factors	factor	NOUN
ijpds-3865	148	37	.	.	PUNCT
ijpds-3865	149	1	there	there	PRON
ijpds-3865	149	2	is	be	VERB
ijpds-3865	149	3	a	a	DET
ijpds-3865	149	4	need	need	NOUN
ijpds-3865	149	5	to	to	PART
ijpds-3865	149	6	develop	develop	VERB
ijpds-3865	149	7	methods	method	NOUN
ijpds-3865	149	8	,	,	PUNCT
ijpds-3865	149	9	such	such	ADJ
ijpds-3865	149	10	as	as	ADP
ijpds-3865	149	11	mathematical	mathematical	ADJ
ijpds-3865	149	12	models	model	NOUN
ijpds-3865	149	13	,	,	PUNCT
ijpds-3865	149	14	to	to	PART
ijpds-3865	149	15	aid	aid	VERB
ijpds-3865	149	16	in	in	ADP
ijpds-3865	149	17	identifying	identify	VERB
ijpds-3865	149	18	the	the	DET
ijpds-3865	149	19	interplay	interplay	NOUN
ijpds-3865	149	20	of	of	ADP
ijpds-3865	149	21	factors	factor	NOUN
ijpds-3865	149	22	that	that	PRON
ijpds-3865	149	23	lead	lead	VERB
ijpds-3865	149	24	to	to	ADP
ijpds-3865	149	25	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	149	26	resistance	resistance	NOUN
ijpds-3865	149	27	.	.	PUNCT
ijpds-3865	150	1	references	reference	NOUN
ijpds-3865	150	2	1	1	NUM
ijpds-3865	150	3	.	.	PUNCT
ijpds-3865	151	1	nahata	nahata	PROPN
ijpds-3865	151	2	mc	mc	PROPN
ijpds-3865	151	3	,	,	PUNCT
ijpds-3865	151	4	barson	barson	PROPN
ijpds-3865	151	5	wj	wj	PROPN
ijpds-3865	151	6	.	.	PUNCT
ijpds-3865	151	7	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	151	8	:	:	PUNCT
ijpds-3865	151	9	a	a	DET
ijpds-3865	151	10	third	third	ADJ
ijpds-3865	151	11	-	-	PUNCT
ijpds-3865	151	12	generation	generation	NOUN
ijpds-3865	151	13	cephalosporin	cephalosporin	NOUN
ijpds-3865	151	14	.	.	PUNCT
ijpds-3865	152	1	vol	vol	NOUN
ijpds-3865	152	2	.	.	PROPN
ijpds-3865	152	3	19	19	NUM
ijpds-3865	152	4	,	,	PUNCT
ijpds-3865	152	5	drug	drug	NOUN
ijpds-3865	152	6	intelligence	intelligence	NOUN
ijpds-3865	152	7	and	and	CCONJ
ijpds-3865	152	8	clinical	clinical	ADJ
ijpds-3865	152	9	pharmacy	pharmacy	NOUN
ijpds-3865	152	10	.	.	PUNCT
ijpds-3865	153	1	1985;19(12	1985;19(12	NUM
ijpds-3865	153	2	)	)	PUNCT
ijpds-3865	153	3	900	900	NUM
ijpds-3865	153	4	-	-	SYM
ijpds-3865	153	5	906	906	NUM
ijpds-3865	153	6	.	.	NOUN
ijpds-3865	154	1	2	2	NUM
ijpds-3865	154	2	.	.	X
ijpds-3865	154	3	villegas	villegas	PROPN
ijpds-3865	154	4	mv	mv	PROPN
ijpds-3865	154	5	,	,	PUNCT
ijpds-3865	154	6	esparza	esparza	PROPN
ijpds-3865	154	7	g	g	PROPN
ijpds-3865	154	8	,	,	PUNCT
ijpds-3865	154	9	reyes	reyes	PROPN
ijpds-3865	154	10	j.	j.	PROPN
ijpds-3865	154	11	should	should	AUX
ijpds-3865	154	12	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	154	13	-	-	PUNCT
ijpds-3865	154	14	resistant	resistant	ADJ
ijpds-3865	154	15	enterobacterales	enterobacterale	NOUN
ijpds-3865	154	16	be	be	AUX
ijpds-3865	154	17	tested	test	VERB
ijpds-3865	154	18	for	for	ADP
ijpds-3865	154	19	esbls	esbls	PROPN
ijpds-3865	154	20	?	?	PUNCT
ijpds-3865	155	1	a	a	DET
ijpds-3865	155	2	pro	pro	ADJ
ijpds-3865	155	3	/	/	ADJ
ijpds-3865	155	4	con	con	ADJ
ijpds-3865	155	5	debate	debate	NOUN
ijpds-3865	155	6	.	.	PUNCT
ijpds-3865	156	1	jacantimicrobial	jacantimicrobial	ADJ
ijpds-3865	156	2	resist	resist	NOUN
ijpds-3865	156	3	.	.	PUNCT
ijpds-3865	157	1	2021;3(2	2021;3(2	NUM
ijpds-3865	157	2	)	)	PUNCT
ijpds-3865	157	3	.	.	PUNCT
ijpds-3865	158	1	3	3	X
ijpds-3865	158	2	.	.	X
ijpds-3865	158	3	piddock	piddock	PROPN
ijpds-3865	158	4	ljv	ljv	PROPN
ijpds-3865	158	5	.	.	PUNCT
ijpds-3865	159	1	the	the	DET
ijpds-3865	159	2	crisis	crisis	NOUN
ijpds-3865	159	3	of	of	ADP
ijpds-3865	159	4	no	no	DET
ijpds-3865	159	5	new	new	ADJ
ijpds-3865	159	6	antibiotics	antibiotic	NOUN
ijpds-3865	159	7	-	-	PUNCT
ijpds-3865	159	8	what	what	PRON
ijpds-3865	159	9	is	be	AUX
ijpds-3865	159	10	the	the	DET
ijpds-3865	159	11	way	way	NOUN
ijpds-3865	159	12	forward	forward	ADV
ijpds-3865	159	13	?	?	PUNCT
ijpds-3865	160	1	the	the	DET
ijpds-3865	160	2	lancet	lancet	ADJ
ijpds-3865	160	3	infectious	infectious	ADJ
ijpds-3865	160	4	diseases	disease	NOUN
ijpds-3865	160	5	.	.	PUNCT
ijpds-3865	160	6	2012	2012	NUM
ijpds-3865	160	7	,	,	PUNCT
ijpds-3865	160	8	12(3	12(3	NUM
ijpds-3865	160	9	)	)	PUNCT
ijpds-3865	160	10	;	;	PUNCT
ijpds-3865	160	11	249	249	NUM
ijpds-3865	160	12	-	-	SYM
ijpds-3865	160	13	253	253	NUM
ijpds-3865	160	14	.	.	PUNCT
ijpds-3865	161	1	4	4	NUM
ijpds-3865	161	2	.	.	X
ijpds-3865	162	1	spellberg	spellberg	PROPN
ijpds-3865	162	2	b	b	PROPN
ijpds-3865	162	3	,	,	PUNCT
ijpds-3865	162	4	gilbert	gilbert	PROPN
ijpds-3865	162	5	dn	dn	PROPN
ijpds-3865	162	6	.	.	PUNCT
ijpds-3865	163	1	the	the	DET
ijpds-3865	163	2	future	future	NOUN
ijpds-3865	163	3	of	of	ADP
ijpds-3865	163	4	antibiotics	antibiotic	NOUN
ijpds-3865	163	5	and	and	CCONJ
ijpds-3865	163	6	resistance	resistance	NOUN
ijpds-3865	163	7	:	:	PUNCT
ijpds-3865	163	8	a	a	DET
ijpds-3865	163	9	tribute	tribute	NOUN
ijpds-3865	163	10	to	to	ADP
ijpds-3865	163	11	a	a	DET
ijpds-3865	163	12	career	career	NOUN
ijpds-3865	163	13	of	of	ADP
ijpds-3865	163	14	leadership	leadership	NOUN
ijpds-3865	163	15	by	by	ADP
ijpds-3865	163	16	john	john	PROPN
ijpds-3865	163	17	bartlett	bartlett	PROPN
ijpds-3865	163	18	.	.	PUNCT
ijpds-3865	164	1	clin	clin	PROPN
ijpds-3865	164	2	infect	infect	PROPN
ijpds-3865	164	3	dis	dis	PROPN
ijpds-3865	164	4	.	.	PUNCT
ijpds-3865	165	1	2014;59	2014;59	PROPN
ijpds-3865	165	2	;	;	PUNCT
ijpds-3865	165	3	71	71	NUM
ijpds-3865	165	4	-	-	SYM
ijpds-3865	165	5	75	75	NUM
ijpds-3865	165	6	.	.	PUNCT
ijpds-3865	166	1	5	5	NUM
ijpds-3865	166	2	.	.	X
ijpds-3865	166	3	rossolini	rossolini	PROPN
ijpds-3865	166	4	gm	gm	PROPN
ijpds-3865	166	5	,	,	PUNCT
ijpds-3865	166	6	arena	arena	NOUN
ijpds-3865	166	7	f	f	PROPN
ijpds-3865	166	8	,	,	PUNCT
ijpds-3865	166	9	pecile	pecile	ADJ
ijpds-3865	166	10	p	p	X
ijpds-3865	166	11	,	,	PUNCT
ijpds-3865	166	12	et	et	PROPN
ijpds-3865	166	13	al	al	PROPN
ijpds-3865	166	14	.	.	PUNCT
ijpds-3865	166	15	update	update	NOUN
ijpds-3865	166	16	on	on	ADP
ijpds-3865	166	17	the	the	DET
ijpds-3865	166	18	antibiotic	antibiotic	ADJ
ijpds-3865	166	19	resistance	resistance	NOUN
ijpds-3865	166	20	crisis	crisis	NOUN
ijpds-3865	166	21	.	.	PUNCT
ijpds-3865	167	1	current	current	ADJ
ijpds-3865	167	2	opinion	opinion	NOUN
ijpds-3865	167	3	in	in	ADP
ijpds-3865	167	4	pharmacology	pharmacology	NOUN
ijpds-3865	167	5	.	.	PUNCT
ijpds-3865	168	1	2014	2014	NUM
ijpds-3865	168	2	,	,	PUNCT
ijpds-3865	168	3	18	18	NUM
ijpds-3865	168	4	;	;	PUNCT
ijpds-3865	168	5	5660	5660	NUM
ijpds-3865	168	6	.	.	PUNCT
ijpds-3865	169	1	6	6	NUM
ijpds-3865	169	2	.	.	X
ijpds-3865	169	3	munita	munita	PROPN
ijpds-3865	169	4	jm	jm	PROPN
ijpds-3865	169	5	,	,	PUNCT
ijpds-3865	169	6	arias	arias	PROPN
ijpds-3865	169	7	ca	ca	PROPN
ijpds-3865	169	8	.	.	PUNCT
ijpds-3865	170	1	mechanisms	mechanism	NOUN
ijpds-3865	170	2	of	of	ADP
ijpds-3865	170	3	antibiotic	antibiotic	ADJ
ijpds-3865	170	4	resistancemunita	resistancemunita	NOUN
ijpds-3865	170	5	,	,	PUNCT
ijpds-3865	170	6	j.	j.	PROPN
ijpds-3865	170	7	m.	m.	PROPN
ijpds-3865	170	8	,	,	PUNCT
ijpds-3865	170	9	&	&	CCONJ
ijpds-3865	170	10	arias	arias	PROPN
ijpds-3865	170	11	,	,	PUNCT
ijpds-3865	170	12	c.	c.	NOUN
ijpds-3865	170	13	a.	a.	NOUN
ijpds-3865	170	14	mechanisms	mechanism	NOUN
ijpds-3865	170	15	of	of	ADP
ijpds-3865	170	16	antibiotic	antibiotic	ADJ
ijpds-3865	170	17	resistance	resistance	NOUN
ijpds-3865	170	18	.	.	PUNCT
ijpds-3865	171	1	microbiology	microbiology	NOUN
ijpds-3865	171	2	spectrum	spectrum	NOUN
ijpds-3865	171	3	,	,	PUNCT
ijpds-3865	171	4	2016	2016	NUM
ijpds-3865	171	5	,	,	PUNCT
ijpds-3865	171	6	4(2	4(2	NUM
ijpds-3865	171	7	)	)	PUNCT
ijpds-3865	171	8	;	;	PUNCT
ijpds-3865	171	9	1–32	1–32	X
ijpds-3865	171	10	.	.	PUNCT
ijpds-3865	172	1	7	7	X
ijpds-3865	172	2	.	.	X
ijpds-3865	173	1	baptista	baptista	PROPN
ijpds-3865	173	2	p	p	PROPN
ijpds-3865	174	1	v.	v.	PROPN
ijpds-3865	174	2	,	,	PUNCT
ijpds-3865	174	3	mccusker	mccusker	PROPN
ijpds-3865	174	4	mp	mp	PROPN
ijpds-3865	174	5	,	,	PUNCT
ijpds-3865	174	6	carvalho	carvalho	NOUN
ijpds-3865	174	7	a	a	PRON
ijpds-3865	174	8	,	,	PUNCT
ijpds-3865	174	9	et	et	PROPN
ijpds-3865	174	10	al	al	PROPN
ijpds-3865	174	11	.	.	PUNCT
ijpds-3865	175	1	nano	nano	NOUN
ijpds-3865	175	2	-	-	PUNCT
ijpds-3865	175	3	strategies	strategy	NOUN
ijpds-3865	175	4	to	to	PART
ijpds-3865	175	5	fight	fight	VERB
ijpds-3865	175	6	multidrug	multidrug	VERB
ijpds-3865	175	7	resistant	resistant	ADJ
ijpds-3865	175	8	bacteria-"a	bacteria-"a	PROPN
ijpds-3865	175	9	battle	battle	NOUN
ijpds-3865	175	10	of	of	ADP
ijpds-3865	175	11	the	the	DET
ijpds-3865	175	12	titans	titan	NOUN
ijpds-3865	175	13	"	"	PUNCT
ijpds-3865	175	14	.	.	PUNCT
ijpds-3865	176	1	frontiers	frontier	NOUN
ijpds-3865	176	2	in	in	ADP
ijpds-3865	176	3	microbiology	microbiology	NOUN
ijpds-3865	176	4	.	.	PUNCT
ijpds-3865	177	1	2018	2018	NUM
ijpds-3865	177	2	,	,	PUNCT
ijpds-3865	177	3	9;1441	9;1441	NUM
ijpds-3865	177	4	.	.	NOUN
ijpds-3865	177	5	8	8	NUM
ijpds-3865	177	6	.	.	PUNCT
ijpds-3865	178	1	zhao	zhao	PROPN
ijpds-3865	178	2	f	f	PROPN
ijpds-3865	178	3	,	,	PUNCT
ijpds-3865	178	4	yang	yang	PROPN
ijpds-3865	178	5	h	h	PROPN
ijpds-3865	178	6	,	,	PUNCT
ijpds-3865	178	7	bi	bi	PROPN
ijpds-3865	178	8	d	d	PROPN
ijpds-3865	178	9	,	,	PUNCT
ijpds-3865	178	10	et	et	PROPN
ijpds-3865	178	11	al	al	PROPN
ijpds-3865	178	12	.	.	PUNCT
ijpds-3865	179	1	a	a	DET
ijpds-3865	179	2	systematic	systematic	ADJ
ijpds-3865	179	3	review	review	NOUN
ijpds-3865	179	4	and	and	CCONJ
ijpds-3865	179	5	metaanalysis	metaanalysis	NOUN
ijpds-3865	179	6	of	of	ADP
ijpds-3865	179	7	antibiotic	antibiotic	ADJ
ijpds-3865	179	8	resistance	resistance	NOUN
ijpds-3865	179	9	patterns	pattern	NOUN
ijpds-3865	179	10	,	,	PUNCT
ijpds-3865	179	11	and	and	CCONJ
ijpds-3865	179	12	the	the	DET
ijpds-3865	179	13	correlation	correlation	NOUN
ijpds-3865	179	14	between	between	ADP
ijpds-3865	179	15	biofilm	biofilm	NOUN
ijpds-3865	179	16	formation	formation	NOUN
ijpds-3865	179	17	with	with	ADP
ijpds-3865	179	18	virulence	virulence	NOUN
ijpds-3865	179	19	factors	factor	NOUN
ijpds-3865	179	20	in	in	ADP
ijpds-3865	179	21	uropathogenic	uropathogenic	ADJ
ijpds-3865	179	22	e.	e.	PROPN
ijpds-3865	179	23	coli	coli	PROPN
ijpds-3865	179	24	isolated	isolate	VERB
ijpds-3865	179	25	from	from	ADP
ijpds-3865	179	26	urinary	urinary	ADJ
ijpds-3865	179	27	tract	tract	NOUN
ijpds-3865	179	28	infections	infection	NOUN
ijpds-3865	179	29	.	.	PUNCT
ijpds-3865	180	1	microbial	microbial	ADJ
ijpds-3865	180	2	pathogenesis	pathogenesis	NOUN
ijpds-3865	180	3	.	.	PUNCT
ijpds-3865	181	1	2020	2020	NUM
ijpds-3865	181	2	,	,	PUNCT
ijpds-3865	181	3	144	144	NUM
ijpds-3865	181	4	;	;	PUNCT
ijpds-3865	181	5	104196	104196	NUM
ijpds-3865	181	6	.	.	PUNCT
ijpds-3865	182	1	9	9	X
ijpds-3865	182	2	.	.	X
ijpds-3865	182	3	gong	gong	PROPN
ijpds-3865	182	4	z	z	PROPN
ijpds-3865	182	5	,	,	PUNCT
ijpds-3865	182	6	lai	lai	PROPN
ijpds-3865	182	7	w	w	PROPN
ijpds-3865	182	8	,	,	PUNCT
ijpds-3865	182	9	liu	liu	PROPN
ijpds-3865	182	10	m	m	PROPN
ijpds-3865	182	11	,	,	PUNCT
ijpds-3865	182	12	et	et	PROPN
ijpds-3865	182	13	al	al	PROPN
ijpds-3865	182	14	.	.	PROPN
ijpds-3865	182	15	novel	novel	ADJ
ijpds-3865	182	16	genes	gene	NOUN
ijpds-3865	182	17	related	relate	VERB
ijpds-3865	182	18	to	to	ADP
ijpds-3865	182	19	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	182	20	mandumpala	mandumpala	NOUN
ijpds-3865	182	21	a	a	DET
ijpds-3865	182	22	caution	caution	NOUN
ijpds-3865	182	23	for	for	ADP
ijpds-3865	182	24	judicial	judicial	ADJ
ijpds-3865	182	25	antibiotic	antibiotic	ADJ
ijpds-3865	182	26	use	use	NOUN
ijpds-3865	182	27	vol	vol	NOUN
ijpds-3865	182	28	2	2	NUM
ijpds-3865	182	29	|	|	NOUN
ijpds-3865	182	30	issue	issue	NOUN
ijpds-3865	182	31	1	1	NUM
ijpds-3865	182	32	|	|	ADV
ijpds-3865	182	33	jan	jan	PROPN
ijpds-3865	182	34	–	–	PUNCT
ijpds-3865	182	35	mar	mar	PROPN
ijpds-3865	182	36	2023	2023	NUM
ijpds-3865	182	37	indian	indian	PROPN
ijpds-3865	182	38	j	j	PROPN
ijpds-3865	182	39	pharm	pharm	PROPN
ijpds-3865	182	40	drug	drug	PROPN
ijpds-3865	182	41	studies	study	NOUN
ijpds-3865	182	42	|	|	ADV
ijpds-3865	182	43	15	15	NUM
ijpds-3865	182	44	resistance	resistance	NOUN
ijpds-3865	182	45	found	find	VERB
ijpds-3865	182	46	among	among	ADP
ijpds-3865	182	47	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	182	48	-	-	PUNCT
ijpds-3865	182	49	resistant	resistant	ADJ
ijpds-3865	182	50	neisseria	neisseria	NOUN
ijpds-3865	182	51	gonorrhoeae	gonorrhoeae	VERB
ijpds-3865	182	52	strains	strain	NOUN
ijpds-3865	182	53	selected	select	VERB
ijpds-3865	182	54	in	in	ADP
ijpds-3865	182	55	vitro	vitro	X
ijpds-3865	182	56	.	.	PUNCT
ijpds-3865	183	1	antimicrob	antimicrob	PROPN
ijpds-3865	183	2	agents	agents	PROPN
ijpds-3865	183	3	chemother	chemother	PROPN
ijpds-3865	183	4	.	.	PUNCT
ijpds-3865	184	1	2016;60(4	2016;60(4	NUM
ijpds-3865	184	2	)	)	PUNCT
ijpds-3865	184	3	;	;	PUNCT
ijpds-3865	184	4	2043	2043	NUM
ijpds-3865	184	5	-	-	SYM
ijpds-3865	184	6	2051	2051	NUM
ijpds-3865	184	7	.	.	PUNCT
ijpds-3865	185	1	10	10	NUM
ijpds-3865	185	2	.	.	PUNCT
ijpds-3865	185	3	chua	chua	PROPN
ijpds-3865	185	4	kyl	kyl	PROPN
ijpds-3865	185	5	,	,	PUNCT
ijpds-3865	185	6	stewardson	stewardson	PROPN
ijpds-3865	185	7	aj	aj	PROPN
ijpds-3865	185	8	.	.	PROPN
ijpds-3865	185	9	individual	individual	ADJ
ijpds-3865	185	10	and	and	CCONJ
ijpds-3865	185	11	community	community	NOUN
ijpds-3865	185	12	predictors	predictor	NOUN
ijpds-3865	185	13	of	of	ADP
ijpds-3865	185	14	urinary	urinary	ADJ
ijpds-3865	185	15	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	185	16	-	-	PUNCT
ijpds-3865	185	17	resistant	resistant	ADJ
ijpds-3865	185	18	escherichia	escherichia	NOUN
ijpds-3865	185	19	coli	coli	NOUN
ijpds-3865	185	20	isolates	isolate	NOUN
ijpds-3865	185	21	,	,	PUNCT
ijpds-3865	185	22	victoria	victoria	PROPN
ijpds-3865	185	23	,	,	PUNCT
ijpds-3865	185	24	australia	australia	PROPN
ijpds-3865	185	25	.	.	PUNCT
ijpds-3865	186	1	antimicrob	antimicrob	PROPN
ijpds-3865	186	2	resist	resist	VERB
ijpds-3865	186	3	infect	infect	ADJ
ijpds-3865	186	4	control	control	NOUN
ijpds-3865	186	5	.	.	PUNCT
ijpds-3865	187	1	2019;8(1	2019;8(1	NOUN
ijpds-3865	187	2	)	)	PUNCT
ijpds-3865	187	3	,	,	PUNCT
ijpds-3865	187	4	36	36	NUM
ijpds-3865	187	5	.	.	NOUN
ijpds-3865	187	6	11	11	NUM
ijpds-3865	187	7	.	.	X
ijpds-3865	188	1	su	su	PROPN
ijpds-3865	188	2	lh	lh	PROPN
ijpds-3865	188	3	,	,	PUNCT
ijpds-3865	188	4	wu	wu	PROPN
ijpds-3865	188	5	tl	tl	PROPN
ijpds-3865	188	6	,	,	PUNCT
ijpds-3865	188	7	chia	chia	PROPN
ijpds-3865	188	8	jh	jh	PROPN
ijpds-3865	188	9	,	,	PUNCT
ijpds-3865	188	10	et	et	PROPN
ijpds-3865	188	11	al	al	PROPN
ijpds-3865	188	12	.	.	PROPN
ijpds-3865	188	13	increase	increase	VERB
ijpds-3865	188	14	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	188	15	resistance	resistance	NOUN
ijpds-3865	188	16	in	in	ADP
ijpds-3865	188	17	salmonella	salmonella	NOUN
ijpds-3865	188	18	isolates	isolate	NOUN
ijpds-3865	188	19	from	from	ADP
ijpds-3865	188	20	a	a	DET
ijpds-3865	188	21	university	university	NOUN
ijpds-3865	188	22	hospital	hospital	NOUN
ijpds-3865	188	23	in	in	ADP
ijpds-3865	188	24	taiwan	taiwan	PROPN
ijpds-3865	188	25	.	.	PUNCT
ijpds-3865	189	1	journal	journal	PROPN
ijpds-3865	189	2	of	of	ADP
ijpds-3865	189	3	antimicrobial	antimicrobial	ADJ
ijpds-3865	189	4	chemotherapy	chemotherapy	NOUN
ijpds-3865	189	5	.	.	PUNCT
ijpds-3865	190	1	2005	2005	NUM
ijpds-3865	190	2	,	,	PUNCT
ijpds-3865	190	3	55	55	NUM
ijpds-3865	190	4	;	;	PUNCT
ijpds-3865	190	5	846	846	NUM
ijpds-3865	190	6	-	-	SYM
ijpds-3865	190	7	853	853	NUM
ijpds-3865	190	8	.	.	PUNCT
ijpds-3865	191	1	12	12	NUM
ijpds-3865	191	2	.	.	PUNCT
ijpds-3865	192	1	tanaka	tanaka	PROPN
ijpds-3865	192	2	m	m	PROPN
ijpds-3865	192	3	,	,	PUNCT
ijpds-3865	192	4	nakayama	nakayama	PROPN
ijpds-3865	192	5	h	h	PROPN
ijpds-3865	192	6	,	,	PUNCT
ijpds-3865	192	7	huruya	huruya	PROPN
ijpds-3865	192	8	k	k	PROPN
ijpds-3865	192	9	,	,	PUNCT
ijpds-3865	192	10	konomi	konomi	PROPN
ijpds-3865	192	11	i	i	PROPN
ijpds-3865	192	12	,	,	PUNCT
ijpds-3865	192	13	irie	irie	PROPN
ijpds-3865	192	14	s	s	PROPN
ijpds-3865	192	15	,	,	PUNCT
ijpds-3865	192	16	kanayama	kanayama	NOUN
ijpds-3865	192	17	a	a	X
ijpds-3865	192	18	,	,	PUNCT
ijpds-3865	192	19	et	et	PROPN
ijpds-3865	192	20	al	al	PROPN
ijpds-3865	192	21	.	.	PUNCT
ijpds-3865	193	1	analysis	analysis	NOUN
ijpds-3865	193	2	of	of	ADP
ijpds-3865	193	3	mutations	mutation	NOUN
ijpds-3865	193	4	within	within	ADP
ijpds-3865	193	5	multiple	multiple	ADJ
ijpds-3865	193	6	genes	gene	NOUN
ijpds-3865	193	7	associated	associate	VERB
ijpds-3865	193	8	with	with	ADP
ijpds-3865	193	9	resistance	resistance	NOUN
ijpds-3865	193	10	in	in	ADP
ijpds-3865	193	11	a	a	DET
ijpds-3865	193	12	clinical	clinical	ADJ
ijpds-3865	193	13	isolate	isolate	NOUN
ijpds-3865	193	14	of	of	ADP
ijpds-3865	193	15	neisseria	neisseria	NOUN
ijpds-3865	193	16	gonorrhoeae	gonorrhoeae	VERB
ijpds-3865	193	17	with	with	ADP
ijpds-3865	193	18	reduced	reduce	VERB
ijpds-3865	193	19	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	193	20	susceptibility	susceptibility	NOUN
ijpds-3865	193	21	that	that	PRON
ijpds-3865	193	22	shows	show	VERB
ijpds-3865	193	23	a	a	DET
ijpds-3865	193	24	multidrug	multidrug	NOUN
ijpds-3865	193	25	-	-	PUNCT
ijpds-3865	193	26	resistant	resistant	ADJ
ijpds-3865	193	27	phenotype	phenotype	NOUN
ijpds-3865	193	28	.	.	PUNCT
ijpds-3865	194	1	int	int	NOUN
ijpds-3865	194	2	j	j	PROPN
ijpds-3865	194	3	antimicrob	antimicrob	PROPN
ijpds-3865	194	4	agents	agent	NOUN
ijpds-3865	194	5	.	.	PUNCT
ijpds-3865	195	1	2006;27(1	2006;27(1	NUM
ijpds-3865	195	2	)	)	PUNCT
ijpds-3865	195	3	,	,	PUNCT
ijpds-3865	195	4	20	20	NUM
ijpds-3865	195	5	-	-	SYM
ijpds-3865	195	6	26	26	NUM
ijpds-3865	195	7	.	.	PUNCT
ijpds-3865	196	1	13	13	NUM
ijpds-3865	196	2	.	.	PUNCT
ijpds-3865	197	1	al	al	PROPN
ijpds-3865	197	2	kraiem	kraiem	PROPN
ijpds-3865	197	3	aa	aa	PROPN
ijpds-3865	197	4	,	,	PUNCT
ijpds-3865	197	5	yang	yang	PROPN
ijpds-3865	197	6	g	g	PROPN
ijpds-3865	197	7	,	,	PUNCT
ijpds-3865	197	8	al	al	PROPN
ijpds-3865	197	9	kraiem	kraiem	PROPN
ijpds-3865	198	1	f	f	PROPN
ijpds-3865	198	2	,	,	PUNCT
ijpds-3865	198	3	et	et	PROPN
ijpds-3865	198	4	al	al	PROPN
ijpds-3865	198	5	.	.	PUNCT
ijpds-3865	198	6	challenges	challenge	NOUN
ijpds-3865	198	7	associated	associate	VERB
ijpds-3865	198	8	with	with	ADP
ijpds-3865	198	9	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	198	10	resistance	resistance	NOUN
ijpds-3865	198	11	in	in	ADP
ijpds-3865	198	12	salmonella	salmonella	NOUN
ijpds-3865	198	13	.	.	PUNCT
ijpds-3865	199	1	front	front	ADJ
ijpds-3865	199	2	life	life	PROPN
ijpds-3865	199	3	sci	sci	PROPN
ijpds-3865	199	4	.	.	PROPN
ijpds-3865	199	5	2018;11(1	2018;11(1	NUM
ijpds-3865	199	6	)	)	PUNCT
ijpds-3865	199	7	,	,	PUNCT
ijpds-3865	199	8	3133	3133	NUM
ijpds-3865	199	9	-	-	SYM
ijpds-3865	199	10	3139	3139	NUM
ijpds-3865	199	11	.	.	PUNCT
ijpds-3865	200	1	14	14	NUM
ijpds-3865	200	2	.	.	PUNCT
ijpds-3865	201	1	muller	muller	PROPN
ijpds-3865	201	2	a	a	PROPN
ijpds-3865	201	3	,	,	PUNCT
ijpds-3865	201	4	lopez	lopez	NOUN
ijpds-3865	201	5	-	-	PUNCT
ijpds-3865	201	6	lozano	lozano	PROPN
ijpds-3865	201	7	jm	jm	PROPN
ijpds-3865	201	8	,	,	PUNCT
ijpds-3865	201	9	bertrand	bertrand	PROPN
ijpds-3865	201	10	x	x	PROPN
ijpds-3865	201	11	,	,	PUNCT
ijpds-3865	201	12	et	et	PROPN
ijpds-3865	201	13	al	al	PROPN
ijpds-3865	201	14	.	.	PROPN
ijpds-3865	201	15	relationship	relationship	NOUN
ijpds-3865	201	16	between	between	ADP
ijpds-3865	201	17	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	201	18	use	use	NOUN
ijpds-3865	201	19	and	and	CCONJ
ijpds-3865	201	20	resistance	resistance	NOUN
ijpds-3865	201	21	to	to	ADP
ijpds-3865	201	22	third	third	ADJ
ijpds-3865	201	23	-	-	PUNCT
ijpds-3865	201	24	generation	generation	NOUN
ijpds-3865	201	25	cephalosporins	cephalosporin	NOUN
ijpds-3865	201	26	among	among	ADP
ijpds-3865	201	27	clinical	clinical	ADJ
ijpds-3865	201	28	strains	strain	NOUN
ijpds-3865	201	29	of	of	ADP
ijpds-3865	201	30	enterobacter	enterobacter	ADJ
ijpds-3865	201	31	cloacae	cloacae	NOUN
ijpds-3865	201	32	.	.	PUNCT
ijpds-3865	202	1	j	j	PROPN
ijpds-3865	202	2	antimicrob	antimicrob	PROPN
ijpds-3865	202	3	chemother	chemother	PROPN
ijpds-3865	202	4	.	.	PUNCT
ijpds-3865	203	1	2004;54(1	2004;54(1	NUM
ijpds-3865	203	2	)	)	PUNCT
ijpds-3865	203	3	,	,	PUNCT
ijpds-3865	203	4	173	173	NUM
ijpds-3865	203	5	-	-	SYM
ijpds-3865	203	6	177	177	NUM
ijpds-3865	203	7	.	.	PUNCT
ijpds-3865	204	1	15	15	NUM
ijpds-3865	204	2	.	.	PUNCT
ijpds-3865	204	3	unemo	unemo	PROPN
ijpds-3865	204	4	m	m	PROPN
ijpds-3865	204	5	,	,	PUNCT
ijpds-3865	204	6	nicholas	nicholas	PROPN
ijpds-3865	204	7	ra	ra	PROPN
ijpds-3865	204	8	.	.	PROPN
ijpds-3865	205	1	emergence	emergence	NOUN
ijpds-3865	205	2	of	of	ADP
ijpds-3865	205	3	multidrug	multidrug	NOUN
ijpds-3865	205	4	-	-	PUNCT
ijpds-3865	205	5	resistant	resistant	ADJ
ijpds-3865	205	6	,	,	PUNCT
ijpds-3865	205	7	extensively	extensively	ADV
ijpds-3865	205	8	drug	drug	NOUN
ijpds-3865	205	9	-	-	PUNCT
ijpds-3865	205	10	resistant	resistant	ADJ
ijpds-3865	205	11	and	and	CCONJ
ijpds-3865	205	12	untreatable	untreatable	ADJ
ijpds-3865	205	13	gonorrhea	gonorrhea	NOUN
ijpds-3865	205	14	.	.	PUNCT
ijpds-3865	206	1	future	future	ADJ
ijpds-3865	206	2	microbiology	microbiology	NOUN
ijpds-3865	206	3	.	.	PUNCT
ijpds-3865	207	1	2012;7(12),1401	2012;7(12),1401	NUM
ijpds-3865	207	2	-	-	SYM
ijpds-3865	207	3	1422	1422	NUM
ijpds-3865	207	4	.	.	PUNCT
ijpds-3865	208	1	16	16	NUM
ijpds-3865	208	2	.	.	PUNCT
ijpds-3865	209	1	tapsall	tapsall	PROPN
ijpds-3865	209	2	jw	jw	PROPN
ijpds-3865	209	3	,	,	PUNCT
ijpds-3865	209	4	ndowa	ndowa	PROPN
ijpds-3865	209	5	f	f	PROPN
ijpds-3865	209	6	,	,	PUNCT
ijpds-3865	209	7	lewis	lewis	PROPN
ijpds-3865	209	8	da	da	PROPN
ijpds-3865	209	9	,	,	PUNCT
ijpds-3865	209	10	et	et	PROPN
ijpds-3865	209	11	al	al	PROPN
ijpds-3865	209	12	.	.	PUNCT
ijpds-3865	210	1	meeting	meet	VERB
ijpds-3865	210	2	the	the	DET
ijpds-3865	210	3	public	public	ADJ
ijpds-3865	210	4	health	health	NOUN
ijpds-3865	210	5	challenge	challenge	NOUN
ijpds-3865	210	6	of	of	ADP
ijpds-3865	210	7	multidrugand	multidrugand	NOUN
ijpds-3865	210	8	extensively	extensively	ADV
ijpds-3865	210	9	drug	drug	NOUN
ijpds-3865	210	10	-	-	PUNCT
ijpds-3865	210	11	resistant	resistant	ADJ
ijpds-3865	210	12	neisseria	neisseria	NOUN
ijpds-3865	210	13	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	210	14	.	.	PUNCT
ijpds-3865	211	1	expert	expert	NOUN
ijpds-3865	211	2	review	review	NOUN
ijpds-3865	211	3	of	of	ADP
ijpds-3865	211	4	anti	anti	ADJ
ijpds-3865	211	5	-	-	ADJ
ijpds-3865	211	6	infective	infective	ADJ
ijpds-3865	211	7	therapy	therapy	NOUN
ijpds-3865	211	8	.	.	PUNCT
ijpds-3865	212	1	2009	2009	NUM
ijpds-3865	212	2	;	;	PUNCT
ijpds-3865	212	3	7(7	7(7	NUM
ijpds-3865	212	4	)	)	PUNCT
ijpds-3865	212	5	,	,	PUNCT
ijpds-3865	212	6	821	821	NUM
ijpds-3865	212	7	-	-	SYM
ijpds-3865	212	8	834	834	NUM
ijpds-3865	212	9	.	.	PUNCT
ijpds-3865	213	1	17	17	NUM
ijpds-3865	213	2	.	.	PUNCT
ijpds-3865	214	1	unemo	unemo	PROPN
ijpds-3865	214	2	m	m	PROPN
ijpds-3865	214	3	,	,	PUNCT
ijpds-3865	214	4	shafer	shafer	PROPN
ijpds-3865	214	5	wm	wm	PROPN
ijpds-3865	214	6	.	.	PROPN
ijpds-3865	214	7	antimicrobial	antimicrobial	ADJ
ijpds-3865	214	8	resistance	resistance	NOUN
ijpds-3865	214	9	in	in	ADP
ijpds-3865	214	10	neisseria	neisseria	PROPN
ijpds-3865	215	1	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	215	2	in	in	ADP
ijpds-3865	215	3	the	the	DET
ijpds-3865	215	4	21st	21st	ADJ
ijpds-3865	215	5	century	century	NOUN
ijpds-3865	215	6	:	:	PUNCT
ijpds-3865	216	1	past	past	ADJ
ijpds-3865	216	2	,	,	PUNCT
ijpds-3865	216	3	evolution	evolution	NOUN
ijpds-3865	216	4	,	,	PUNCT
ijpds-3865	216	5	and	and	CCONJ
ijpds-3865	216	6	future	future	NOUN
ijpds-3865	216	7	.	.	PUNCT
ijpds-3865	217	1	clin	clin	PROPN
ijpds-3865	217	2	microbiol	microbiol	PROPN
ijpds-3865	217	3	rev	rev	VERB
ijpds-3865	217	4	.	.	PUNCT
ijpds-3865	218	1	2014;27(3),587	2014;27(3),587	PROPN
ijpds-3865	218	2	-	-	SYM
ijpds-3865	218	3	613	613	NUM
ijpds-3865	218	4	.	.	NOUN
ijpds-3865	218	5	18	18	NUM
ijpds-3865	218	6	.	.	PUNCT
ijpds-3865	219	1	cadosch	cadosch	PROPN
ijpds-3865	219	2	d	d	PROPN
ijpds-3865	219	3	,	,	PUNCT
ijpds-3865	219	4	garcia	garcia	PROPN
ijpds-3865	219	5	v	v	PROPN
ijpds-3865	219	6	,	,	PUNCT
ijpds-3865	219	7	jensen	jensen	PROPN
ijpds-3865	219	8	js	js	PROPN
ijpds-3865	219	9	,	,	PUNCT
ijpds-3865	219	10	et	et	PROPN
ijpds-3865	219	11	al	al	PROPN
ijpds-3865	219	12	.	.	PUNCT
ijpds-3865	220	1	understanding	understand	VERB
ijpds-3865	220	2	the	the	DET
ijpds-3865	220	3	spread	spread	NOUN
ijpds-3865	220	4	of	of	ADP
ijpds-3865	220	5	de	de	X
ijpds-3865	220	6	novo	novo	NOUN
ijpds-3865	220	7	and	and	CCONJ
ijpds-3865	220	8	transmitted	transmit	VERB
ijpds-3865	220	9	macrolide	macrolide	NOUN
ijpds-3865	220	10	-	-	PUNCT
ijpds-3865	220	11	resistance	resistance	NOUN
ijpds-3865	220	12	in	in	ADP
ijpds-3865	220	13	mycoplasma	mycoplasma	NOUN
ijpds-3865	220	14	genitalium	genitalium	NOUN
ijpds-3865	220	15	.	.	PUNCT
ijpds-3865	221	1	peerj	peerj	PROPN
ijpds-3865	221	2	.	.	PUNCT
ijpds-3865	222	1	2020;2020(4	2020;2020(4	NUM
ijpds-3865	222	2	)	)	PUNCT
ijpds-3865	222	3	.	.	PUNCT
ijpds-3865	223	1	19	19	NUM
ijpds-3865	223	2	.	.	X
ijpds-3865	223	3	unemo	unemo	PROPN
ijpds-3865	223	4	m.	m.	PROPN
ijpds-3865	223	5	current	current	ADJ
ijpds-3865	223	6	and	and	CCONJ
ijpds-3865	223	7	future	future	ADJ
ijpds-3865	223	8	antimicrobial	antimicrobial	ADJ
ijpds-3865	223	9	treatment	treatment	NOUN
ijpds-3865	223	10	of	of	ADP
ijpds-3865	223	11	gonorrhoea	gonorrhoea	NOUN
ijpds-3865	223	12	the	the	DET
ijpds-3865	223	13	rapidly	rapidly	ADV
ijpds-3865	223	14	evolving	evolve	VERB
ijpds-3865	223	15	neisseria	neisseria	NOUN
ijpds-3865	223	16	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	223	17	continues	continue	VERB
ijpds-3865	223	18	to	to	PART
ijpds-3865	223	19	challenge	challenge	VERB
ijpds-3865	223	20	.	.	PUNCT
ijpds-3865	224	1	bmc	bmc	ADJ
ijpds-3865	224	2	infectious	infectious	ADJ
ijpds-3865	224	3	diseases	disease	NOUN
ijpds-3865	224	4	.	.	PUNCT
ijpds-3865	225	1	2015	2015	NUM
ijpds-3865	225	2	;	;	PUNCT
ijpds-3865	225	3	15	15	NUM
ijpds-3865	225	4	,	,	PUNCT
ijpds-3865	225	5	364	364	NUM
ijpds-3865	225	6	.	.	NOUN
ijpds-3865	225	7	20	20	NUM
ijpds-3865	225	8	.	.	PUNCT
ijpds-3865	226	1	lewis	lewis	PROPN
ijpds-3865	226	2	da	da	PROPN
ijpds-3865	226	3	.	.	PUNCT
ijpds-3865	227	1	the	the	DET
ijpds-3865	227	2	gonococcus	gonococcus	NOUN
ijpds-3865	227	3	fights	fight	VERB
ijpds-3865	227	4	back	back	ADV
ijpds-3865	227	5	:	:	PUNCT
ijpds-3865	227	6	is	be	AUX
ijpds-3865	227	7	this	this	DET
ijpds-3865	227	8	time	time	NOUN
ijpds-3865	227	9	a	a	DET
ijpds-3865	227	10	knock	knock	NOUN
ijpds-3865	227	11	out	out	ADP
ijpds-3865	227	12	?	?	PUNCT
ijpds-3865	228	1	sexually	sexually	ADV
ijpds-3865	228	2	transmitted	transmit	VERB
ijpds-3865	228	3	infections	infection	NOUN
ijpds-3865	228	4	.	.	PUNCT
ijpds-3865	229	1	2010	2010	NUM
ijpds-3865	229	2	;	;	PUNCT
ijpds-3865	229	3	86(6	86(6	NUM
ijpds-3865	229	4	)	)	PUNCT
ijpds-3865	229	5	,	,	PUNCT
ijpds-3865	229	6	415	415	NUM
ijpds-3865	229	7	-	-	SYM
ijpds-3865	229	8	421	421	NUM
ijpds-3865	229	9	.	.	PUNCT
ijpds-3865	230	1	21	21	NUM
ijpds-3865	230	2	.	.	PUNCT
ijpds-3865	231	1	poncin	poncin	PROPN
ijpds-3865	231	2	t	t	PROPN
ijpds-3865	231	3	,	,	PUNCT
ijpds-3865	231	4	fouere	fouere	PROPN
ijpds-3865	231	5	s	s	NOUN
ijpds-3865	231	6	,	,	PUNCT
ijpds-3865	231	7	braille	braille	NOUN
ijpds-3865	231	8	a	a	PRON
ijpds-3865	231	9	,	,	PUNCT
ijpds-3865	231	10	et	et	PROPN
ijpds-3865	231	11	al	al	PROPN
ijpds-3865	231	12	.	.	PROPN
ijpds-3865	231	13	multidrug	multidrug	NOUN
ijpds-3865	231	14	-	-	PUNCT
ijpds-3865	231	15	resistant	resistant	ADJ
ijpds-3865	231	16	neisseria	neisseria	NOUN
ijpds-3865	231	17	gonorrhoeae	gonorrhoeae	VERB
ijpds-3865	231	18	failing	fail	VERB
ijpds-3865	231	19	treatment	treatment	NOUN
ijpds-3865	231	20	with	with	ADP
ijpds-3865	231	21	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	231	22	and	and	CCONJ
ijpds-3865	231	23	doxycycline	doxycycline	NOUN
ijpds-3865	231	24	in	in	ADP
ijpds-3865	231	25	france	france	PROPN
ijpds-3865	231	26	,	,	PUNCT
ijpds-3865	231	27	november	november	PROPN
ijpds-3865	231	28	2017	2017	NUM
ijpds-3865	231	29	.	.	PUNCT
ijpds-3865	232	1	eurosurveillance	eurosurveillance	NOUN
ijpds-3865	232	2	.	.	PUNCT
ijpds-3865	233	1	2018;23(21	2018;23(21	NUM
ijpds-3865	233	2	)	)	PUNCT
ijpds-3865	233	3	.	.	PUNCT
ijpds-3865	234	1	22	22	NUM
ijpds-3865	234	2	.	.	PUNCT
ijpds-3865	235	1	bignell	bignell	PROPN
ijpds-3865	235	2	c	c	PROPN
ijpds-3865	235	3	,	,	PUNCT
ijpds-3865	235	4	unemo	unemo	NOUN
ijpds-3865	235	5	m.	m.	NOUN
ijpds-3865	235	6	2012	2012	NUM
ijpds-3865	235	7	european	european	ADJ
ijpds-3865	235	8	guideline	guideline	NOUN
ijpds-3865	235	9	on	on	ADP
ijpds-3865	235	10	the	the	DET
ijpds-3865	235	11	diagnosis	diagnosis	NOUN
ijpds-3865	235	12	and	and	CCONJ
ijpds-3865	235	13	treatment	treatment	NOUN
ijpds-3865	235	14	of	of	ADP
ijpds-3865	235	15	gonorrhoea	gonorrhoea	NOUN
ijpds-3865	235	16	in	in	ADP
ijpds-3865	235	17	adults	adult	NOUN
ijpds-3865	235	18	.	.	PUNCT
ijpds-3865	236	1	int	int	NOUN
ijpds-3865	236	2	j	j	PROPN
ijpds-3865	236	3	std	std	X
ijpds-3865	236	4	aids	aids	PROPN
ijpds-3865	236	5	.	.	PUNCT
ijpds-3865	237	1	2013;24(2	2013;24(2	NUM
ijpds-3865	237	2	)	)	PUNCT
ijpds-3865	237	3	.	.	PUNCT
ijpds-3865	238	1	23	23	NUM
ijpds-3865	238	2	.	.	X
ijpds-3865	239	1	workowski	workowski	PROPN
ijpds-3865	239	2	ka	ka	PROPN
ijpds-3865	239	3	,	,	PUNCT
ijpds-3865	239	4	bolan	bolan	PROPN
ijpds-3865	239	5	ga	ga	PROPN
ijpds-3865	239	6	.	.	PROPN
ijpds-3865	239	7	sexually	sexually	ADV
ijpds-3865	239	8	transmitted	transmit	VERB
ijpds-3865	239	9	diseases	disease	NOUN
ijpds-3865	239	10	treatment	treatment	NOUN
ijpds-3865	239	11	guidelines	guideline	NOUN
ijpds-3865	239	12	,	,	PUNCT
ijpds-3865	239	13	2015	2015	NUM
ijpds-3865	239	14	.	.	PUNCT
ijpds-3865	240	1	mmwr	mmwr	ADJ
ijpds-3865	240	2	recomm	recomm	NOUN
ijpds-3865	240	3	reports	report	NOUN
ijpds-3865	240	4	.	.	PUNCT
ijpds-3865	241	1	2015;64(3	2015;64(3	NUM
ijpds-3865	241	2	)	)	PUNCT
ijpds-3865	241	3	.	.	PUNCT
ijpds-3865	242	1	24	24	NUM
ijpds-3865	242	2	.	.	PUNCT
ijpds-3865	242	3	bignell	bignell	PROPN
ijpds-3865	242	4	c	c	PROPN
ijpds-3865	242	5	,	,	PUNCT
ijpds-3865	242	6	fitzgerald	fitzgerald	PROPN
ijpds-3865	242	7	m.	m.	PROPN
ijpds-3865	242	8	uk	uk	PROPN
ijpds-3865	242	9	national	national	PROPN
ijpds-3865	242	10	guideline	guideline	NOUN
ijpds-3865	242	11	for	for	ADP
ijpds-3865	242	12	the	the	DET
ijpds-3865	242	13	management	management	NOUN
ijpds-3865	242	14	of	of	ADP
ijpds-3865	242	15	gonorrhoea	gonorrhoea	NOUN
ijpds-3865	242	16	in	in	ADP
ijpds-3865	242	17	adults	adult	NOUN
ijpds-3865	242	18	,	,	PUNCT
ijpds-3865	242	19	2011	2011	NUM
ijpds-3865	242	20	.	.	PUNCT
ijpds-3865	243	1	int	int	NOUN
ijpds-3865	243	2	j	j	PROPN
ijpds-3865	243	3	std	std	X
ijpds-3865	243	4	aids	aids	PROPN
ijpds-3865	243	5	.	.	PUNCT
ijpds-3865	244	1	2011;22(10	2011;22(10	NUM
ijpds-3865	244	2	)	)	PUNCT
ijpds-3865	244	3	,	,	PUNCT
ijpds-3865	244	4	541	541	NUM
ijpds-3865	244	5	-	-	SYM
ijpds-3865	244	6	547	547	NUM
ijpds-3865	244	7	.	.	NUM
ijpds-3865	245	1	25	25	NUM
ijpds-3865	245	2	.	.	PUNCT
ijpds-3865	246	1	lewis	lewis	PROPN
ijpds-3865	246	2	da	da	PROPN
ijpds-3865	246	3	.	.	PUNCT
ijpds-3865	247	1	global	global	ADJ
ijpds-3865	247	2	resistance	resistance	NOUN
ijpds-3865	247	3	of	of	ADP
ijpds-3865	247	4	neisseria	neisseria	PROPN
ijpds-3865	247	5	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	247	6	:	:	PUNCT
ijpds-3865	247	7	when	when	SCONJ
ijpds-3865	247	8	theory	theory	NOUN
ijpds-3865	247	9	becomes	become	VERB
ijpds-3865	247	10	reality	reality	NOUN
ijpds-3865	247	11	.	.	PUNCT
ijpds-3865	248	1	current	current	ADJ
ijpds-3865	248	2	opinion	opinion	NOUN
ijpds-3865	248	3	in	in	ADP
ijpds-3865	248	4	infectious	infectious	ADJ
ijpds-3865	248	5	diseases	disease	NOUN
ijpds-3865	248	6	.	.	PUNCT
ijpds-3865	249	1	2014	2014	NUM
ijpds-3865	249	2	;	;	PUNCT
ijpds-3865	249	3	27(1	27(1	NUM
ijpds-3865	249	4	)	)	PUNCT
ijpds-3865	249	5	,	,	PUNCT
ijpds-3865	249	6	62	62	NUM
ijpds-3865	249	7	-	-	SYM
ijpds-3865	249	8	67	67	NUM
ijpds-3865	249	9	.	.	PUNCT
ijpds-3865	250	1	26	26	NUM
ijpds-3865	250	2	.	.	PUNCT
ijpds-3865	250	3	unemo	unemo	PROPN
ijpds-3865	250	4	m	m	PROPN
ijpds-3865	250	5	,	,	PUNCT
ijpds-3865	250	6	golparian	golparian	PROPN
ijpds-3865	250	7	d	d	PROPN
ijpds-3865	250	8	,	,	PUNCT
ijpds-3865	250	9	eyre	eyre	PROPN
ijpds-3865	250	10	dw	dw	PROPN
ijpds-3865	250	11	.	.	PROPN
ijpds-3865	250	12	antimicrobial	antimicrobial	ADJ
ijpds-3865	250	13	resistance	resistance	NOUN
ijpds-3865	250	14	in	in	ADP
ijpds-3865	250	15	neisseria	neisseria	PROPN
ijpds-3865	250	16	gonorrhoeae	gonorrhoeae	PROPN
ijpds-3865	250	17	and	and	CCONJ
ijpds-3865	250	18	treatment	treatment	NOUN
ijpds-3865	250	19	of	of	ADP
ijpds-3865	250	20	gonorrhea	gonorrhea	NOUN
ijpds-3865	250	21	.	.	PUNCT
ijpds-3865	251	1	in	in	ADP
ijpds-3865	251	2	:	:	PUNCT
ijpds-3865	251	3	methods	method	NOUN
ijpds-3865	251	4	in	in	ADP
ijpds-3865	251	5	molecular	molecular	ADJ
ijpds-3865	251	6	biology	biology	NOUN
ijpds-3865	251	7	.	.	PUNCT
ijpds-3865	252	1	2019,37	2019,37	NUM
ijpds-3865	252	2	-	-	PUNCT
ijpds-3865	252	3	58	58	NUM
ijpds-3865	252	4	.	.	PUNCT
ijpds-3865	253	1	27	27	NUM
ijpds-3865	253	2	.	.	PUNCT
ijpds-3865	254	1	ison	ison	NOUN
ijpds-3865	254	2	ca	can	AUX
ijpds-3865	254	3	,	,	PUNCT
ijpds-3865	254	4	deal	deal	VERB
ijpds-3865	254	5	c	c	PROPN
ijpds-3865	254	6	,	,	PUNCT
ijpds-3865	254	7	unemo	unemo	NOUN
ijpds-3865	254	8	m.	m.	NOUN
ijpds-3865	254	9	current	current	ADJ
ijpds-3865	254	10	and	and	CCONJ
ijpds-3865	254	11	future	future	ADJ
ijpds-3865	254	12	treatment	treatment	NOUN
ijpds-3865	254	13	options	option	NOUN
ijpds-3865	254	14	for	for	ADP
ijpds-3865	254	15	gonorrhoea	gonorrhoea	NOUN
ijpds-3865	254	16	.	.	PUNCT
ijpds-3865	255	1	sex	sex	NOUN
ijpds-3865	255	2	transm	transm	PROPN
ijpds-3865	255	3	infect	infect	VERB
ijpds-3865	255	4	.	.	PUNCT
ijpds-3865	256	1	2013;89(suppl	2013;89(suppl	NOUN
ijpds-3865	256	2	.	.	PUNCT
ijpds-3865	257	1	4	4	NUM
ijpds-3865	257	2	)	)	PUNCT
ijpds-3865	257	3	.	.	PUNCT
ijpds-3865	258	1	28	28	NUM
ijpds-3865	258	2	.	.	PUNCT
ijpds-3865	259	1	bruhn	bruhn	NOUN
ijpds-3865	259	2	df	df	PROPN
ijpds-3865	259	3	,	,	PUNCT
ijpds-3865	259	4	waidyarachchi	waidyarachchi	ADJ
ijpds-3865	259	5	sl	sl	PROPN
ijpds-3865	259	6	,	,	PUNCT
ijpds-3865	259	7	madhura	madhura	PROPN
ijpds-3865	259	8	db	db	PROPN
ijpds-3865	259	9	,	,	PUNCT
ijpds-3865	259	10	et	et	PROPN
ijpds-3865	259	11	al	al	PROPN
ijpds-3865	259	12	.	.	PROPN
ijpds-3865	259	13	aminomethyl	aminomethyl	PROPN
ijpds-3865	259	14	spectinomycins	spectinomycin	NOUN
ijpds-3865	259	15	as	as	ADP
ijpds-3865	259	16	therapeutics	therapeutic	NOUN
ijpds-3865	259	17	for	for	ADP
ijpds-3865	259	18	drug	drug	NOUN
ijpds-3865	259	19	-	-	PUNCT
ijpds-3865	259	20	resistant	resistant	ADJ
ijpds-3865	259	21	respiratory	respiratory	ADJ
ijpds-3865	259	22	tract	tract	NOUN
ijpds-3865	259	23	and	and	CCONJ
ijpds-3865	259	24	sexually	sexually	ADV
ijpds-3865	259	25	transmitted	transmit	VERB
ijpds-3865	259	26	bacterial	bacterial	ADJ
ijpds-3865	259	27	infections	infection	NOUN
ijpds-3865	259	28	.	.	PUNCT
ijpds-3865	260	1	sci	sci	PROPN
ijpds-3865	260	2	transl	transl	PROPN
ijpds-3865	260	3	med	med	PROPN
ijpds-3865	260	4	.	.	PUNCT
ijpds-3865	261	1	2015;7(288	2015;7(288	NUM
ijpds-3865	261	2	)	)	PUNCT
ijpds-3865	261	3	.	.	PUNCT
ijpds-3865	262	1	29	29	NUM
ijpds-3865	262	2	.	.	PUNCT
ijpds-3865	263	1	savage	savage	ADJ
ijpds-3865	263	2	vj	vj	PROPN
ijpds-3865	263	3	,	,	PUNCT
ijpds-3865	263	4	charrier	charrier	NOUN
ijpds-3865	263	5	c	c	PROPN
ijpds-3865	263	6	,	,	PUNCT
ijpds-3865	263	7	salisbury	salisbury	PROPN
ijpds-3865	263	8	am	be	AUX
ijpds-3865	263	9	,	,	PUNCT
ijpds-3865	263	10	et	et	PROPN
ijpds-3865	263	11	al	al	PROPN
ijpds-3865	263	12	.	.	PROPN
ijpds-3865	264	1	biological	biological	ADJ
ijpds-3865	264	2	profiling	profiling	NOUN
ijpds-3865	264	3	of	of	ADP
ijpds-3865	264	4	novel	novel	ADJ
ijpds-3865	264	5	tricyclic	tricyclic	ADJ
ijpds-3865	264	6	inhibitors	inhibitor	NOUN
ijpds-3865	264	7	of	of	ADP
ijpds-3865	264	8	bacterial	bacterial	ADJ
ijpds-3865	264	9	dna	dna	NOUN
ijpds-3865	264	10	gyrase	gyrase	NOUN
ijpds-3865	264	11	and	and	CCONJ
ijpds-3865	264	12	topoisomerase	topoisomerase	NOUN
ijpds-3865	264	13	iv	iv	NUM
ijpds-3865	264	14	.	.	PUNCT
ijpds-3865	265	1	j	j	PROPN
ijpds-3865	265	2	antimicrob	antimicrob	PROPN
ijpds-3865	265	3	chemother	chemother	PROPN
ijpds-3865	265	4	.	.	PUNCT
ijpds-3865	266	1	2016;71(7),19051913	2016;71(7),19051913	NUM
ijpds-3865	266	2	.	.	PUNCT
ijpds-3865	267	1	30	30	NUM
ijpds-3865	267	2	.	.	PUNCT
ijpds-3865	268	1	unemo	unemo	PROPN
ijpds-3865	268	2	m	m	PROPN
ijpds-3865	268	3	,	,	PUNCT
ijpds-3865	268	4	bradshaw	bradshaw	PROPN
ijpds-3865	268	5	cs	cs	PROPN
ijpds-3865	268	6	,	,	PUNCT
ijpds-3865	268	7	hocking	hocking	PROPN
ijpds-3865	268	8	js	js	PROPN
ijpds-3865	268	9	,	,	PUNCT
ijpds-3865	268	10	et	et	PROPN
ijpds-3865	268	11	al	al	PROPN
ijpds-3865	268	12	.	.	PROPN
ijpds-3865	268	13	sexually	sexually	ADV
ijpds-3865	268	14	transmitted	transmit	VERB
ijpds-3865	268	15	infections	infection	NOUN
ijpds-3865	268	16	:	:	PUNCT
ijpds-3865	268	17	challenges	challenge	VERB
ijpds-3865	268	18	ahead	ahead	ADV
ijpds-3865	268	19	.	.	PUNCT
ijpds-3865	269	1	the	the	DET
ijpds-3865	269	2	lancet	lancet	ADJ
ijpds-3865	269	3	infectious	infectious	ADJ
ijpds-3865	269	4	diseases	disease	NOUN
ijpds-3865	269	5	.	.	PUNCT
ijpds-3865	270	1	2017,235	2017,235	NUM
ijpds-3865	270	2	-	-	SYM
ijpds-3865	270	3	279	279	NUM
ijpds-3865	270	4	.	.	PUNCT
ijpds-3865	271	1	31	31	NUM
ijpds-3865	271	2	.	.	PUNCT
ijpds-3865	272	1	vila	vila	PROPN
ijpds-3865	272	2	j	j	PROPN
ijpds-3865	272	3	,	,	PUNCT
ijpds-3865	272	4	ruiz	ruiz	PROPN
ijpds-3865	272	5	j	j	PROPN
ijpds-3865	272	6	,	,	PUNCT
ijpds-3865	272	7	gallardo	gallardo	PROPN
ijpds-3865	272	8	f	f	AUX
ijpds-3865	272	9	,	,	PUNCT
ijpds-3865	272	10	et	et	PROPN
ijpds-3865	272	11	al	al	PROPN
ijpds-3865	272	12	.	.	PROPN
ijpds-3865	273	1	aeromonas	aeromonas	PROPN
ijpds-3865	273	2	spp	spp	PROPN
ijpds-3865	273	3	.	.	PUNCT
ijpds-3865	274	1	and	and	CCONJ
ijpds-3865	274	2	traveler	traveler	NOUN
ijpds-3865	274	3	’s	’s	PART
ijpds-3865	274	4	diarrhea	diarrhea	PROPN
ijpds-3865	274	5	:	:	PUNCT
ijpds-3865	274	6	clinical	clinical	ADJ
ijpds-3865	274	7	features	feature	NOUN
ijpds-3865	274	8	and	and	CCONJ
ijpds-3865	274	9	antimicrobial	antimicrobial	ADJ
ijpds-3865	274	10	resistance	resistance	NOUN
ijpds-3865	274	11	.	.	PUNCT
ijpds-3865	275	1	emerg	emerg	PROPN
ijpds-3865	275	2	infect	infect	PROPN
ijpds-3865	275	3	dis	dis	PROPN
ijpds-3865	275	4	.	.	PUNCT
ijpds-3865	276	1	2003;9(5),552	2003;9(5),552	NUM
ijpds-3865	276	2	-	-	SYM
ijpds-3865	276	3	555	555	NUM
ijpds-3865	276	4	.	.	PUNCT
ijpds-3865	277	1	32	32	NUM
ijpds-3865	277	2	.	.	PUNCT
ijpds-3865	278	1	janda	janda	PROPN
ijpds-3865	278	2	jm	jm	PROPN
ijpds-3865	278	3	,	,	PUNCT
ijpds-3865	278	4	abbott	abbott	PROPN
ijpds-3865	278	5	sl	sl	PROPN
ijpds-3865	278	6	.	.	PUNCT
ijpds-3865	279	1	the	the	DET
ijpds-3865	279	2	genus	genus	PROPN
ijpds-3865	279	3	aeromonas	aeromona	NOUN
ijpds-3865	279	4	:	:	PUNCT
ijpds-3865	279	5	taxonomy	taxonomy	NOUN
ijpds-3865	279	6	,	,	PUNCT
ijpds-3865	279	7	pathogenicity	pathogenicity	NOUN
ijpds-3865	279	8	,	,	PUNCT
ijpds-3865	279	9	and	and	CCONJ
ijpds-3865	279	10	infection	infection	NOUN
ijpds-3865	279	11	.	.	PUNCT
ijpds-3865	280	1	clinical	clinical	ADJ
ijpds-3865	280	2	microbiology	microbiology	NOUN
ijpds-3865	280	3	reviews	review	NOUN
ijpds-3865	280	4	.	.	PUNCT
ijpds-3865	281	1	2010;23(1),35	2010;23(1),35	NOUN
ijpds-3865	281	2	-	-	PUNCT
ijpds-3865	281	3	73	73	NUM
ijpds-3865	281	4	.	.	PUNCT
ijpds-3865	282	1	33	33	NUM
ijpds-3865	282	2	.	.	PUNCT
ijpds-3865	283	1	essers	esser	NOUN
ijpds-3865	283	2	b	b	NUM
ijpds-3865	283	3	,	,	PUNCT
ijpds-3865	283	4	burnens	burnens	PROPN
ijpds-3865	283	5	ap	ap	PROPN
ijpds-3865	283	6	,	,	PUNCT
ijpds-3865	283	7	lanfranchini	lanfranchini	PROPN
ijpds-3865	283	8	fm	fm	PROPN
ijpds-3865	283	9	,	,	PUNCT
ijpds-3865	283	10	et	et	PROPN
ijpds-3865	283	11	al	al	PROPN
ijpds-3865	283	12	.	.	PROPN
ijpds-3865	283	13	acute	acute	PROPN
ijpds-3865	283	14	communityacquired	communityacquire	VERB
ijpds-3865	283	15	diarrhea	diarrhea	NOUN
ijpds-3865	283	16	requiring	require	VERB
ijpds-3865	283	17	hospital	hospital	NOUN
ijpds-3865	283	18	admission	admission	NOUN
ijpds-3865	283	19	in	in	ADP
ijpds-3865	283	20	swiss	swiss	ADJ
ijpds-3865	283	21	children	child	NOUN
ijpds-3865	283	22	.	.	PUNCT
ijpds-3865	284	1	clin	clin	PROPN
ijpds-3865	284	2	infect	infect	PROPN
ijpds-3865	284	3	dis	dis	PROPN
ijpds-3865	284	4	.	.	PUNCT
ijpds-3865	285	1	2000;31(1),192	2000;31(1),192	NUM
ijpds-3865	285	2	-	-	SYM
ijpds-3865	285	3	196	196	NUM
ijpds-3865	285	4	.	.	PUNCT
ijpds-3865	286	1	34	34	NUM
ijpds-3865	286	2	.	.	PUNCT
ijpds-3865	286	3	mandal	mandal	PROPN
ijpds-3865	286	4	j	j	PROPN
ijpds-3865	286	5	,	,	PUNCT
ijpds-3865	286	6	dhodapkar	dhodapkar	ADJ
ijpds-3865	286	7	r	r	NOUN
ijpds-3865	286	8	,	,	PUNCT
ijpds-3865	286	9	srinivas	srinivas	PROPN
ijpds-3865	286	10	acharya	acharya	PROPN
ijpds-3865	286	11	n	n	PROPN
ijpds-3865	286	12	,	,	PUNCT
ijpds-3865	286	13	et	et	PROPN
ijpds-3865	286	14	al	al	PROPN
ijpds-3865	286	15	.	.	PUNCT
ijpds-3865	286	16	urinary	urinary	ADJ
ijpds-3865	286	17	tract	tract	NOUN
ijpds-3865	286	18	infection	infection	NOUN
ijpds-3865	286	19	due	due	ADP
ijpds-3865	286	20	to	to	ADP
ijpds-3865	286	21	aeromonas	aeromonas	PROPN
ijpds-3865	286	22	spp	spp	PROPN
ijpds-3865	286	23	.	.	PROPN
ijpds-3865	286	24	,	,	PUNCT
ijpds-3865	286	25	a	a	DET
ijpds-3865	286	26	lesser	lesser	ADV
ijpds-3865	286	27	known	know	VERB
ijpds-3865	286	28	causative	causative	ADJ
ijpds-3865	286	29	bacterium	bacterium	NOUN
ijpds-3865	286	30	.	.	PUNCT
ijpds-3865	287	1	j	j	PROPN
ijpds-3865	287	2	infect	infect	PROPN
ijpds-3865	287	3	dev	dev	PROPN
ijpds-3865	287	4	ctries	ctrie	NOUN
ijpds-3865	287	5	.	.	PUNCT
ijpds-3865	288	1	2010;4(10),679	2010;4(10),679	NUM
ijpds-3865	288	2	-	-	SYM
ijpds-3865	288	3	681	681	NUM
ijpds-3865	288	4	.	.	PUNCT
ijpds-3865	289	1	35	35	NUM
ijpds-3865	289	2	.	.	PUNCT
ijpds-3865	290	1	marchandin	marchandin	VERB
ijpds-3865	290	2	h	h	NOUN
ijpds-3865	290	3	,	,	PUNCT
ijpds-3865	290	4	godreuil	godreuil	PROPN
ijpds-3865	290	5	s	s	PROPN
ijpds-3865	290	6	,	,	PUNCT
ijpds-3865	290	7	darbas	darbas	PROPN
ijpds-3865	290	8	h	h	PROPN
ijpds-3865	290	9	,	,	PUNCT
ijpds-3865	290	10	et	et	PROPN
ijpds-3865	290	11	al	al	PROPN
ijpds-3865	290	12	.	.	PROPN
ijpds-3865	290	13	extended	extend	VERB
ijpds-3865	290	14	-	-	PUNCT
ijpds-3865	290	15	spectrum	spectrum	NOUN
ijpds-3865	290	16	βlactamase	βlactamase	NOUN
ijpds-3865	290	17	tem-24	tem-24	ADP
ijpds-3865	290	18	in	in	ADP
ijpds-3865	290	19	an	an	DET
ijpds-3865	290	20	aeromonas	aeromonas	PROPN
ijpds-3865	290	21	clinical	clinical	ADJ
ijpds-3865	290	22	strain	strain	NOUN
ijpds-3865	290	23	:	:	PUNCT
ijpds-3865	290	24	acquisition	acquisition	NOUN
ijpds-3865	290	25	from	from	ADP
ijpds-3865	290	26	the	the	DET
ijpds-3865	290	27	prevalent	prevalent	ADJ
ijpds-3865	290	28	enterobacter	enterobacter	NOUN
ijpds-3865	290	29	aerogenes	aerogene	NOUN
ijpds-3865	290	30	clone	clone	NOUN
ijpds-3865	290	31	in	in	ADP
ijpds-3865	290	32	france.antimicrobial	france.antimicrobial	ADJ
ijpds-3865	290	33	agents	agent	NOUN
ijpds-3865	290	34	and	and	CCONJ
ijpds-3865	290	35	chemotherapy	chemotherapy	NOUN
ijpds-3865	290	36	.	.	PUNCT
ijpds-3865	291	1	2003	2003	NUM
ijpds-3865	291	2	,	,	PUNCT
ijpds-3865	291	3	14;39943999	14;39943999	NUM
ijpds-3865	291	4	.	.	PUNCT
ijpds-3865	292	1	36	36	NUM
ijpds-3865	292	2	.	.	PUNCT
ijpds-3865	293	1	wu	wu	PROPN
ijpds-3865	293	2	cj	cj	PROPN
ijpds-3865	293	3	,	,	PUNCT
ijpds-3865	293	4	chuang	chuang	PROPN
ijpds-3865	293	5	yc	yc	PROPN
ijpds-3865	293	6	,	,	PUNCT
ijpds-3865	293	7	lee	lee	PROPN
ijpds-3865	293	8	mf	mf	PROPN
ijpds-3865	293	9	,	,	PUNCT
ijpds-3865	293	10	et	et	PROPN
ijpds-3865	293	11	al	al	PROPN
ijpds-3865	293	12	.	.	PUNCT
ijpds-3865	293	13	bacteremia	bacteremia	NOUN
ijpds-3865	293	14	due	due	ADP
ijpds-3865	293	15	to	to	ADP
ijpds-3865	293	16	extendedspectrum	extendedspectrum	VERB
ijpds-3865	293	17	-	-	PUNCT
ijpds-3865	293	18	β	β	NOUN
ijpds-3865	293	19	-	-	PUNCT
ijpds-3865	293	20	lactamase	lactamase	NOUN
ijpds-3865	293	21	-	-	PUNCT
ijpds-3865	293	22	producing	produce	VERB
ijpds-3865	293	23	aeromonas	aeromonas	PROPN
ijpds-3865	293	24	spp	spp	NOUN
ijpds-3865	293	25	.	.	PUNCT
ijpds-3865	294	1	at	at	ADP
ijpds-3865	294	2	a	a	DET
ijpds-3865	294	3	medical	medical	ADJ
ijpds-3865	294	4	center	center	NOUN
ijpds-3865	294	5	in	in	ADP
ijpds-3865	294	6	southern	southern	ADJ
ijpds-3865	294	7	taiwan	taiwan	PROPN
ijpds-3865	294	8	.	.	PUNCT
ijpds-3865	295	1	antimicrob	antimicrob	PROPN
ijpds-3865	295	2	agents	agents	PROPN
ijpds-3865	295	3	chemother	chemother	PROPN
ijpds-3865	295	4	.	.	PUNCT
ijpds-3865	296	1	2011;55(12),5813	2011;55(12),5813	NUM
ijpds-3865	296	2	-	-	PUNCT
ijpds-3865	296	3	5818	5818	NUM
ijpds-3865	296	4	.	.	PUNCT
ijpds-3865	297	1	37	37	NUM
ijpds-3865	297	2	.	.	PUNCT
ijpds-3865	298	1	arlet	arlet	VERB
ijpds-3865	298	2	g	g	PROPN
ijpds-3865	298	3	,	,	PUNCT
ijpds-3865	298	4	barrett	barrett	PROPN
ijpds-3865	298	5	tj	tj	PROPN
ijpds-3865	298	6	,	,	PUNCT
ijpds-3865	298	7	butaye	butaye	VERB
ijpds-3865	298	8	p	p	NOUN
ijpds-3865	298	9	,	,	PUNCT
ijpds-3865	298	10	et	et	PROPN
ijpds-3865	298	11	al	al	PROPN
ijpds-3865	298	12	.	.	PROPN
ijpds-3865	298	13	salmonella	salmonella	PROPN
ijpds-3865	298	14	resistant	resistant	ADJ
ijpds-3865	298	15	to	to	ADP
ijpds-3865	298	16	extended	extend	VERB
ijpds-3865	298	17	-	-	PUNCT
ijpds-3865	298	18	spectrum	spectrum	NOUN
ijpds-3865	298	19	cephalosporins	cephalosporin	NOUN
ijpds-3865	298	20	:	:	PUNCT
ijpds-3865	298	21	prevalence	prevalence	NOUN
ijpds-3865	298	22	and	and	CCONJ
ijpds-3865	298	23	epidemiology	epidemiology	NOUN
ijpds-3865	298	24	.	.	PUNCT
ijpds-3865	299	1	microbes	microbe	NOUN
ijpds-3865	299	2	and	and	CCONJ
ijpds-3865	299	3	infection	infection	NOUN
ijpds-3865	299	4	.	.	PUNCT
ijpds-3865	300	1	2006;8(7)1945	2006;8(7)1945	NUM
ijpds-3865	300	2	-	-	SYM
ijpds-3865	300	3	1950	1950	NUM
ijpds-3865	300	4	.	.	PUNCT
ijpds-3865	301	1	38	38	NUM
ijpds-3865	301	2	.	.	PUNCT
ijpds-3865	302	1	su	su	PROPN
ijpds-3865	302	2	lh	lh	PROPN
ijpds-3865	302	3	,	,	PUNCT
ijpds-3865	302	4	chiu	chiu	PROPN
ijpds-3865	302	5	ch	ch	PROPN
ijpds-3865	302	6	,	,	PUNCT
ijpds-3865	302	7	chu	chu	PROPN
ijpds-3865	302	8	c	c	PROPN
ijpds-3865	302	9	,	,	PUNCT
ijpds-3865	302	10	ou	ou	PROPN
ijpds-3865	302	11	jt	jt	PROPN
ijpds-3865	302	12	.	.	PUNCT
ijpds-3865	303	1	antimicrobial	antimicrobial	ADJ
ijpds-3865	303	2	resistance	resistance	NOUN
ijpds-3865	303	3	in	in	ADP
ijpds-3865	303	4	nontyphoid	nontyphoid	ADJ
ijpds-3865	303	5	salmonella	salmonella	NOUN
ijpds-3865	303	6	serotypes	serotype	NOUN
ijpds-3865	303	7	:	:	PUNCT
ijpds-3865	303	8	a	a	DET
ijpds-3865	303	9	global	global	ADJ
ijpds-3865	303	10	challenge	challenge	NOUN
ijpds-3865	303	11	.	.	PUNCT
ijpds-3865	304	1	clinical	clinical	ADJ
ijpds-3865	304	2	infectious	infectious	ADJ
ijpds-3865	304	3	diseases	disease	NOUN
ijpds-3865	304	4	.	.	PUNCT
ijpds-3865	305	1	2004	2004	NUM
ijpds-3865	305	2	,	,	PUNCT
ijpds-3865	305	3	39(4	39(4	NUM
ijpds-3865	305	4	)	)	PUNCT
ijpds-3865	305	5	;	;	PUNCT
ijpds-3865	305	6	546	546	NUM
ijpds-3865	305	7	-	-	SYM
ijpds-3865	305	8	551	551	NUM
ijpds-3865	305	9	.	.	NUM
ijpds-3865	305	10	39	39	NUM
ijpds-3865	305	11	.	.	PUNCT
ijpds-3865	306	1	chiu	chiu	PROPN
ijpds-3865	306	2	ch	ch	PROPN
ijpds-3865	306	3	,	,	PUNCT
ijpds-3865	306	4	su	su	PROPN
ijpds-3865	306	5	lh	lh	PROPN
ijpds-3865	306	6	,	,	PUNCT
ijpds-3865	306	7	chu	chu	PROPN
ijpds-3865	306	8	c	c	PROPN
ijpds-3865	306	9	,	,	PUNCT
ijpds-3865	306	10	et	et	PROPN
ijpds-3865	306	11	al	al	PROPN
ijpds-3865	306	12	.	.	PUNCT
ijpds-3865	306	13	isolation	isolation	NOUN
ijpds-3865	306	14	of	of	ADP
ijpds-3865	306	15	salmonella	salmonella	PROPN
ijpds-3865	306	16	enterica	enterica	PROPN
ijpds-3865	306	17	serotype	serotype	PROPN
ijpds-3865	306	18	choleraesuis	choleraesuis	NOUN
ijpds-3865	306	19	resistant	resistant	ADJ
ijpds-3865	306	20	to	to	ADP
ijpds-3865	306	21	ceftriaxone	ceftriaxone	NOUN
ijpds-3865	306	22	and	and	CCONJ
ijpds-3865	306	23	ciprofloxacin	ciprofloxacin	PROPN
ijpds-3865	306	24	.	.	PUNCT
ijpds-3865	307	1	lancet	lancet	PROPN
ijpds-3865	307	2	.	.	PUNCT
ijpds-3865	308	1	2004;363(9417	2004;363(9417	NUM
ijpds-3865	308	2	)	)	PUNCT
ijpds-3865	308	3	.	.	PUNCT
ijpds-3865	309	1	40	40	NUM
ijpds-3865	309	2	.	.	PUNCT
ijpds-3865	310	1	ye	ye	PRON
ijpds-3865	310	2	j	j	PROPN
ijpds-3865	310	3	,	,	PUNCT
ijpds-3865	310	4	su	su	PROPN
ijpds-3865	310	5	lh	lh	PROPN
ijpds-3865	310	6	,	,	PUNCT
ijpds-3865	310	7	chen	chen	PROPN
ijpds-3865	310	8	cl	cl	PROPN
ijpds-3865	310	9	,	,	PUNCT
ijpds-3865	310	10	et	et	PROPN
ijpds-3865	310	11	al	al	PROPN
ijpds-3865	310	12	.	.	PUNCT
ijpds-3865	310	13	analysis	analysis	NOUN
ijpds-3865	310	14	of	of	ADP
ijpds-3865	310	15	psc138	psc138	PROPN
ijpds-3865	310	16	,	,	PUNCT
ijpds-3865	310	17	the	the	DET
ijpds-3865	310	18	multidrug	multidrug	NOUN
ijpds-3865	310	19	resistance	resistance	NOUN
ijpds-3865	310	20	plasmid	plasmid	NOUN
ijpds-3865	310	21	of	of	ADP
ijpds-3865	310	22	salmonella	salmonella	PROPN
ijpds-3865	310	23	enterica	enterica	PROPN
ijpds-3865	310	24	serotype	serotype	PROPN
ijpds-3865	310	25	choleraesuis	choleraesuis	PROPN
ijpds-3865	310	26	sc	sc	PROPN
ijpds-3865	310	27	-	-	PUNCT
ijpds-3865	310	28	b67	b67	NOUN
ijpds-3865	310	29	.	.	PUNCT
ijpds-3865	311	1	plasmid	plasmid	NOUN
ijpds-3865	311	2	.	.	PUNCT
ijpds-3865	312	1	2011;65(2),132	2011;65(2),132	NUM
ijpds-3865	312	2	-	-	SYM
ijpds-3865	312	3	140	140	NUM
ijpds-3865	312	4	.	.	NOUN
ijpds-3865	313	1	41	41	NUM
ijpds-3865	313	2	.	.	PUNCT
ijpds-3865	314	1	su	su	PROPN
ijpds-3865	315	1	l	l	PROPN
ijpds-3865	315	2	-	-	PROPN
ijpds-3865	315	3	h	h	PROPN
ijpds-3865	315	4	,	,	PUNCT
ijpds-3865	315	5	teng	teng	PROPN
ijpds-3865	315	6	w	w	PROPN
ijpds-3865	315	7	-	-	PUNCT
ijpds-3865	315	8	s	s	PROPN
ijpds-3865	315	9	,	,	PUNCT
ijpds-3865	315	10	chen	chen	PROPN
ijpds-3865	315	11	c	c	PROPN
ijpds-3865	315	12	-	-	PUNCT
ijpds-3865	315	13	l	l	NOUN
ijpds-3865	315	14	,	,	PUNCT
ijpds-3865	315	15	et	et	PROPN
ijpds-3865	315	16	al	al	PROPN
ijpds-3865	315	17	.	.	PUNCT
ijpds-3865	316	1	increasing	increase	VERB
ijpds-3865	316	2	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	316	3	resistance	resistance	NOUN
ijpds-3865	316	4	in	in	ADP
ijpds-3865	316	5	salmonellae	salmonellae	PROPN
ijpds-3865	316	6	,	,	PUNCT
ijpds-3865	316	7	taiwan	taiwan	PROPN
ijpds-3865	316	8	.	.	PUNCT
ijpds-3865	317	1	emerg	emerg	PROPN
ijpds-3865	317	2	infect	infect	PROPN
ijpds-3865	317	3	dis	dis	PROPN
ijpds-3865	317	4	.	.	PUNCT
ijpds-3865	318	1	2011;17(6),1086	2011;17(6),1086	NUM
ijpds-3865	318	2	-	-	SYM
ijpds-3865	318	3	1090	1090	NUM
ijpds-3865	318	4	.	.	PUNCT
ijpds-3865	319	1	42	42	NUM
ijpds-3865	319	2	.	.	PUNCT
ijpds-3865	320	1	hunsperger	hunsperger	PROPN
ijpds-3865	320	2	e	e	PROPN
ijpds-3865	320	3	,	,	PUNCT
ijpds-3865	320	4	juma	juma	PROPN
ijpds-3865	320	5	b	b	PROPN
ijpds-3865	320	6	,	,	PUNCT
ijpds-3865	320	7	onyango	onyango	NOUN
ijpds-3865	320	8	c	c	NOUN
ijpds-3865	320	9	,	,	PUNCT
ijpds-3865	320	10	et	et	PROPN
ijpds-3865	320	11	al	al	PROPN
ijpds-3865	320	12	.	.	PUNCT
ijpds-3865	321	1	building	build	VERB
ijpds-3865	321	2	laboratory	laboratory	NOUN
ijpds-3865	321	3	capacity	capacity	NOUN
ijpds-3865	321	4	to	to	PART
ijpds-3865	321	5	detect	detect	VERB
ijpds-3865	321	6	and	and	CCONJ
ijpds-3865	321	7	characterize	characterize	VERB
ijpds-3865	321	8	pathogens	pathogen	NOUN
ijpds-3865	321	9	of	of	ADP
ijpds-3865	321	10	public	public	ADJ
ijpds-3865	321	11	and	and	CCONJ
ijpds-3865	321	12	global	global	ADJ
ijpds-3865	321	13	health	health	NOUN
ijpds-3865	321	14	security	security	NOUN
ijpds-3865	321	15	concern	concern	NOUN
ijpds-3865	321	16	in	in	ADP
ijpds-3865	321	17	kenya	kenya	PROPN
ijpds-3865	321	18	.	.	PUNCT
ijpds-3865	322	1	bmc	bmc	ADJ
ijpds-3865	322	2	public	public	ADJ
ijpds-3865	322	3	health	health	NOUN
ijpds-3865	322	4	.	.	PUNCT
ijpds-3865	323	1	2019;19	2019;19	NUM
ijpds-3865	323	2	.	.	PUNCT
ijpds-3865	324	1	43	43	NUM
ijpds-3865	324	2	.	.	PUNCT
ijpds-3865	325	1	ho	ho	PROPN
ijpds-3865	325	2	pl	pl	PROPN
ijpds-3865	325	3	,	,	PUNCT
ijpds-3865	325	4	lo	lo	PROPN
ijpds-3865	325	5	wu	wu	PROPN
ijpds-3865	325	6	,	,	PUNCT
ijpds-3865	325	7	yeung	yeung	PROPN
ijpds-3865	325	8	mk	mk	PROPN
ijpds-3865	325	9	,	,	PUNCT
ijpds-3865	325	10	et	et	PROPN
ijpds-3865	325	11	al	al	PROPN
ijpds-3865	325	12	.	.	PUNCT
ijpds-3865	326	1	dissemination	dissemination	NOUN
ijpds-3865	326	2	of	of	ADP
ijpds-3865	326	3	phk01	phk01	PROPN
ijpds-3865	326	4	-	-	PUNCT
ijpds-3865	326	5	like	like	ADJ
ijpds-3865	326	6	incompatibility	incompatibility	NOUN
ijpds-3865	326	7	group	group	NOUN
ijpds-3865	326	8	incfii	incfii	ADJ
ijpds-3865	326	9	plasmids	plasmid	NOUN
ijpds-3865	326	10	encoding	encode	VERB
ijpds-3865	326	11	ctx	ctx	NOUN
ijpds-3865	326	12	-	-	NOUN
ijpds-3865	326	13	m-14	m-14	PROPN
ijpds-3865	326	14	in	in	ADP
ijpds-3865	326	15	escherichia	escherichia	NOUN
ijpds-3865	326	16	coli	coli	NOUN
ijpds-3865	326	17	from	from	ADP
ijpds-3865	326	18	human	human	ADJ
ijpds-3865	326	19	and	and	CCONJ
ijpds-3865	326	20	animal	animal	NOUN
ijpds-3865	326	21	sources	source	NOUN
ijpds-3865	326	22	.	.	PUNCT
ijpds-3865	327	1	vet	vet	NOUN
ijpds-3865	327	2	microbiol	microbiol	PROPN
ijpds-3865	327	3	.	.	PUNCT
ijpds-3865	328	1	2012;158(1–2	2012;158(1–2	NUM
ijpds-3865	328	2	)	)	PUNCT
ijpds-3865	328	3	.	.	PUNCT
ijpds-3865	329	1	44	44	NUM
ijpds-3865	329	2	.	.	PUNCT
ijpds-3865	330	1	luk	luk	PROPN
ijpds-3865	330	2	-	-	PUNCT
ijpds-3865	330	3	in	in	NOUN
ijpds-3865	330	4	s	s	PROPN
ijpds-3865	330	5	,	,	PUNCT
ijpds-3865	330	6	chatsuwan	chatsuwan	NOUN
ijpds-3865	330	7	t	t	PROPN
ijpds-3865	330	8	,	,	PUNCT
ijpds-3865	330	9	pulsrikarn	pulsrikarn	ADV
ijpds-3865	330	10	c	c	NOUN
ijpds-3865	330	11	,	,	PUNCT
ijpds-3865	330	12	et	et	PROPN
ijpds-3865	330	13	al	al	PROPN
ijpds-3865	330	14	..	..	PROPN
ijpds-3865	330	15	high	high	ADJ
ijpds-3865	330	16	prevalence	prevalence	NOUN
ijpds-3865	330	17	of	of	ADP
ijpds-3865	330	18	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	330	19	resistance	resistance	NOUN
ijpds-3865	330	20	among	among	ADP
ijpds-3865	330	21	invasive	invasive	ADJ
ijpds-3865	330	22	salmonella	salmonella	NOUN
ijpds-3865	330	23	enterica	enterica	PROPN
ijpds-3865	330	24	serotype	serotype	PROPN
ijpds-3865	330	25	choleraesuis	choleraesuis	PROPN
ijpds-3865	330	26	isolates	isolate	NOUN
ijpds-3865	330	27	in	in	ADP
ijpds-3865	330	28	thailand	thailand	PROPN
ijpds-3865	330	29	:	:	PUNCT
ijpds-3865	330	30	the	the	DET
ijpds-3865	330	31	emergence	emergence	NOUN
ijpds-3865	330	32	and	and	CCONJ
ijpds-3865	330	33	increase	increase	NOUN
ijpds-3865	330	34	of	of	ADP
ijpds-3865	330	35	ctx	ctx	NOUN
ijpds-3865	330	36	-	-	PUNCT
ijpds-3865	330	37	m-55	m-55	VERB
ijpds-3865	330	38	in	in	ADP
ijpds-3865	330	39	ciprofloxacin	ciprofloxacin	NOUN
ijpds-3865	330	40	-	-	PUNCT
ijpds-3865	330	41	resistant	resistant	ADJ
ijpds-3865	330	42	s.	s.	PROPN
ijpds-3865	330	43	choleraesuis	choleraesuis	PROPN
ijpds-3865	330	44	isolates	isolate	NOUN
ijpds-3865	330	45	.	.	PUNCT
ijpds-3865	331	1	int	int	PROPN
ijpds-3865	331	2	j	j	PROPN
ijpds-3865	331	3	med	med	PROPN
ijpds-3865	331	4	microbiol	microbiol	PROPN
ijpds-3865	331	5	.	.	PUNCT
ijpds-3865	332	1	2018;308(4),447	2018;308(4),447	NUM
ijpds-3865	332	2	-	-	SYM
ijpds-3865	332	3	453	453	NUM
ijpds-3865	332	4	.	.	X
ijpds-3865	332	5	45	45	NUM
ijpds-3865	332	6	.	.	PUNCT
ijpds-3865	332	7	li	li	PROPN
ijpds-3865	332	8	wc	wc	PROPN
ijpds-3865	332	9	,	,	PUNCT
ijpds-3865	332	10	huang	huang	PROPN
ijpds-3865	332	11	fy	fy	PROPN
ijpds-3865	332	12	,	,	PUNCT
ijpds-3865	332	13	liu	liu	PROPN
ijpds-3865	332	14	cp	cp	PROPN
ijpds-3865	332	15	,	,	PUNCT
ijpds-3865	332	16	et	et	PROPN
ijpds-3865	332	17	al	al	PROPN
ijpds-3865	332	18	.	.	PUNCT
ijpds-3865	333	1	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	333	2	resistance	resistance	NOUN
ijpds-3865	333	3	of	of	ADP
ijpds-3865	333	4	nontyphoidal	nontyphoidal	ADJ
ijpds-3865	333	5	salmonella	salmonella	PROPN
ijpds-3865	333	6	enterica	enterica	PROPN
ijpds-3865	333	7	iolates	iolate	VERB
ijpds-3865	333	8	in	in	ADP
ijpds-3865	333	9	northern	northern	ADJ
ijpds-3865	333	10	taiwan	taiwan	PROPN
ijpds-3865	333	11	attributable	attributable	ADJ
ijpds-3865	333	12	to	to	ADP
ijpds-3865	333	13	production	production	NOUN
ijpds-3865	333	14	of	of	ADP
ijpds-3865	333	15	ctx	ctx	NOUN
ijpds-3865	333	16	-	-	NOUN
ijpds-3865	333	17	m-14	m-14	PROPN
ijpds-3865	333	18	and	and	CCONJ
ijpds-3865	333	19	cmy-2	cmy-2	ADP
ijpds-3865	333	20	β	β	NOUN
ijpds-3865	333	21	-	-	NOUN
ijpds-3865	333	22	lactamases	lactamase	NOUN
ijpds-3865	333	23	.	.	PUNCT
ijpds-3865	334	1	j	j	PROPN
ijpds-3865	334	2	clin	clin	PROPN
ijpds-3865	334	3	microbiol	microbiol	PROPN
ijpds-3865	334	4	.	.	PUNCT
ijpds-3865	335	1	2005;43(7),3237	2005;43(7),3237	NUM
ijpds-3865	335	2	-	-	SYM
ijpds-3865	335	3	3243	3243	NUM
ijpds-3865	335	4	.	.	PUNCT
ijpds-3865	336	1	46	46	NUM
ijpds-3865	336	2	.	.	PUNCT
ijpds-3865	337	1	müderris	müderris	PROPN
ijpds-3865	337	2	t	t	PROPN
ijpds-3865	337	3	,	,	PUNCT
ijpds-3865	337	4	ürkmez	ürkmez	PROPN
ijpds-3865	337	5	fy	fy	PROPN
ijpds-3865	337	6	,	,	PUNCT
ijpds-3865	337	7	küçüker	küçüker	PROPN
ijpds-3865	337	8	sa	sa	PROPN
ijpds-3865	337	9	,	,	PUNCT
ijpds-3865	337	10	et	et	PROPN
ijpds-3865	337	11	al	al	PROPN
ijpds-3865	337	12	.	.	PROPN
ijpds-3865	338	1	siprofloksasine	siprofloksasine	PROPN
ijpds-3865	338	2	dirençli	dirençli	PROPN
ijpds-3865	338	3	salmonella	salmonella	PROPN
ijpds-3865	338	4	serotip	serotip	VERB
ijpds-3865	338	5	kentucky	kentucky	PROPN
ijpds-3865	338	6	bakteriyemisi	bakteriyemisi	PROPN
ijpds-3865	338	7	:	:	PUNCT
ijpds-3865	338	8	olgu	olgu	ADJ
ijpds-3865	338	9	sunumu	sunumu	NOUN
ijpds-3865	338	10	ve	ve	VERB
ijpds-3865	338	11	literatürün	literatürün	ADJ
ijpds-3865	338	12	gözden	gözden	ADJ
ijpds-3865	338	13	geçirilmesi	geçirilmesi	NOUN
ijpds-3865	338	14	.	.	PUNCT
ijpds-3865	339	1	mikrobiyol	mikrobiyol	PROPN
ijpds-3865	339	2	bul	bul	PROPN
ijpds-3865	339	3	.	.	PUNCT
ijpds-3865	340	1	2016;50(4),598	2016;50(4),598	NUM
ijpds-3865	340	2	-	-	SYM
ijpds-3865	340	3	605	605	NUM
ijpds-3865	340	4	.	.	PUNCT
ijpds-3865	341	1	47	47	NUM
ijpds-3865	341	2	.	.	PUNCT
ijpds-3865	342	1	zalewska	zalewska	VERB
ijpds-3865	342	2	-	-	PUNCT
ijpds-3865	342	3	piątek	piątek	PROPN
ijpds-3865	342	4	b	b	PROPN
ijpds-3865	342	5	,	,	PUNCT
ijpds-3865	342	6	piątek	piątek	PROPN
ijpds-3865	342	7	r.	r.	PROPN
ijpds-3865	342	8	bacteriophages	bacteriophage	NOUN
ijpds-3865	342	9	as	as	ADP
ijpds-3865	342	10	potential	potential	ADJ
ijpds-3865	342	11	tools	tool	NOUN
ijpds-3865	342	12	for	for	ADP
ijpds-3865	342	13	use	use	NOUN
ijpds-3865	342	14	in	in	ADP
ijpds-3865	342	15	antimicrobial	antimicrobial	ADJ
ijpds-3865	342	16	therapy	therapy	NOUN
ijpds-3865	342	17	and	and	CCONJ
ijpds-3865	342	18	vaccine	vaccine	NOUN
ijpds-3865	342	19	development	development	NOUN
ijpds-3865	342	20	.	.	PUNCT
ijpds-3865	343	1	pharmaceuticals	pharmaceutical	NOUN
ijpds-3865	343	2	.	.	PUNCT
ijpds-3865	344	1	2021,14(4);331	2021,14(4);331	X
ijpds-3865	344	2	.	.	X
ijpds-3865	345	1	48	48	NUM
ijpds-3865	345	2	.	.	PUNCT
ijpds-3865	346	1	keusch	keusch	PROPN
ijpds-3865	346	2	gt	gt	PROPN
ijpds-3865	346	3	,	,	PUNCT
ijpds-3865	346	4	bennish	bennish	VERB
ijpds-3865	346	5	ml	ml	PROPN
ijpds-3865	346	6	.	.	PUNCT
ijpds-3865	346	7	shigellosis	shigellosis	NOUN
ijpds-3865	346	8	:	:	PUNCT
ijpds-3865	346	9	recent	recent	ADJ
ijpds-3865	346	10	progress	progress	NOUN
ijpds-3865	346	11	,	,	PUNCT
ijpds-3865	346	12	persisting	persist	VERB
ijpds-3865	346	13	problems	problem	NOUN
ijpds-3865	346	14	and	and	CCONJ
ijpds-3865	346	15	research	research	NOUN
ijpds-3865	346	16	issues	issue	NOUN
ijpds-3865	346	17	.	.	PUNCT
ijpds-3865	347	1	pediatr	pediatr	ADJ
ijpds-3865	347	2	infect	infect	VERB
ijpds-3865	347	3	dis	dis	PROPN
ijpds-3865	347	4	j.	j.	PROPN
ijpds-3865	347	5	1989;8(10),713719	1989;8(10),713719	PROPN
ijpds-3865	347	6	.	.	PROPN
ijpds-3865	347	7	49	49	NUM
ijpds-3865	347	8	.	.	PUNCT
ijpds-3865	348	1	fontaine	fontaine	PROPN
ijpds-3865	348	2	o.	o.	PROPN
ijpds-3865	348	3	antibiotics	antibiotic	NOUN
ijpds-3865	348	4	in	in	ADP
ijpds-3865	348	5	the	the	DET
ijpds-3865	348	6	management	management	NOUN
ijpds-3865	348	7	of	of	ADP
ijpds-3865	348	8	shigellosis	shigellosis	NOUN
ijpds-3865	348	9	in	in	ADP
ijpds-3865	348	10	children	child	NOUN
ijpds-3865	348	11	:	:	PUNCT
ijpds-3865	348	12	what	what	DET
ijpds-3865	348	13	role	role	NOUN
ijpds-3865	348	14	for	for	ADP
ijpds-3865	348	15	the	the	DET
ijpds-3865	348	16	quinolones	quinolone	NOUN
ijpds-3865	348	17	?	?	PUNCT
ijpds-3865	349	1	rev	rev	AUX
ijpds-3865	349	2	infect	infect	PROPN
ijpds-3865	349	3	dis	dis	PROPN
ijpds-3865	349	4	.	.	PUNCT
ijpds-3865	350	1	1989;11	1989;11	NUM
ijpds-3865	350	2	.	.	PUNCT
ijpds-3865	351	1	50	50	NUM
ijpds-3865	351	2	.	.	PUNCT
ijpds-3865	352	1	sack	sack	NOUN
ijpds-3865	352	2	rb	rb	PROPN
ijpds-3865	352	3	,	,	PUNCT
ijpds-3865	352	4	rahman	rahman	PROPN
ijpds-3865	352	5	m	m	PROPN
ijpds-3865	352	6	,	,	PUNCT
ijpds-3865	352	7	yunus	yunus	PROPN
ijpds-3865	352	8	m	m	PROPN
ijpds-3865	352	9	,	,	PUNCT
ijpds-3865	352	10	et	et	PROPN
ijpds-3865	352	11	al	al	PROPN
ijpds-3865	352	12	.	.	PUNCT
ijpds-3865	353	1	antimicrobial	antimicrobial	ADJ
ijpds-3865	353	2	resistance	resistance	NOUN
ijpds-3865	353	3	in	in	ADP
ijpds-3865	353	4	organisms	organism	NOUN
ijpds-3865	353	5	causing	cause	VERB
ijpds-3865	353	6	diarrheal	diarrheal	ADJ
ijpds-3865	353	7	disease	disease	NOUN
ijpds-3865	353	8	.	.	PUNCT
ijpds-3865	354	1	clin	clin	PROPN
ijpds-3865	354	2	infect	infect	PROPN
ijpds-3865	354	3	dis	dis	PROPN
ijpds-3865	354	4	.	.	PUNCT
ijpds-3865	355	1	1997;24(1	1997;24(1	NUM
ijpds-3865	355	2	suppl	suppl	ADJ
ijpds-3865	355	3	.	.	PUNCT
ijpds-3865	355	4	)	)	PUNCT
ijpds-3865	355	5	.	.	PUNCT
ijpds-3865	356	1	51	51	NUM
ijpds-3865	356	2	.	.	PUNCT
ijpds-3865	357	1	bhattacharya	bhattacharya	PROPN
ijpds-3865	357	2	sk	sk	PROPN
ijpds-3865	357	3	,	,	PUNCT
ijpds-3865	357	4	sarkar	sarkar	PROPN
ijpds-3865	357	5	k	k	PROPN
ijpds-3865	357	6	,	,	PUNCT
ijpds-3865	357	7	balakrish	balakrish	PROPN
ijpds-3865	357	8	nair	nair	PROPN
ijpds-3865	357	9	g	g	PROPN
ijpds-3865	357	10	,	,	PUNCT
ijpds-3865	358	1	et	et	PROPN
ijpds-3865	358	2	al	al	PROPN
ijpds-3865	358	3	.	.	PROPN
ijpds-3865	358	4	multidrugmandumpala	multidrugmandumpala	PROPN
ijpds-3865	359	1	a	a	DET
ijpds-3865	359	2	caution	caution	NOUN
ijpds-3865	359	3	for	for	ADP
ijpds-3865	359	4	judicial	judicial	ADJ
ijpds-3865	359	5	antibiotic	antibiotic	ADJ
ijpds-3865	359	6	use	use	NOUN
ijpds-3865	359	7	vol	vol	NOUN
ijpds-3865	359	8	2	2	NUM
ijpds-3865	359	9	|	|	NOUN
ijpds-3865	359	10	issue	issue	NOUN
ijpds-3865	359	11	1	1	NUM
ijpds-3865	359	12	|	|	ADV
ijpds-3865	359	13	jan	jan	PROPN
ijpds-3865	359	14	–	–	PUNCT
ijpds-3865	359	15	mar	mar	PROPN
ijpds-3865	359	16	2023	2023	NUM
ijpds-3865	359	17	indian	indian	PROPN
ijpds-3865	359	18	j	j	PROPN
ijpds-3865	359	19	pharm	pharm	PROPN
ijpds-3865	359	20	drug	drug	PROPN
ijpds-3865	359	21	studies	study	NOUN
ijpds-3865	359	22	|	|	ADV
ijpds-3865	359	23	16	16	NUM
ijpds-3865	359	24	resistant	resistant	ADJ
ijpds-3865	359	25	shigella	shigella	NOUN
ijpds-3865	359	26	dysenteriae	dysenteriae	NOUN
ijpds-3865	359	27	type	type	NOUN
ijpds-3865	359	28	1	1	NUM
ijpds-3865	359	29	in	in	ADP
ijpds-3865	359	30	south	south	PROPN
ijpds-3865	359	31	asia	asia	PROPN
ijpds-3865	359	32	.	.	PUNCT
ijpds-3865	360	1	lancet	lancet	VERB
ijpds-3865	360	2	infectious	infectious	ADJ
ijpds-3865	360	3	diseases	disease	NOUN
ijpds-3865	360	4	.	.	PUNCT
ijpds-3865	361	1	2003,3(12);775	2003,3(12);775	X
ijpds-3865	361	2	.	.	NOUN
ijpds-3865	361	3	52	52	NUM
ijpds-3865	361	4	.	.	PUNCT
ijpds-3865	362	1	ahamed	ahamed	PROPN
ijpds-3865	362	2	j	j	PROPN
ijpds-3865	362	3	,	,	PUNCT
ijpds-3865	362	4	gangopadhyay	gangopadhyay	PROPN
ijpds-3865	362	5	j	j	PROPN
ijpds-3865	362	6	,	,	PUNCT
ijpds-3865	362	7	kundu	kundu	PROPN
ijpds-3865	362	8	m	m	PROPN
ijpds-3865	362	9	,	,	PUNCT
ijpds-3865	362	10	et	et	PROPN
ijpds-3865	362	11	al	al	PROPN
ijpds-3865	362	12	.	.	PROPN
ijpds-3865	362	13	mechanisms	mechanism	NOUN
ijpds-3865	362	14	of	of	ADP
ijpds-3865	362	15	quinolone	quinolone	ADJ
ijpds-3865	362	16	resistance	resistance	NOUN
ijpds-3865	362	17	in	in	ADP
ijpds-3865	362	18	clinical	clinical	ADJ
ijpds-3865	362	19	isolates	isolate	NOUN
ijpds-3865	362	20	of	of	ADP
ijpds-3865	362	21	shigella	shigella	PROPN
ijpds-3865	362	22	dysenteriae	dysenteriae	NOUN
ijpds-3865	362	23	,	,	PUNCT
ijpds-3865	362	24	antimicrobial	antimicrobial	ADJ
ijpds-3865	362	25	agents	agent	NOUN
ijpds-3865	362	26	and	and	CCONJ
ijpds-3865	362	27	chemotherapy	chemotherapy	NOUN
ijpds-3865	362	28	.	.	PUNCT
ijpds-3865	362	29	1999;43(4	1999;43(4	NUM
ijpds-3865	362	30	)	)	PUNCT
ijpds-3865	362	31	.	.	PUNCT
ijpds-3865	363	1	53	53	NUM
ijpds-3865	363	2	.	.	PUNCT
ijpds-3865	364	1	sur	sur	PROPN
ijpds-3865	364	2	d	d	PROPN
ijpds-3865	364	3	,	,	PUNCT
ijpds-3865	364	4	niyogi	niyogi	ADV
ijpds-3865	364	5	sk	sk	VERB
ijpds-3865	364	6	,	,	PUNCT
ijpds-3865	364	7	sur	sur	PROPN
ijpds-3865	364	8	s	s	PROPN
ijpds-3865	364	9	,	,	PUNCT
ijpds-3865	364	10	et	et	PROPN
ijpds-3865	364	11	al	al	PROPN
ijpds-3865	364	12	.	.	PROPN
ijpds-3865	364	13	multidrug	multidrug	NOUN
ijpds-3865	364	14	-	-	PUNCT
ijpds-3865	364	15	resistant	resistant	ADJ
ijpds-3865	364	16	shigella	shigella	NOUN
ijpds-3865	364	17	dysenteriae	dysenteriae	NOUN
ijpds-3865	364	18	type	type	NOUN
ijpds-3865	364	19	1	1	NUM
ijpds-3865	364	20	:	:	PUNCT
ijpds-3865	364	21	forerunners	forerunner	NOUN
ijpds-3865	364	22	of	of	ADP
ijpds-3865	364	23	a	a	DET
ijpds-3865	364	24	new	new	ADJ
ijpds-3865	364	25	epidemic	epidemic	NOUN
ijpds-3865	364	26	strain	strain	NOUN
ijpds-3865	364	27	in	in	ADP
ijpds-3865	364	28	eastern	eastern	PROPN
ijpds-3865	364	29	india	india	PROPN
ijpds-3865	364	30	.	.	PUNCT
ijpds-3865	365	1	emerging	emerge	VERB
ijpds-3865	365	2	infectious	infectious	ADJ
ijpds-3865	365	3	diseases	disease	NOUN
ijpds-3865	365	4	.	.	PUNCT
ijpds-3865	366	1	2003;9(3),404	2003;9(3),404	NUM
ijpds-3865	366	2	-	-	SYM
ijpds-3865	366	3	405	405	NUM
ijpds-3865	366	4	.	.	PUNCT
ijpds-3865	367	1	54	54	NUM
ijpds-3865	367	2	.	.	PUNCT
ijpds-3865	367	3	talukder	talukder	PROPN
ijpds-3865	367	4	ka	ka	PROPN
ijpds-3865	367	5	,	,	PUNCT
ijpds-3865	367	6	khajanchi	khajanchi	PROPN
ijpds-3865	367	7	bk	bk	PROPN
ijpds-3865	367	8	,	,	PUNCT
ijpds-3865	367	9	islam	islam	PROPN
ijpds-3865	367	10	ma	ma	PROPN
ijpds-3865	367	11	,	,	PUNCT
ijpds-3865	367	12	et	et	PROPN
ijpds-3865	367	13	al	al	PROPN
ijpds-3865	367	14	.	.	PUNCT
ijpds-3865	368	1	genetic	genetic	ADJ
ijpds-3865	368	2	relatedness	relatedness	NOUN
ijpds-3865	368	3	of	of	ADP
ijpds-3865	368	4	ciprofloxacin	ciprofloxacin	NOUN
ijpds-3865	368	5	-	-	PUNCT
ijpds-3865	368	6	resistant	resistant	ADJ
ijpds-3865	368	7	shigella	shigella	NOUN
ijpds-3865	368	8	dysenteriae	dysenteriae	NOUN
ijpds-3865	368	9	type	type	NOUN
ijpds-3865	368	10	1	1	NUM
ijpds-3865	368	11	strains	strain	NOUN
ijpds-3865	368	12	isolated	isolate	VERB
ijpds-3865	368	13	in	in	ADP
ijpds-3865	368	14	south	south	PROPN
ijpds-3865	368	15	asia	asia	PROPN
ijpds-3865	368	16	.	.	PUNCT
ijpds-3865	369	1	j	j	PROPN
ijpds-3865	369	2	antimicrob	antimicrob	PROPN
ijpds-3865	369	3	chemother	chemother	PROPN
ijpds-3865	369	4	.	.	PUNCT
ijpds-3865	370	1	2004;54(4),730734	2004;54(4),730734	X
ijpds-3865	370	2	.	.	PUNCT
ijpds-3865	371	1	55	55	NUM
ijpds-3865	371	2	.	.	PUNCT
ijpds-3865	372	1	gu	gu	NOUN
ijpds-3865	372	2	b	b	PROPN
ijpds-3865	372	3	,	,	PUNCT
ijpds-3865	372	4	zhou	zhou	PROPN
ijpds-3865	372	5	m	m	PROPN
ijpds-3865	372	6	,	,	PUNCT
ijpds-3865	372	7	ke	ke	PROPN
ijpds-3865	372	8	x	x	PROPN
ijpds-3865	372	9	,	,	PUNCT
ijpds-3865	372	10	et	et	PROPN
ijpds-3865	372	11	al	al	PROPN
ijpds-3865	372	12	.	.	PROPN
ijpds-3865	372	13	comparison	comparison	NOUN
ijpds-3865	372	14	of	of	ADP
ijpds-3865	372	15	resistance	resistance	NOUN
ijpds-3865	372	16	to	to	ADP
ijpds-3865	372	17	thirdgeneration	thirdgeneration	NOUN
ijpds-3865	372	18	cephalosporins	cephalosporin	NOUN
ijpds-3865	372	19	in	in	ADP
ijpds-3865	372	20	shigella	shigella	PROPN
ijpds-3865	372	21	between	between	ADP
ijpds-3865	372	22	europe	europe	PROPN
ijpds-3865	372	23	-	-	PUNCT
ijpds-3865	372	24	america	america	PROPN
ijpds-3865	372	25	and	and	CCONJ
ijpds-3865	372	26	asia	asia	PROPN
ijpds-3865	372	27	-	-	PUNCT
ijpds-3865	372	28	africa	africa	PROPN
ijpds-3865	372	29	from	from	ADP
ijpds-3865	372	30	1998	1998	NUM
ijpds-3865	372	31	to	to	ADP
ijpds-3865	372	32	2012	2012	NUM
ijpds-3865	372	33	.	.	PUNCT
ijpds-3865	373	1	epidemiology	epidemiology	NOUN
ijpds-3865	373	2	and	and	CCONJ
ijpds-3865	373	3	infection	infection	NOUN
ijpds-3865	373	4	.	.	PUNCT
ijpds-3865	374	1	2015;143(18),2687	2015;143(18),2687	NUM
ijpds-3865	374	2	-	-	SYM
ijpds-3865	374	3	2699	2699	NUM
ijpds-3865	374	4	.	.	PUNCT
ijpds-3865	375	1	56	56	NUM
ijpds-3865	375	2	.	.	PUNCT
ijpds-3865	376	1	zhang	zhang	PROPN
ijpds-3865	376	2	c	c	PROPN
ijpds-3865	376	3	ling	ling	PROPN
ijpds-3865	376	4	,	,	PUNCT
ijpds-3865	376	5	shen	shen	NOUN
ijpds-3865	376	6	l	l	PROPN
ijpds-3865	376	7	meng	meng	PROPN
ijpds-3865	376	8	,	,	PUNCT
ijpds-3865	376	9	chu	chu	PROPN
ijpds-3865	376	10	x	x	PROPN
ijpds-3865	376	11	,	,	PUNCT
ijpds-3865	376	12	et	et	PROPN
ijpds-3865	376	13	al	al	PROPN
ijpds-3865	376	14	.	.	PUNCT
ijpds-3865	377	1	[	[	X
ijpds-3865	377	2	drug	drug	NOUN
ijpds-3865	377	3	resistance	resistance	NOUN
ijpds-3865	377	4	and	and	CCONJ
ijpds-3865	377	5	molecular	molecular	ADJ
ijpds-3865	377	6	epidemiology	epidemiology	NOUN
ijpds-3865	377	7	of	of	ADP
ijpds-3865	377	8	shigella	shigella	PROPN
ijpds-3865	377	9	isolated	isolate	VERB
ijpds-3865	377	10	from	from	ADP
ijpds-3865	377	11	children	child	NOUN
ijpds-3865	377	12	with	with	ADP
ijpds-3865	377	13	diarrhea	diarrhea	NOUN
ijpds-3865	377	14	]	]	PUNCT
ijpds-3865	377	15	.	.	PUNCT
ijpds-3865	378	1	zhonghua	zhonghua	PROPN
ijpds-3865	378	2	er	er	INTJ
ijpds-3865	378	3	ke	ke	PROPN
ijpds-3865	378	4	za	za	PROPN
ijpds-3865	378	5	zhi	zhi	PROPN
ijpds-3865	378	6	.	.	PUNCT
ijpds-3865	379	1	2012;50(10	2012;50(10	NUM
ijpds-3865	379	2	)	)	PUNCT
ijpds-3865	379	3	.	.	PUNCT
ijpds-3865	380	1	57	57	NUM
ijpds-3865	380	2	.	.	PUNCT
ijpds-3865	380	3	bonkoungou	bonkoungou	PROPN
ijpds-3865	380	4	ijo	ijo	PROPN
ijpds-3865	380	5	,	,	PUNCT
ijpds-3865	380	6	haukka	haukka	ADJ
ijpds-3865	380	7	k	k	NOUN
ijpds-3865	380	8	,	,	PUNCT
ijpds-3865	380	9	österblad	österblad	ADJ
ijpds-3865	380	10	m	m	PROPN
ijpds-3865	380	11	,	,	PUNCT
ijpds-3865	380	12	et	et	PROPN
ijpds-3865	380	13	al	al	PROPN
ijpds-3865	380	14	.	.	PROPN
ijpds-3865	381	1	bacterial	bacterial	ADJ
ijpds-3865	381	2	and	and	CCONJ
ijpds-3865	381	3	viral	viral	ADJ
ijpds-3865	381	4	etiology	etiology	NOUN
ijpds-3865	381	5	of	of	ADP
ijpds-3865	381	6	childhood	childhood	NOUN
ijpds-3865	381	7	diarrhea	diarrhea	NOUN
ijpds-3865	381	8	in	in	ADP
ijpds-3865	381	9	ouagadougou	ouagadougou	PROPN
ijpds-3865	381	10	,	,	PUNCT
ijpds-3865	381	11	burkina	burkina	PROPN
ijpds-3865	381	12	faso	faso	PROPN
ijpds-3865	381	13	.	.	PUNCT
ijpds-3865	382	1	bmc	bmc	PROPN
ijpds-3865	382	2	pediatr	pediatr	PROPN
ijpds-3865	382	3	.	.	PUNCT
ijpds-3865	382	4	2013;13(1),36	2013;13(1),36	NOUN
ijpds-3865	382	5	.	.	PUNCT
ijpds-3865	383	1	58	58	NUM
ijpds-3865	383	2	.	.	PUNCT
ijpds-3865	384	1	yang	yang	PROPN
ijpds-3865	384	2	h	h	PROPN
ijpds-3865	384	3	,	,	PUNCT
ijpds-3865	384	4	chen	chen	PROPN
ijpds-3865	384	5	g	g	PROPN
ijpds-3865	384	6	,	,	PUNCT
ijpds-3865	384	7	zhu	zhu	PROPN
ijpds-3865	384	8	y	y	PROPN
ijpds-3865	384	9	,	,	PUNCT
ijpds-3865	384	10	et	et	PROPN
ijpds-3865	384	11	al	al	PROPN
ijpds-3865	384	12	.	.	PROPN
ijpds-3865	384	13	surveillance	surveillance	NOUN
ijpds-3865	384	14	of	of	ADP
ijpds-3865	384	15	antimicrobial	antimicrobial	ADJ
ijpds-3865	384	16	susceptibility	susceptibility	NOUN
ijpds-3865	384	17	patterns	pattern	NOUN
ijpds-3865	384	18	among	among	ADP
ijpds-3865	384	19	shigella	shigella	PROPN
ijpds-3865	384	20	species	specie	NOUN
ijpds-3865	384	21	isolated	isolate	VERB
ijpds-3865	384	22	in	in	ADP
ijpds-3865	384	23	china	china	PROPN
ijpds-3865	384	24	during	during	ADP
ijpds-3865	384	25	the	the	DET
ijpds-3865	384	26	7	7	NUM
ijpds-3865	384	27	-	-	PUNCT
ijpds-3865	384	28	year	year	NOUN
ijpds-3865	384	29	period	period	NOUN
ijpds-3865	384	30	of	of	ADP
ijpds-3865	384	31	2005	2005	NUM
ijpds-3865	384	32	-	-	SYM
ijpds-3865	384	33	2011	2011	NUM
ijpds-3865	384	34	.	.	PUNCT
ijpds-3865	385	1	ann	ann	PROPN
ijpds-3865	385	2	lab	lab	PROPN
ijpds-3865	385	3	med	med	PROPN
ijpds-3865	385	4	.	.	PUNCT
ijpds-3865	386	1	2013;33(2),111	2013;33(2),111	NUM
ijpds-3865	386	2	-	-	SYM
ijpds-3865	386	3	115	115	NUM
ijpds-3865	386	4	.	.	PUNCT
ijpds-3865	387	1	59	59	NUM
ijpds-3865	387	2	.	.	PUNCT
ijpds-3865	387	3	pechere	pechere	PROPN
ijpds-3865	387	4	jc	jc	PROPN
ijpds-3865	387	5	.	.	PUNCT
ijpds-3865	388	1	why	why	SCONJ
ijpds-3865	388	2	are	be	AUX
ijpds-3865	388	3	carbapenems	carbapenem	NOUN
ijpds-3865	388	4	active	active	ADJ
ijpds-3865	388	5	against	against	ADP
ijpds-3865	388	6	enterobacter	enterobacter	ADJ
ijpds-3865	388	7	cloacae	cloacae	NOUN
ijpds-3865	388	8	resistant	resistant	ADJ
ijpds-3865	388	9	to	to	ADP
ijpds-3865	388	10	third	third	ADJ
ijpds-3865	388	11	generation	generation	NOUN
ijpds-3865	388	12	cephalosporins	cephalosporin	NOUN
ijpds-3865	388	13	?	?	PUNCT
ijpds-3865	389	1	in	in	ADP
ijpds-3865	389	2	:	:	PUNCT
ijpds-3865	389	3	scandinavian	scandinavian	ADJ
ijpds-3865	389	4	journal	journal	NOUN
ijpds-3865	389	5	of	of	ADP
ijpds-3865	389	6	infectious	infectious	ADJ
ijpds-3865	389	7	diseases	disease	NOUN
ijpds-3865	389	8	,	,	PUNCT
ijpds-3865	389	9	supplement	supplement	NOUN
ijpds-3865	389	10	.	.	PUNCT
ijpds-3865	389	11	1991	1991	NUM
ijpds-3865	389	12	.	.	PUNCT
ijpds-3865	390	1	60	60	NUM
ijpds-3865	390	2	.	.	PUNCT
ijpds-3865	391	1	fouhy	fouhy	PROPN
ijpds-3865	391	2	f	f	PROPN
ijpds-3865	391	3	,	,	PUNCT
ijpds-3865	391	4	guinane	guinane	NOUN
ijpds-3865	391	5	cm	cm	PROPN
ijpds-3865	391	6	,	,	PUNCT
ijpds-3865	391	7	hussey	hussey	PROPN
ijpds-3865	391	8	s	s	PROPN
ijpds-3865	391	9	,	,	PUNCT
ijpds-3865	391	10	et	et	PROPN
ijpds-3865	391	11	al	al	PROPN
ijpds-3865	391	12	.	.	PROPN
ijpds-3865	391	13	high	high	ADJ
ijpds-3865	391	14	-	-	PUNCT
ijpds-3865	391	15	throughput	throughput	NOUN
ijpds-3865	391	16	sequencing	sequencing	NOUN
ijpds-3865	391	17	reveals	reveal	VERB
ijpds-3865	391	18	the	the	DET
ijpds-3865	391	19	incomplete	incomplete	ADJ
ijpds-3865	391	20	,	,	PUNCT
ijpds-3865	391	21	short	short	ADJ
ijpds-3865	391	22	-	-	PUNCT
ijpds-3865	391	23	term	term	NOUN
ijpds-3865	391	24	recovery	recovery	NOUN
ijpds-3865	391	25	of	of	ADP
ijpds-3865	391	26	infant	infant	NOUN
ijpds-3865	391	27	gut	gut	NOUN
ijpds-3865	391	28	microbiota	microbiota	NOUN
ijpds-3865	391	29	following	follow	VERB
ijpds-3865	391	30	parenteral	parenteral	ADJ
ijpds-3865	391	31	antibiotic	antibiotic	ADJ
ijpds-3865	391	32	treatment	treatment	NOUN
ijpds-3865	391	33	with	with	ADP
ijpds-3865	391	34	ampicillin	ampicillin	NOUN
ijpds-3865	391	35	and	and	CCONJ
ijpds-3865	391	36	gentamicin	gentamicin	NOUN
ijpds-3865	391	37	.	.	PUNCT
ijpds-3865	392	1	antimicrob	antimicrob	PROPN
ijpds-3865	392	2	agents	agents	PROPN
ijpds-3865	392	3	chemother	chemother	PROPN
ijpds-3865	392	4	.	.	PUNCT
ijpds-3865	393	1	2012;56(11),5811	2012;56(11),5811	X
ijpds-3865	393	2	-	-	PUNCT
ijpds-3865	393	3	5820	5820	NUM
ijpds-3865	393	4	.	.	PUNCT
ijpds-3865	394	1	61	61	NUM
ijpds-3865	394	2	.	.	PUNCT
ijpds-3865	395	1	liu	liu	PROPN
ijpds-3865	395	2	s	s	PROPN
ijpds-3865	395	3	,	,	PUNCT
ijpds-3865	395	4	fang	fang	PROPN
ijpds-3865	395	5	r	r	PROPN
ijpds-3865	395	6	,	,	PUNCT
ijpds-3865	395	7	zhang	zhang	PROPN
ijpds-3865	395	8	y	y	PROPN
ijpds-3865	395	9	,	,	PUNCT
ijpds-3865	395	10	et	et	PROPN
ijpds-3865	395	11	al	al	PROPN
ijpds-3865	395	12	.	.	PUNCT
ijpds-3865	395	13	characterization	characterization	NOUN
ijpds-3865	395	14	of	of	ADP
ijpds-3865	395	15	resistance	resistance	NOUN
ijpds-3865	395	16	mechanisms	mechanism	NOUN
ijpds-3865	395	17	of	of	ADP
ijpds-3865	395	18	enterobacter	enterobacter	ADJ
ijpds-3865	395	19	cloacae	cloacae	NOUN
ijpds-3865	395	20	complex	complex	NOUN
ijpds-3865	395	21	co	co	NOUN
ijpds-3865	395	22	-	-	ADJ
ijpds-3865	395	23	resistant	resistant	ADJ
ijpds-3865	395	24	to	to	ADP
ijpds-3865	395	25	carbapenem	carbapenem	PROPN
ijpds-3865	395	26	and	and	CCONJ
ijpds-3865	395	27	colistin	colistin	PROPN
ijpds-3865	395	28	.	.	PUNCT
ijpds-3865	396	1	bmc	bmc	PROPN
ijpds-3865	396	2	microbiol	microbiol	PROPN
ijpds-3865	396	3	.	.	PUNCT
ijpds-3865	397	1	2021;21(1),208	2021;21(1),208	NUM
ijpds-3865	397	2	.	.	X
ijpds-3865	398	1	62	62	NUM
ijpds-3865	398	2	.	.	PUNCT
ijpds-3865	399	1	kang	kang	PROPN
ijpds-3865	399	2	ci	ci	PROPN
ijpds-3865	399	3	,	,	PUNCT
ijpds-3865	399	4	kim	kim	PROPN
ijpds-3865	399	5	sh	sh	PROPN
ijpds-3865	399	6	,	,	PUNCT
ijpds-3865	399	7	wan	wan	PROPN
ijpds-3865	399	8	bp	bp	PROPN
ijpds-3865	399	9	,	,	PUNCT
ijpds-3865	399	10	et	et	PROPN
ijpds-3865	399	11	al	al	PROPN
ijpds-3865	399	12	.	.	PUNCT
ijpds-3865	399	13	bloodstream	bloodstream	PROPN
ijpds-3865	399	14	infections	infection	NOUN
ijpds-3865	399	15	caused	cause	VERB
ijpds-3865	399	16	by	by	ADP
ijpds-3865	399	17	enterobacter	enterobacter	ADJ
ijpds-3865	399	18	species	specie	NOUN
ijpds-3865	399	19	:	:	PUNCT
ijpds-3865	399	20	predictors	predictor	NOUN
ijpds-3865	399	21	of	of	ADP
ijpds-3865	399	22	30	30	NUM
ijpds-3865	399	23	-	-	PUNCT
ijpds-3865	399	24	day	day	NOUN
ijpds-3865	399	25	mortality	mortality	NOUN
ijpds-3865	399	26	rate	rate	NOUN
ijpds-3865	399	27	and	and	CCONJ
ijpds-3865	399	28	impact	impact	NOUN
ijpds-3865	399	29	of	of	ADP
ijpds-3865	399	30	broad	broad	ADJ
ijpds-3865	399	31	-	-	PUNCT
ijpds-3865	399	32	spectrum	spectrum	NOUN
ijpds-3865	399	33	cephalosporin	cephalosporin	NOUN
ijpds-3865	399	34	resistance	resistance	NOUN
ijpds-3865	399	35	on	on	ADP
ijpds-3865	399	36	outcome	outcome	NOUN
ijpds-3865	399	37	.	.	PUNCT
ijpds-3865	400	1	clin	clin	PROPN
ijpds-3865	400	2	infect	infect	PROPN
ijpds-3865	400	3	dis	dis	PROPN
ijpds-3865	400	4	.	.	PUNCT
ijpds-3865	401	1	2004;39(6),812	2004;39(6),812	NUM
ijpds-3865	401	2	-	-	SYM
ijpds-3865	401	3	820	820	NUM
ijpds-3865	401	4	.	.	PUNCT
ijpds-3865	402	1	how	how	SCONJ
ijpds-3865	402	2	to	to	PART
ijpds-3865	402	3	cite	cite	VERB
ijpds-3865	402	4	this	this	DET
ijpds-3865	402	5	article	article	NOUN
ijpds-3865	402	6	:	:	PUNCT
ijpds-3865	402	7	janice	janice	PROPN
ijpds-3865	402	8	jacson	jacson	PROPN
ijpds-3865	402	9	mandumpala	mandumpala	NOUN
ijpds-3865	402	10	.	.	PUNCT
ijpds-3865	403	1	ceftriaxone	ceftriaxone	PROPN
ijpds-3865	403	2	resistance	resistance	PROPN
ijpds-3865	403	3	–	–	PUNCT
ijpds-3865	403	4	a	a	DET
ijpds-3865	403	5	caution	caution	NOUN
ijpds-3865	403	6	for	for	ADP
ijpds-3865	403	7	judicial	judicial	ADJ
ijpds-3865	403	8	antibiotic	antibiotic	ADJ
ijpds-3865	403	9	use	use	NOUN
ijpds-3865	403	10	.	.	PUNCT
ijpds-3865	404	1	indian	indian	PROPN
ijpds-3865	404	2	j	j	PROPN
ijpds-3865	404	3	pharm	pharm	PROPN
ijpds-3865	404	4	drug	drug	PROPN
ijpds-3865	404	5	studies	study	NOUN
ijpds-3865	404	6	.	.	PUNCT
ijpds-3865	405	1	2023	2023	NUM
ijpds-3865	405	2	:	:	PUNCT
ijpds-3865	406	1	2(1	2(1	NUM
ijpds-3865	406	2	)	)	PUNCT
ijpds-3865	406	3	;	;	PUNCT
ijpds-3865	406	4	11	11	NUM
ijpds-3865	406	5	-	-	SYM
ijpds-3865	406	6	16	16	NUM
ijpds-3865	406	7	.	.	PUNCT
ijpds-3865	407	1	funding	funding	NOUN
ijpds-3865	407	2	:	:	PUNCT
ijpds-3865	407	3	none	none	NOUN
ijpds-3865	407	4	conflict	conflict	NOUN
ijpds-3865	407	5	of	of	ADP
ijpds-3865	407	6	interest	interest	NOUN
ijpds-3865	407	7	:	:	PUNCT
ijpds-3865	407	8	none	none	NOUN
ijpds-3865	407	9	stated	state	VERB